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Globally as well as nationally, AIDS is politically contested. Since AIDS was first identified 
in   1981   there   have   been   several   responses   to   the   pandemic,   reflecting   AIDS’   biomedical,  
political and social nature and implications. Although there are many ways to frame and 
approach AIDS, no single approach appears to be universally superior to any other, especially 
as these various approaches are essential for a comprehensive global response to the 
pandemic. However, these several responses can also represent contested constructs of how 
AIDS is inter-subjectively problematised based on different ontological understandings and 
epistemological preferences. The existence of such contested constructs suggests that 
multilateral AIDS governance is shaped by binaries and zero-sum games where the overall 
approach ought to be holistic. As such, some scholars claim that HIV is increasingly treated 
as something medical, and outside the context of overall development issues, sexual and 
reproductive health, human rights and structural violence. Recently, Vanwesenbeeck (2011) 
offered a simplified model   of   ‘high-road’   and   ‘low-road’   solutions   to   the   pandemic,  
problematising   specifically   the   global   policy/political   response.   Vanwesenbeeck’s   model  
suggests that biomedical, vertically distributed and asexual high-road approaches are 
prioritised at the expense of the more community oriented, sexual and rights-based low-road 
approaches. This, Vanwesenbeeck argues, is because current ideas and norms of the market, 
moralism and medicalisation are more aligned with the de-contextual, de-sexual and 
quantifiable characteristics of high-road approaches. This study tests the analytical utility of 
Vanwesenbeeck’s  model   with   a   case   study   of   the   policy   and   political   narratives   emerging  
from  the  International  AIDS  Society’s  nine  International  AIDS  Conferences  from  1996 until 
2012.   The   research   question   this   study   investigates   is   thus:   Can   Vanwesenbeeck’s   (2011)  
model of high-road and low-road solutions be identified in and illuminate the policy ideas, 
problem definitions and political binaries that play out in the discourse surrounding the 
biennial International AIDS Conferences between 1996 and 2012? This main research 
question is complemented by three sub-questions concerning 1) the strengths and limitations 
of   Vanwesenbeeck’s   model,   2)   the   general   trends   and   developments in global AIDS 
policy/political responses during, before and after the biennial International AIDS 
Conferences and 3) the impact of the Global Financial Crisis on the global AIDS response. 
Applying a qualitative methodology, the study finds that Vanwesenbeeck’s  model  can  both  be  
identified in and elucidate the political discourses, policy implementations and binaries 
surrounding the International AIDS Conferences between 1996 and 2012, albeit not all. The 
analytical   utility   of   Vanwesenbeeck’s   model   is   limited by oversimplification of the high-
road/low-road binary and the exclusion of alternative ideas for high-road prioritisation, such 
as humanitarianism, securitisation/sensationalism and the neoliberal ideological link between 
medicalisation and the market, as well as negligence of the impact of the Global Financial 
Crisis. 




Vigs is internasionaal sowel as nasionaal polities omstrede. Sedert Vigs die eerste keer in 1981 
geïdentifiseer is, was daar al verskeie reaksies op die pandemie wat die biomediese, politieke en 
maatskaplike aard en implikasies van die siekte weerspieël. Hoewel daar verskillende maniere is 
om Vigs te beskou en te benader, blyk geen enkele benadering universeel superieur te wees nie, 
veral aangesien al hierdie verskillende benaderinge   noodsaaklik   is   vir   ’n   omvattende   globale  
reaksie op die pandemie. Tog kan hierdie verskillende reaksies ook as betwiste konstrukte 
beskou word van hoe Vigs intersubjektief op grond van verskillende ontologiese begrippe en 
epistemologiese voorkeure geproblematiseer word. Die bestaan van sulke betwiste konstrukte 
gee te kenne dat multilaterale Vigsbestuur deur binêre en nulsombenaderinge gekenmerk word, 
terwyl die algehele benadering veronderstel is om holisties te wees. Sommige vakkundiges 
beweer dan  ook  dat  MIV  al  hoe  meer  as   ’n  mediese  probleem  hanteer  word,  buite  die  konteks  
van oorkoepelende ontwikkelingskwessies, seksuele en voortplantingsgesondheid, menseregte en 
strukturele   geweld.   Vanwesenbeeck   (2011)   het   onlangs   ’n   vereenvoudigde   model   van  
sogenaamde   ‘grootpad-’   en   ‘smalpadoplossings’   vir   die   pandemie   aan   die   hand   gedoen   wat  
spesifiek die algehele beleids-/politieke reaksie problematiseer. Vanwesenbeeck se model voer 
aan dat biomediese, vertikaal verspreide en aseksuele grootpadbenaderinge dikwels ten koste van 
die meer gemeenskapsgerigte, seksuele en regtegebaseerde smalpadbenaderinge gekies word. 
Dít, reken Vanwesenbeeck, is omdat huidige denke en norme met betrekking tot die mark, 
moraliteit en medikalisasie eerder met die kontekslose, geslaglose en kwantifiseerbare kenmerke 
van grootpadbenaderinge strook. Hierdie studie het die analitiese nut van Vanwesenbeeck se 
model  getoets  met  behulp  van   ’n  gevallestudie  van  die  beleids- en politieke narratiewe uit die 
Internasionale Vigsvereniging se nege internasionale vigskonferensies vanaf 1996 tot 2012. Die 
navorsingsvraag van hierdie studie was dus: Kan Vanwesenbeeck (2011) se model van grootpad- 
en smalpadoplossings geïdentifiseer word in, en lig werp op, die beleidsidees, 
probleemomskrywings en politieke teenpole wat uit die diskoers by die tweejaarlikse 
internasionale vigskonferensies vanaf 1996 tot 2012 gespruit het? Hierdie hoofnavorsingsvraag 
is aangevul deur drie verdere vrae oor (i) die sterkpunte en beperkinge van Vanwesenbeeck se 
model, (ii) die algemene tendense en ontwikkelings in wêreldwye beleids-/politieke reaksies op 
Vigs gedurende, voor en na die tweejaarlikse internasionale Vigskonferensies, en (iii) die impak 
van die wêreldwye finansiële krisis op die wêreldwye Vigsreaksie. Met behulp   van   ’n  
kwalitatiewe metodologie het hierdie studie bevind dat Vanwesenbeeck se model wél 
geïdentifiseer kan word in, en lig werp op, sommige van die politieke diskoerse, 
beleidsinwerkingstelling en teenpole waartoe die internasionale vigskonferensies tussen 1996 en 
2012 gelei het. Die analitiese nut van Vanwesenbeeck se model word egter beperk deur die 
oorvereenvoudiging van die grootpad-/smalpad-teenpole en die uitsluiting van alternatiewe idees 
oor die prioritisering van grootpadoplossings, soos filantropie, sekuritasie/sensasionalisme en die 
neoliberale ideologiese verband tussen medikalisasie en die mark, sowel as die verontagsaming 
van die impak van die wêreldwye finansiële krisis.  
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Chapter 1: Introduction 
1.1 Background and rationale 
The human immunodeficiency virus (HIV) and the Acquired Immune Deficiency Syndrome 
(AIDS) have affected the world beyond imagination the last three decades, and still poses 
“one   of   the   world’s  most   serious   health   challenges”   (UNAIDS,   2012:8).   According   to   the  
newest statistics from the Joint United Nations Programme on HIV/AIDS (UNAIDS), 34 
million people were living with HIV and 1.7 million people died of AIDS in 2011 (UNAIDS, 
2012:14). Mostly attacking human beings at the prime of their lives, AIDS has structural 
implications beyond misery and death. It affects local communities, wipes out entire 
generations, makes children orphans, and puts pressure on economies where a decreasing sick 
workforce is demanding increasing health care. AIDS is human. It is widespread globally, can 
cross borders and affect anyone on its way, yet it is selectively cruel to the resource-weak. 
This makes AIDS an issue of global political and medical – as well as local and regional – 
human rights concerns (Greene et al., 2012:iv, 3; Heywood, 2009:15-16; OHCHR, s.a.).  
AIDS can be dealt with in numerous ways, all of which are essential to fight it. Medically, 
scientists have for decades worked towards finding a cure for AIDS, and have made great 
accomplishments in developing antiretroviral therapy (ART), which has improved quality of 
life for people living with HIV, saved people from dying of AIDS-related diseases and 
prevented mother-to-child transmissions (MTCT) of HIV (WHO et al., 2011:5). Also, doctors 
are approaching HIV and AIDS with their medical expertise by caring for patients and 
distributing medicines. Politically, domestic governments have national plans and strategies, 
while   organisations   like   the   United   States   President’s   Emergency   Plan   for   AIDS   relief  
(PEPFAR) and UNAIDS, are examples of bilateral and multilateral approaches. Efforts have 
been made both to treat those already infected and to prevent the virus to from spreading 
further. The growing awareness and effectiveness in approaching the pandemic have reaped 
results. The number of new infections per annum decreased from 3.2 million in 2001 to 2.5 
million in 2011 (UNAIDS, 2012:14). Access to health facilities and ART, although still 
lacking substantially in crucial regions, has increased (WHO et al., 2011:5).  
This more effective response to HIV and AIDS has taken time; varying responses have also 
been difficult to coordinate as the disease engages many actors and cross over several 
disciplines, although the overall goal – to prevent people from dying of AIDS and acquire 
HIV – remains the same.  




It is possible to identify contested constructs of AIDS as a political problem. These constructs 
include 1) medical and developmental problem definitions, 2) a treatment vs. prevention 
binary, and 3) human rights vs. public health, as well as 4) domestic and multilateral 
approaches.  
Claims have been made that HIV is increasingly treated as something medical, and outside 
the context of overall development issues and sexual and reproductive health (SRH) (Germain 
et al., 2009:840-842; Vanwesenbeeck, 2011:291-292),  although  “[t]he  importance  of  linking  
[SRH] and HIV   is   widely   recognized”   (WHO   et al., 2009:1). Another concern is that the 
increased focus on treatment after the ART breakthrough in 1996 has overshadowed 
prevention efforts (Biehl, 2007:1085; Knight, 2008:172). Some critics have gone so far as to 
claim that   “[f]rom   the   very   beginning   of   the   global   response   to   the   AIDS   pandemic,  
prevention  has  been  marginalised.  Treatment  has  dominated”  (Horton  &  Das,  2008:421).  This  
accusation is not supported by policy documents like the 1998 Geneva Principle, which 
“provided  for  a  balance  between  community  and  science”  (Kallings  &  McClure,  2008:28),  or  
the  view  that  the  2004  International  AIDS  Conference  was  held  in  Bangkok  to  “recognize  the  
effectiveness   of   Thailand’s   prevention   programme”   (Kallings   &   McClure,   2008:38).  
However, others argue that although prevention has been at the core of the agenda, more 
money has initially been distributed to treatment because it does not have to deal with cultural 
and political complexities that a focus on prevention provokes (Knight, 2008:87). The fact 
that Peter Piot, then Under Secretary-General of the United Nations (UN) and Executive 
Director of UNAIDS, emphasised at the   2002   Barcelona   conference   that   “prevention   and  
treatment  should  not  be  seen  as  competing  aims”  (Bliss,  2012:14, see also Knight, 2008:166) 
and that UNAIDS in 2004 issued a similar statement (Knight, 2008:172) indicates both that 
prevention has been on the agenda and that it is in increasing danger of becoming 
marginalised. Recently, significant scientific developments have led to an emphasis on 
‘treatment   as   prevention’   in   an   effort   to   show   the   connection   between   the   two   (Bliss,  
2012:16).       
These constructed problem definitions and concomitant policy responses are a problem 
because the implication is that zero-sum games emerge where one side of a binary is being 
sacrificed for the other side to succeed, ignoring that there are many ways of equal importance 
needed to approach the pandemic. People are still getting infected and dying, which illustrates 
the growing concern  that  “[c]urrent  strategies  for  HIV  prevention,  treatment,  care  and  support  
will not take us to our ultimate  goals”  (UNAIDS,  2010a:3). 




1.2 Problematising contestations 
The construction of political and policy problems as indicated above is a topic in theories of 
public  policy  and  International  Relations  (IR).  Bacchi  (2009)  investigates  how  governments’  
public policies are (unintentionally) shaped by assumptions about what needs to be fixed. 
Policies assume a need for improvement, which indicates that there is something to repair in 
the first place – a  clear  understanding  of  what  the  ‘problem’  is  (Bacchi,  2009;;  Howlett  et al., 
2009:4, 93). The response to this problem is dependent on how it initially is represented and 
problematised – or  “call[ed]  into question”  (Dean,  2010:38).  By  acknowledging  that problems 
are problematised and defined within a context we also acknowledge that there is an idea 
space  limiting  the  scope  of  what  the  problem  ‘is’  and  what  the  ‘solutions’  might  be  (Osborne,  
1997:74). In the process of simplifying problems and solutions to them, ideas about how 
problems   are   understood   are   taken   for   granted   and   “[o]nly   part   of   a   story   is   being   told”  
(Bacchi, 2009:xii; see also Osborne, 1997:75). This questioning of the status quo and what it 
produces is also put forward on the international (and IR theoretical) level, by constructivists. 
Focusing on the relationship between materialism and ideas, constructivists interrogate how 
ideas and norms are affecting and affected by the inter-subjectivity of actors within the global 
structure, shaping interests and global policies. In other words, constructivists argue that 
international responses are not made in a vacuum of complete objectivity, but are moulded by 
ideas  and  ontological  assumptions  of  ‘how  the  world  is’  (Barnett,  2008:162-163; Finnemore 
& Sikkink, 1998:888-892; Hopf, 1998:176, 182; Reus-Smit, 2005:196; Wendt, 1992:398).  
Focusing on multilateral responses towards HIV and AIDS, Vanwesenbeeck (2011) 
constructed a model that interrogates the global problematisation of the pandemic. Making a 
distinction   between   ‘high-road’   and   ‘low-road’   solutions,   she   argues   that biomedical, non-
sexual, clinical and individualised high-road approaches have been prioritised at the expense 
of low-road approaches focused on sexual and reproductive health, sexuality, sexual HIV 
transmission, communities and care. This binary of problem definitions and response 
mechanisms is constructed despite the fact that both are needed in order to address the AIDS 
pandemic comprehensively. Vanwesenbeeck argues that high-road solutions receive more 
ideational and material support than low-road solutions because it is easier and more 
beneficial for donors and policymakers to treat people as patients than to acknowledge the 
sexual and cultural or political contexts of HIV/AIDS. This, she claims, is a response to 
current ideas of moralism, medicalisation and the neoliberal market, shaped by influential 
policymakers   and   donors’   overall   assumptions   about   the   world.   Differently   put,   high-road 
prioritisation is a consequence of how AIDS has been understood and problematised globally.  




Vanwesenbeeck’s  (2011)  model  suggests   that   responses  based  on  moral  norms,  exemplified  
by   PEPFAR’s   initial   emphasis   on   abstinence   from   sex,   have   negatively affected low-road 
solutions’   emphasis   on   sex   and   sexuality.   Moralistic norms also, according to 
Vanwesenbeeck, agree with contemporary ideas of non-sexual scientific fixes and 
medicalisation; approaches that are easier to implement and evaluate than more complicated 
cultural and political ones. Furthermore, ideas of medicalisation suit the pharmaceutical 
industry and the neoliberal market. Thus, Vanwesenbeeck argues, current problem definitions 
of HIV and AIDS brush low-road solutions under the carpet; medical high-road solutions win 
the constructed zero-sum game.  
1.3 A thesis and a test 
This   study   investigates   the  utility  of  Vanwesenbeeck’s   (2011)  model   and  how  policy   ideas,  
problem definitions and constructed binaries play out in multilateral responses to HIV and 
AIDS.   Vanwesenbeeck’s   argument   is   holistic,   yet   not   without   limitations,   as   she   merely  
investigates changes in donor contributions without ever referring to the Global Financial 
Crisis or its effect on decreased HIV funding after 2008 (WHO et al., 2011:8). In this study, 
Vanwesenbeeck’s   model   is   tested   through   an   examination   of   the   International   AIDS  
Conferences arranged between 1996 and 2012.  
Initially co-organised by the US Centers for Disease Control and Prevention (CDC), Emory 
University and the World Health Organisation (WHO) in 1985 as a scientific meeting, the 
International AIDS Conferences have since 1988 been hosted and institutionalised by the 
International  AIDS  Society   (IAS).  The   IAS’ new mission for the conferences was holistic, 
and included socio-cultural as well as medical factors (Bliss, 2012:1, 4; Kallings & McClure, 
2008:15), leading the biennial conferences to become comprehensive meetings that serve as 
important arenas for cross-levelled knowledge exchange, human rights activism, and debates 
within HIV and AIDS. Over the years, the conferences have witnessed frustration, 
accusations, and controversial disagreements, but also more recent scientific, economic, 
political and social developments within HIV (Bliss, 2012; Kallings & McClure, 2008). As 
such, these global AIDS conferences have become a theatre where disputes have raged, 
consensus has been sought and discarded, and policy alternatives debated; they provide a 
vivid forum for the development and contestation of the meta-discursive as well as actual 
political environment that informs AIDS problems and policy thinking at multilateral, 
international and domestic levels.  




The International AIDS Conferences are, of course, only one among many responses to the 
pandemic, and cannot possibly account for all the events, developments, and responses within 
the  field.  However,  they  “are  the  largest  assemblies  of  global  health  professionals  focused  on  
a single disease and among the largest  regular  global  meetings  of  any  kind”  (Bliss,  2012:1).  
Moreover, the effects of the conferences are not limited to the meetings themselves; important 
civil society engagement and policy outcomes are happening outside the venues – during, 
before or after the event itself. Therefore, the International AIDS Conferences serve as a case 
study for the purposes of this research project. The conference dates are used as pinpoints in 
history to try to recognise important developments in multilateral AIDS governance, starting 
with the scientific breakthrough in Vancouver in 1996 – which provided encouraging news in 
the development of ART – up until the latest conference in Washington D.C. in 2012. A brief 
overview of the overall conference trends and events in this period can be viewed in the 
following table. 
Table 1.1: IAS conference trends and key events 
Year Conference trends Outside events High-road Low-road Tendencies 
1996 Vancouver - ART breakthrough 
- Call for resources 
- UNAIDS’  first  meeting  
 
B
uilding of institutions 
1997    
1998 Geneva - The Geneva Principle 
- Treatment vs. prevention 
- Treatment side effects 
- North-South 
  
1999    
2000 Durban - Developing world 
- Access to treatment 
- Call for resources 
- MDG 
- Accelerating Access 
Initiative (AAI) 
- Cheaper drugs 
 
2001  - UNGASS 
- Funding starts to 
increase 
- Doha Declaration - 
TRIPS 
 
2002 Barcelona - Access to treatment 
- WHO  ‘3  by  5’:  3  million  on  
ART by 2005 
- Treatment vs. prevention 
- Increased participation by 
prominent leaders 
- The Global Fund to 
Fight AIDS, Tuberculosis 
and  Malaria’s  (the  Global  




2003  - PEPFAR’s  first  launch  
2004 Bangkok - Women in focus 
- Universal access to 
treatment, care and prevention 
- Call for funding  The 
Global Fund 
- Call for more scientific 
content 
  
2005    
2006 Toronto - Treatment vs. prevention  
treatment as prevention 
(TASP) 
- Prevention technologies 
- Pressure on pharmaceutical 
- UN General Assembly 
Political Declaration on 
HIV/AIDS  access to 
treatment, prevention and 
care for all by 2010 
 





- Call for more scientific 
content 
- Gender sensitive 
2007   
2008 Mexico City - Universal access to 
treatment 
- Discrimination and stigma 
- Global Financial Crisis 
- PEPFAR announce $48 
billion commitment 
 Rem
edicalisation and eventual funding cuts 
2009    
2010 Vienna - The Vienna Declaration  
- TASP 
- Prevention technologies 
- Treatment 2.0  
- Human Rights 
- Funding cuts 
  
2011  - HPTN 052 trial: TASP 
- UN General Assembly 
Political Declaration on 
HIV/AIDS  access to 
treatment, prevention and 




- The Washington D.C. 
Declaration: end AIDS   
- Scientific developments  
TASP  eradiction of AIDS 
- Human rights 
- Call for resources  
  
 
The general tendencies and high-road/low-road trends referred to in this table are only 
suggesting an overall picture, and cannot convey a complex reality. For instance, high-road 
and low-road trends should not be understood as mutually exclusive. The greyed out blocks 
are only indicating which approach that is believed to be most dominant in periods of time. 
An updated version of this preliminary table can be found in Chapter 3. 
As the table shows, despite the scientific ART breakthrough presented at the 1996 
International AIDS Conference in Vancouver, the reality of medical side effects and limited 
access to ART ensured a continued low-road emphasis the following years, especially when it 
came to preventing the sexual transmission of HIV. Community involvement and increased 
attention to the situation in the developing world, which were accentuated at the conferences 
in Geneva and Durban, also underscore this low-road trend. At the same time, calls for more 
resources increasingly became a topic during the International AIDS Conferences in order to 
meet the opportunities and challenges posed by ART. This quest for funding was followed by 
a growing concern that treatment efforts would financially overrule sexual prevention 
approaches (Bliss, 2012:11-13; Knight, 2008:87). During this period prominent institutions 
were established to coordinate the global AIDS response, starting with UNAIDS in 1996; the 
Accelerating Access Initiative (AAI) made sure cheaper international drug prices were 
negotiated, and the Doha Declaration of 2001 increased the access to generic medicines by 




respecting rights to public health over the Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPS). 
During this period of increased funding, access to ART was increasingly on the agenda, 
exemplified  by  the  WHO’s  ‘3  by  5’  initiative  to  get  three  million  people  on  treatment  by  2005  
(Bliss, 2012:13; Knight, 2008:166). The constructed divide between treatment and prevention 
continued to grow, but low-road solutions were still an important part of the agenda. For 
instance, the 2004 International AIDS Conference in Bangkok had a strong focus on 
prevention   of   sexual   transmission   and   women’s   vulnerable   position   in   the   pandemic.  
However, during the Toronto International AIDS Conference in 2006, there were indicators 
that  the  ‘high  road’  biomedical  focus  started  to  surpass  the  low-road agenda, as in addition to 
its emphasis on gender inequalities and violence new discoveries sparked discussions about 
biomedical  prevention  efforts  and  ‘treatment  as  prevention’  (Bliss,  2012:16;;  IAS,  2007:13-14; 
Kallings & McClure, 2008:38). This biomedical high-road trend is increasingly recognisable 
in the years to follow, emphasised by scientific breakthroughs like the HPTN 052 trial, 
confirming that ART can lower sexual transmission rates (IAS, 2012:7; WHO, 2012:6). Low-
road solutions cannot be said to have diminished entirely from the agenda, but it is possible to 
recognise  Vanwesenbeeck’s  model  in  what  seems  to  be  an increasingly medicalised high-road 
focus. Not elaborated upon by Vanwesenbeeck, however, is how access to funds can be a 
forceful factor affecting which ideas and approaches to adhere to. During 2009, and 
progressively more in 2010, HIV funding came to a halt in what is believed to be a reaction to 
The Global Financial Crisis (WHO et al., 2011:8). This global recession, therefore, should be 
taken into account in an analysis of Vanwesenbeeck’s  model.   
1.4 Problem statement 
Globally as well as nationally, HIV/AIDS is politically contested. In addition to the grand 
binary of biomedical vs. behavioural conceptualisations and responses, Political Science and 
its cognate disciplines have offered problem definitions emanating from Policy Studies and 
International Relations. Ostensibly, these conceptualisations frame the epidemiological and 
the programmatic challenges of the global epidemic, as well as appropriate responses to it; 
although there are many ways to frame and approach AIDS, no single approach appears to be 
universally superior to any other. Recently, however, Vanwesenbeeck (2011) offered a 
simplified   model   of   ‘high-road’   and ‘low-road’   solutions   to   the   pandemic, problematising 
specifically  the  global  policy/political  response.  If  Vanwesenbeeck’s  model  can be accurately 
identified and applied in global political responses to the pandemic, it might have analytical 
utility by simplifying the complexity and narrowing the scope of effective and sustainable 




policy responses. This study is elucidating and testing  Vanwesenbeeck’s  model  with  a  case  
study  of   the  policy  and  political  narratives  emerging   from   the   International  AIDS  Society’s  
nine International AIDS Conferences from 1996 until 2012. This analysis is complemented by 
an interview with a key civil society informant (see Neuman, 2011:454) from the Treatment 
Action Campaign who was present at many of the nine conferences.   
1.5 Research question and theoretical framework 
The research question this study investigates is: 
Can  Vanwesenbeeck’s  (2011)  model  of  high-road and low-road solutions be identified in and 
illuminate the policy ideas, problem definitions and political binaries that play out in the 
discourse surrounding the biennial International AIDS Conferences between 1996 and 2012? 
Sub-questions supporting this primary research question include the following: 
 What  are  the  strengths  and  limitations  of  Vanwesenbeeck’s  (2011)  model? 
 What have been the general trends and developments in global AIDS policy/political 
responses as presented by policymakers, donors, civil society and multilateral 
organisations during, before and after the biennial International AIDS Conferences? 
 Has the Global Financial Crisis affected the global AIDS response, and if so, in what 
way(s)?  
The main focus of this study is Vanwesenbeeck’s   (2011)  model  of  high-road and low-road 
responses to the HIV/AIDS pandemic. She argues that non-sexual, biomedical, ART-focused 
and individualised HIV responses – what  she  calls  ‘high-road’  solutions  – are prioritised by 
the global community at the expense   of   ‘low-road’   solutions   that   emphasise   sexual   and  
reproductive health, communities, prevention of sexual transmission, human rights and 
gender, despite the recognition that both approaches are needed to fight the pandemic. The 
Vanwesenbeeck model is theoretically contextualised in public policy problematisations 
(Bacchi, 2009) and   IR   constructivists’   emphasis   on   how   global   policies   are   not   based   on  
objective truths, but shaped by ideas and norms obtained through inter-subjective interactions 
(Barnett, 2008:162-163; Hopf, 1998:176, 182; Reus-Smit, 2005:196). Importantly, this 
theoretical   background   is   only   used   to   illuminate   important   insights   in   Vanwesenbeeck’s  
model, and is not used as prominent analytical tools in and of themselves. The findings are 
supported by a semi-structured interview with a key informant from civil society who 
attended many of these conferences.  
 




1.6 Research design and methods 
This study is descriptive and explanatory (Neuman, 2011:38-40). It is descriptive because it 
seeks to historically outline and describe how global AIDS agendas and policies have 
developed surrounding the International AIDS Conferences between 1996 and 2012. It is 
explanatory  in   the  sense  that   it  aims  to  test   the  utility  of  Vanwesenbeeck’s  (2011)  model  of 
high-road and low-road approaches for explaining this historical development. In so doing, 
the   study  engages   explanatory   research   for   interrogating  “why things   are   the  way   they  are”  
(Neuman, 2011:39, original emphasis).  
The overall method applied in this study is qualitative. It is mainly based on interpretations of 
secondary  sources  accessed  through  Stellenbosch  University’s  library  and  databases,  as  well  
as primary source reports and policy statements from the IAS and its conferences, multilateral 
organisations, governments and the global HIV/AIDS civil society. This information is 
complemented by primary data gathered from a semi-structured interview of a key informant 
who attended many of the International AIDS Conferences between 1996 and 2012. It must 
be   stressed   that   the   interviewee’s   informed   experiences   and   reflections   are   only  
complementary to the overall findings in the earlier stages of the study, and are therefore not 
the principal source of information. The semi-structured interview is chosen in order to allow 
for a free flow of reflections and probing, while not getting off-topic (Flick, 2011:112-113). 
The interviewee is an experienced professional from the Treatment Action Campaign (TAC) 
and the former AIDS Law Project (ALP) in South Africa. The TAC has extensive experience 
with HIV/AIDS policies and mobilisation, and is accessibly situated in Muizenberg outside 
Cape Town. While this study could have benefited from more than one personal interview, 
this ideal is unfortunately unobtainable due to time constraints. 
1.7 Limitations of the study 
This study is affected by the limitations of qualitative methods in general. A qualitative 
approach is essential for this study in order to obtain an in-depth understanding necessary for 
an analysis of the discourse around a complex, multifaceted and sensitive topic. However, 
qualitative data are not as precisely accumulated or measurable as data from the more 
standardised quantitative or mix-method approaches (Neuman, 2011:174). Therefore, the 
overall analysis of agenda-setting in multilateral AIDS governance and the test of 
Vanwesenbeeck’s   (2011)  model   are   affected  by   qualitative   approaches’   supposedly   inferior  
ability  to  generalise  or  strive  for  ‘objective  truths’  compared  to  their  methodological  cousins. 
Then again, the aim of this thesis is to gain insights in global AIDS agendas by analysing 
whether the themes, discourses and policy outcomes around and during the International 




AIDS Conferences indicates a   recognisable   pattern   aligned   with   Vanwesenbeeck’s (2011) 
model, and qualitative research is well suited to such research.  
Hence, as the research question also suggests, this thesis is working with two limitations 
concerning the case study itself and the timeframe of the study. As mentioned earlier, the 
International AIDS Conferences cannot represent the entire idea space of multilateral AIDS 
agendas and responses. They are, however, important meeting places where much of the 
contemporary AIDS agendas are discussed by multiple actors on various levels. The 
timeframe of the study, 1996 to 2012, is evidently also excluding information from before or 
after this time. There are two reasons why this timeframe is chosen. First of all, there have 
been 19 International AIDS Conferences in total, and to focus on all of them would 
compromise the quality of the analysis. Second, the years in focus are important markers for 
recent developments in AIDS responses. The year 1996 provided significant developments 
affecting global AIDS policies and responses, exemplified by the biomedical ART 
breakthrough and the establishment of UNAIDS. Also, Vanwesenbeeck (2011:290) starts her 
analysis around this time, with the acknowledgement of the Cairo Agenda in 1995. The last 
International AIDS Conference was held in Washington D.C. in 2012, which is also why 
2012  is  the  last  year  of  focus  in  this  study.  The  limitations  with  Vanwesenbeeck’s  model  itself  
are further discussed in Chapter 2. 
1.8 Chapter outline 
Chapter 1: Introduction. The aim of this chapter is to introduce the reader to the background 
and main discussions around the topic, to present the problem statement and research 
question, and to demonstrate the theoretical background and model. The research method 
used and the limitations of the study are also elaborated upon. 
Chapter  2:  Theoretical  background  and  Vanwesenbeeck’s  model. This chapter aims to further 
elaborate on the background theories of public policy problematisations and IR 
constructivism   for   illuminating  Vanwesenbeeck’s   (2011)  model.  A  discussion   of   the  model  
itself, including contributions and limitations, represents the main bulk of this chapter.  
Chapter 3: Historical outline, 1996-2012. In this chapter the history of the International AIDS 
Conferences (from 1996 to 2012) and what has been discussed and occurred during, before 
and after these conferences are viewed in detail. The aim of this chapter is to highlight the 
main agendas recognised in this historical outline and to view these from different 
frameworks that illuminate various sides of how multilateral AIDS governance has 
developed.  A  few  references  are  made  already  here  to  Vanwesenbeeck’s  (2011)  model. 




Chapter  4:  Analysis  of  Vanwesenbeeck’s  model. This chapter presents an overall analysis of 
Vanwesenbeeck’s   (2011)   model   and   its   utility   for   explaining   key events and historical 
developments as presented in Chapter 3. This analysis is complemented with inputs and 
quotes from an interview with a key informant from the TAC.  
Chapter 5: Conclusion, and Future Agendas. This concluding chapter provides a summary of 
the  study,   the  main  points   that  can  be  drawn   from   the  analysis  of  Vanwesenbeeck’s   (2011)  
model and specifically answers the research questions. This chapter also suggests focuses for 
future research.  
1.9 Conclusion 
This chapter introduced the background of the research topic, the challenges and questions 
under examination, the methodology that is used to investigate these questions, and the 
limitations of the study. This study investigates agenda-setting within multilateral AIDS 
governance by testing the   utility   of  Vanwesenbeeck’s   (2011)  model   of   high-road and low-
road solutions by using the International AIDS Conferences between 1996 and 2012 as an 
historical case study.  
Vanwesenbeeck argues that biomedical high-road approaches to the pandemic are prioritised 
at the expense of more contextual low-road approaches. The following chapter discusses this 
model after a brief elaboration of the theoretical background used to illuminate 
Vanwesenbeeck’s  points. 
  




Chapter 2: Theoretical background and Vanwesenbeeck’s  model 
2.1 Introduction 
Since AIDS was discovered in the 1980s, there have been several responses to the pandemic 
on various levels. AIDS is of biomedical, political and social concerns. Scientists are 
constantly investigating how the HI-virus works in the human body to improve already 
existing biomedical interventions, or even develop a vaccine or cure. Also, HIV is 
physiologically discriminating certain groups over others, such as women and men who have 
sex with men (MSM), due to the nature of intercourse itself. Still, transmission of the virus is 
not only biological; it is also attached to social, political and cultural contexts. Sexual 
violence, for instance, and a lack of power to negotiate sexual matters are closely linked to the 
spread of the pandemic. It is therefore important that the global response to HIV and AIDS 
remains diverse. As Chapter 1 pointed out, some scholars argue that this is not the case. One 
of them, Vanwesenbeeck (2011), has made a model differentiating between the biomedical 
‘high-road’   and   the   more   sexual   and   community   oriented   ‘low-road’   when   analysing  
multilateral AIDS responses. Her argument is that international policymakers and donors are, 
due to contemporary ideas of the neoliberal market, morals and medicalisation, prioritising 
high-road solutions at the expense of the low-road.   This   study   is   testing  Vanwesenbeeck’s  
model by using the nine International AIDS Conferences between 1996 and 2012 as historical 
markers. The aim of the study is to see if Vanwesenbeeck’s  model  can  be   identified   in  and  
highlight the policies, binaries and ideas in the discourse before, during and after these 
conferences.   The   purpose   of   this   chapter   is   therefore   to   discuss   Vanwesenbeeck’s   model  
itself, as well as its limitations and strengths. Before this is done in the latter part of the 
chapter, the model is first theoretically contextualised within public policy problematisations 
and IR constructivism.  
2.2 Theoretical background 
Although Vanwesenbeeck (2011) does not explicitly state any theoretical preferences, her 
model can be illuminated in the constructivist framework of ideational and structural 
approaches. Expanding in the 1990s primarily as a reaction to exclusively materialist theories 
– specifically the conventional theories of neorealism and neoliberal institutionalism – and 
meta-theoretical critical theory, constructivism presented a challenge to understandings of 
ontology and epistemology. Constructivists reject a purely material ontology by emphasising 
how ideas are enforcing and reinforced by the physical world, thereby arguing that 
understandings   of   ‘how   the  world  works’   are   inter-subjective and not objective. They also 




criticise theories conforming to solely positivist and/or meta-theoretical epistemologies, 
claiming that “research   strategies   should   be   question-driven rather than method-driven”  
(Wendt, 1992:423; see also Reus-Smit, 2005:188, 194-196). Constructivist ideas can be 
recognised  in  Vanwesenbeeck’s  model  due  to  her  theorising  on  how  contemporary  ideas  and  
norms – referred to by her as forces of the market, medicalisation and morality – shape 
multilateral policy outcomes and how epistemological preferences are benefiting the one 
category of AIDS responses over the other. The theoretical background used in this study is 
thus rooted in the post-material ontology and pluralistic epistemology found in constructivist 
IR theory and in some constructivist-inspired public policy analyses (Bacchi, 2009). This 
section starts with the latter: a public health policy view that questions the process of 
policymaking   itself   and   the   identification   of   ‘problems’.   This   can   give   insight   to  
Vanwesenbeeck’s  model  by  illuminating  how  the  understanding  of  AIDS  as  a  policy  problem  
(and thus the response) is affected by subjective ideas and belief systems. Further on, this is 
linked  to  the  international  level  through  an  IR  theoretical  section  on  constructivism’s  view  on  
ontology and epistemology, before the main section focuses on Vanwesenbeeck’s   model  
itself.  
2.2.1 Public policy and problem representations 
Domestically and internationally, there seems to be a constant presence of objective and 
intolerable challenges that need to be dealt with through policies. For instance, most people 
will not argue against the statement that HIV causes such a huge challenge that 
comprehensive  responses  are  required.  Hence  it  makes  sense  that  “[e]arly  works  in  the  policy  
sciences  often  assumed  that  problems  had  an  ‘objective’  existence”  (Howlett  et al., 2009:93) 
and  why  “the  presumption  that  the  purpose  of  policy  is  to  solve  ‘social  problems’  remains  a  
grounding   premise   in   most   conventional   approaches   to   policy   analysis”   (Bacchi,   2009:x,  
emphasis removed). Also logically, in conventional public policy, the success of a policy is 
measured according to how effectively it managed to solve the problem, if it did. 
Conventional public policy, whether viewing policies as direct responses to existing problems 
or as more selective outcomes of negotiations among different interests, can be referred to as 
‘reactive’   or   ‘positivist’   because   they   are   responding   to   ‘objective’   problems   that   are  
‘neutrally’   evaluated   within   the   same   framework   (Howlett   et al., 2009:178-179; Osborne, 
1997:173-174).  
This  process  seems  reasonable,  yet  a  ‘positivist’  view  on  the  role  of  policies  also  “assume[s]  
the   existence   of   a   ‘problem’   that   needs   ‘fixing’”   (Bacchi,   2009:xi).   While   certainly   not  
arguing that responding to challenges is unnecessary, some scholars question the conventional 




view on how policies take shape. They claim that in the conventional approach ‘problems’  are  
viewed as value-free and exogenous, existing in their own right and independent of social 
interactions.   These   scholars’   argument   is   that   what  might   seem   as   clear   understandings   of  
what a problem is and what the adequate solution(s) ought to be, actually are affected by how 
the  ‘problem’  is  represented  in  the  first  place  (Bacchi,  2009:x-xi; Howlett et al., 2009:4). In 
other words, public policies are products of ideas of what needs to be fixed – of what the 
implied   problem   is.   The   identification   of   a   ‘problem’   is   shaped   by taken-for-granted 
assumptions   in   policymakers’   understanding   of   the   world.   This   definition   process   – how 
‘problems’   are   problematised,   or   “thought   about   as   ‘problems’”   (Bacchi,   2009:xi;;   see   also  
Dean, 2010:38) – “is  very  much  a  socially  constructed  process since it involves the creation of 
accepted definitions of normalcy and what constitutes an undesirable deviation from that 
status”  (McRobbie  &  Thornton,  1995,  paraphrased  in  Howlett  et al., 2009:93). According to 
this view, public policies are therefore shaped, albeit not deliberately, by how problems are 
initially   understood,   problematised   and   represented.   Linked   to   Vanwesenbeeck’s   (2011)  
model the argument is not that AIDS is a constructed problem or that some understandings of 
AIDS are superior to others, but that current responses to the pandemic – what 
Vanwesenbeeck claims are primarily so-called   ‘high-road   solutions’   – are shaped within 
someone’s  understanding  of  the  world  and  how  AIDS  works  within  it.   
The notion of problematisation is important, for it recognises the significance of ideas; the 
construction  of  problems  and  policies  are  not  simply  shaped  by  actors’  own  material  interests,  
but created in the ontological idea space   of   how   a   ‘problem’   is   understood.   Moreover,  
problematisation is not something one can merely avoid. To problematise issues is essential in 
order to create any policies at all; without making sense of an issue challenges would stay 
incomprehensibly complex. Simplification as a characteristic of problematisation can 
therefore be understood as a necessary good (Osborne, 1997:74-75). How AIDS is 
problematised  is  also  deciding  which  policies  not  to  pursue.  ‘Bad’  policies  are  discarded.  The  
downside  of  this  simplification,  as  already  implied,  is  that  the  understanding  of  the  ‘problem’  
and what it contains is (inter-)subjective, shaped within present assumptions of what is 
important and what can be excluded. This is again limiting the idea space from which policy 
decisions   are   shaped   and   affecting   what   is   viewed   as   ‘bad’   policies   (Bacchi, 2009:xii; 
Osborne,   1997:75).   Bacchi’s   (2009:x)   argument   is   therefore   that   the   construction   of  
‘problems’  followed  by  their  ‘adequate  solutions’  is  not  exogenous  and  independent  of  ideas  
and  society.  Rather,   ‘problems’  are  unintentionally  moulded  by  given assumptions; they are 
endogenous   and   a   product   of   problematisations.   Therefore,   she   states,   “we   are   governed  




through   problematisations   rather   than   through   policies”   (Bacchi,   2009:xi).   Relating   this   to  
Vanwesenbeeck’s   (2011)   model,   the   argument   is   that   current understandings and 
problematisations of AIDS are excluding low-road solutions from multilateral policy 
responses. 
2.2.2 Constructivism 
Similar to these public policy theorists, IR constructivists are concerned with presuppositions 
and what is taken for granted, although their level of analysis is global. According to 
constructivists, ideas and norms do not exist in a vacuum; they are created and recreated 
through inter-subjective interaction. Emphasising the interrelation between these ideas and the 
materialistic world, contra the exclusively materialistic theories constructivism developed in 
reaction  to,  constructivists  believe  “that  systems  of  shared  ideas,  beliefs  and  values  […]  have  
structural characteristics, and that they exert a powerful influence on social and political 
action”  (Reus-Smit, 2005:196). According to constructivists, as well as policy analysts such 
as Bacchi (2009:5), the base of assumptions from where decisions and policies are made is 
shaped by ontological beliefs. Put differently, inter-subjective ideas and norms affect and are 
affected   by   numerous   physical   ‘realities’,   forming   and/or   legitimising   socially   dependent  
materials.  Constructivists  refer  to  these  phenomena  as  ‘social  facts’.  The  latter  often  have  an  
unquestionable and natural legitimacy, although they are constructed by human interaction. 
They  are  much  more   than  simply  naturally  existing   ‘realities’;;   their  existence   is   ensured  by  
ideas and norms. For instance, constructivists in IR claim that money, sovereignty and 
humanitarian   interventions   are   ‘social   facts’   (Barnett,   2008:165;;   Brown,   2005:49;;   Ruggie,  
1998:856; Wendt, 1992:392). 
‘Social   facts’   also   reinforce   contemporary   norms,   ideas   and   identities.   Due   to   the  
constructivist   belief   that   “[i]dentities   are   the   basis   of   interests”   (Wendt,   1992:398),   an  
interrogation of how these identities are constructed is important to understand international 
responses (Reus-Smit, 2005:197). In doing this, constructivists confront the neorealist and 
neoliberal institutionalist materialistic ontological assumption that fails to acknowledge the 
importance of idea accumulation. Constructivists interrogates the ontology of the status quo 
by  questioning  how  and  why  ‘social  facts’,  often  in  the  form  of  institutions,  came  into  being  
instead of merely accepting their presence and exports as natural and given (Ruggie, 
1998:855,  863).  Hence,  similar  to  Bacchi’s  ‘problems’,  constructivists  claim  that  interests  and  
actions are endogenous – shaped by ideas and norms – not exogenous and self-evident. 
Exogenous materialistic rational choice explanations to global policies are therefore viewed as 
insufficient, as these leave out important parts of the decision making process and how global 




actors – and rationality itself – are affected by ideas and norms that are often taken for granted 
(Finnemore & Sikkink, 1998:888-892; Reus-Smit, 2005:197-199; Ruggie, 1998:864; Wendt, 
1992:392).   Furthermore,   the   constructivist   notion   of   ‘norm   cascades’   can   elucidate   how  
norms are also accepted due to international pressure and the legitimacy of certain norm 
entrepreneurs (Finnemore & Sikkink, 1998). Global policies, therefore, do not exist 
independently of a net of social interaction and ideas; they are socially constructed.  
An example of this point can be illustrated with  Vanwesenbeeck’s  (2011)  model:  a   rational  
choice explanation to the high-road/low-road divide and the claimed prioritisation to high-
road approaches would naturally argue that the support of the high-road is grounded in the 
rationality  of  policymakers’ informed decisions, whatever they are based in. A constructivist 
view,   however,   would   look   at   the   ideas   and   norms   affecting   policymakers’   decisions.  
Vanwesenbeeck’s   argument   that   the   market,   medicalisation   and  morals   are   affecting   high-
road prioritisation suggests that ideas and norms are important in investigating how AIDS is 
understood as a policy problem, and therefore needs to be illuminated by a theory that 
acknowledges the complex relationship between ideas and materialism. Neorealists and 
neoliberal institutionalists’   almost   paranoid  preoccupation  with  power   relations   and   rational  
choice can, ironically, from a constructivist point of view be argued to be naïve for neglecting 
the importance of ideational forces behind global power relations.  
When it comes to epistemology, constructivists are divided. It is not the purpose of this thesis 
to elaborate on this dispute. However, to claim that they are pluralistic would on a general 
level   be   a   fair   understanding   of   constructivists’   relationship   to   epistemology and 
methodology. For the purpose of this study, the most important point to make here is that 
constructivists do not conform to one single approach when doing research. It is also worth 
repeating that constructivism developed in reaction both to the solely positivist causal 
explanatory epistemological approach and to the meta-theoretical   epistemology’s   lack   of  
focus on empirical findings (Reus-Smit, 2005:188, 194-196; Wendt, 1992:423).  
This  applies  to  Vanwesenbeeck’s  (2011)  model  because  high-road and low-road solutions are 
separated in epistemological and methodological concerns. High-road solutions are more 
aligned with a positivist epistemology due to its links to biomedicine and the natural sciences. 
These solutions, including the less clinical parts of the high-road, are also much easier to 
measure through the use of quantitative methods, especially Randomised Controlled Trials 
(RCTs). Low-road solutions are, due to their emphasis on more complex cultural and political 
contexts, more aligned with a post-positivist epistemology that does not believe in causal 




explanations  as  natural   ‘laws’   for  complex  social  phenomena.  To  get   to   the  bottom  of   low-
road approaches more in-depth qualitative research has to be done, which takes time and 
provides results that cannot be generalised to the same extent. Low-road solutions, therefore, 
have   a   very   different   relationship   to   the   notion   of   ‘evidence’,   ‘knowledge’   and   ‘causality’  
than high-road  approaches.  Vanwesenbeeck’s  emphasis  on  how  both  approaches  are  needed 
in the global AIDS response shows an inclination towards a constructivist pluralistic view on 
epistemology. The epistemological concerns mentioned here, linked to what Vanwesenbeeck 
argues   is   an   increased   ‘medicalisation’   in   the   multilateral   AIDS   response, are discussed 
further   in   the   next   section,   which   elaborates   on   Vanwesenbeeck’s   model,   including   its 
strengths and weaknesses. 
2.3 High-road and low-road solutions: a model 
After years of mobilising a global response towards AIDS, the results are promising; there is a 
decline in new HIV infections and ARTs are saving people from dying of AIDS (UNAIDS, 
2012:14; WHO et al., 2011:5). Multilateral and cross-disciplinal efforts are essential in the 
continuation of this trend, as HIV and AIDS are of medical as well as of social and political 
concerns. However, the multifaceted nature of the pandemic also creates challenges of 
contested constructs of the overall AIDS policy problem. As Section 2.2 discussed, the 
understanding of AIDS as a problem is affected by inter-subjective ontological and 
epistemological assumptions rooted in ideas and norms. Inter-subjective problematisations of 
AIDS are thereby affecting what various actors think global policy responses ought to be. 
This is a problem because policies that are supposed to be equal and working towards the 
same goal – saving people from dying of AIDS and prevent further HIV infections – are 
suddenly in danger of working against each other, for instance by competing for funding 
(Germain et al., 2009:840).  
Vanwesenbeeck’s  (2011)  model  of  ‘high-road’  and  ‘low-road’  solutions  interrogates  how  the  
AIDS pandemic has been problematised and responded to globally, arguing that ideas and 
norms   are   affecting   policymakers   and   donors   to   prioritise   ‘easy’   biomedical   high-road 
approaches over more socially complex and sexualised low-road solutions. The theoretical 
background  for  how  Vanwesenbeeck’s  model  is  understood  in  this  study  has  been  illustrated  
in the first part of this chapter, and the remaining part is devoted to the model itself. First, 
high-road and low-road solutions are explained separately, before exploring what 
Vanwesenbeeck believes the underlying ideas and norms are for high-road prioritisation – 
specifically medicalisation, morals and the market. During this latter section strengths and 
limitations  of  Vanwesenbeeck’s  model  are  also  discussed.   




2.3.1 High-road solutions 
Vanwesenbeeck’s   (2011)   cluster   of   high-road solutions incorporate AIDS responses where 
there is an individualised focus on people living with HIV  as  ‘patients’  and  on  finding  a  cure  
and/or vaccine. Thus, high-road approaches are biomedical, non-sexual, clinical and 
medicalised. They are typically understood as medical services provided vertically, or top-
down,   and   “[i]n   the   context   of   the   fight   against AIDS, antiretroviral therapy (ART) is the 
typical high-road   solution”   (Vanwesenbeeck,   2011:289).   The   prevention   technologies  
emerging around the 2006 International AIDS Conference (IAS, 2007:13-14) – biomedical 
and non-sexual prevention efforts exemplified   by   drugs   to   prevent   MTCT,   ‘treatment   as  
prevention’   and   male   circumcision   programmes   – are also high-road solutions because of 
their biomedical (contra sexual) focus. Positively, solutions specifically focused on 
biomedical interventions are more universal than approaches associated with the more 
socially determined low-road. Compared to complex and varying cultural contexts, the 
individual   human   body’s   biological   reactions   are  much   easier   to   generalise.   They   are   also  
more straightforward and short-term oriented in their goals (Vanwesenbeeck, 2011:290, 293-
294). Methodologically, these scientific and widespread features make high-road approaches 
easier to study, implement and measure through positivist ideals and quantitative methods 
(Boyce et al., 2007:9; Horton & Das, 2008:421-422). Consequently, high-road approaches 
can be quickly evaluated according to measurable efficacy. Failed solutions can be discarded 
and replaced with more efficient ones. The approaches that have positive outcomes in so-
called evidence-based research have material proof to back up their plea for donor support.    
In this context it is important to remember that high-road solutions are biomedical, and 
therefore cannot by themselves portray the complex political and social sides of the AIDS 
pandemic. High-road approaches are inherently de-contextualising. They are often focused on 
groups believed to be in high risk of HIV infection, including commercial sex workers and 
injecting drug users. High-road solutions seek to clinically help these people, but do not target 
the social context they are coming from and living in, or the deeper structural reasons for why 
an infection happened in the first place (Vanwesenbeeck, 2011:290). High-road approaches 
are also de-sexualising; instead of working within the framework of sexual rights, which 
acknowledges not only reality but also natural aspects of sexuality, they promote sexual 
abstinence. This de-sexualisation has been institutionalised by, for instance, placing 
HIV/AIDS and sexual health  in  separate  Millennium  Development  Goals  (MDG)  “as  though  
HIV were transmitted by mosquitoes or waterborne parasites rather than by human sexual and 
reproductive   behaviour”   (Germain   et al., 2009:842; see also Vanwesenbeeck, 2011:291). 




High-road approaches’   separation from cultural and sexual contexts makes them more 
straightforward and easier to measure, but is also the reason why they cannot stand alone in 
multilateral AIDS responses.   
2.3.2 Low-road solutions 
The approaches needed to balance out high-road   solutions   are   in  Vanwesenbeeck’s   (2011)  
model referred to as low-road solutions. Low-road solutions emphasise the significance of 
communities, strengthening of local capacities and the greater context of development in their 
AIDS responses. These approaches are horizontally distributed and relatively cheap (as 
compared to the top-down distributions of the more expensive high-road), focused on human 
rights, care, wellbeing, and sexual and reproductive health and rights (SRHR). 
“[C]omprehensive   sexuality   education and condom use promotion are typical low-road 
solutions”  (Vanwesenbeeck,  2011:290),  hence,   they  recognise  that   the  majority  of  new  HIV  
infections are transmitted through sexual activity (Boyce et al., 2007:2; UNAIDS, 2012:16). 
These sexualised and gender attentive low-road approaches aim to encourage dialogue and 
awareness of sexuality and sexual rights, especially among youths.  
This contextualisation of AIDS within the overall global challenges of development, social 
justice, human rights and sexual and reproductive health and rights is also recognised in the 
Cairo Agenda following the 1994 International Conference on Population and Development 
(ICPD). The Cairo Agenda emphasises that overall human wellbeing and rights to make 
independent life choices are essential for global development (Greer et al., 2009:674). AIDS 
is   seen   as   part   of   the   greater   context   of   sexual   and   reproductive   health,   such   as   women’s  
rights to family planning and control over their own bodies (Germain et al., 2009:840), which 
is why Vanwesenbeeck (2011:290) exemplifies the Cairo Agenda as an institutionalised low-
road approach. Hence, low-road   solutions   puts   a   framework   around   the   pandemic’s   now  
widely recognised ties to power, discrimination and sexual violence (Jewkes et al., 2010:46; 
Petersen et al., 2005:1234).  
Wanting to contextualise AIDS responses shows low-road  approaches’  view  of  HIV/AIDS  as  
part of the bigger environment of health, care and wellbeing, and their commitment to long-
term results. Therefore, issues of concern to low-road approaches are to create sustainable 
solutions and to avoid that programmes specifically focused on HIV take health personnel 
away from other health tasks, which has been a fear after HIV funding increased (Germain et 
al., 2009:841; Mangham & Hanson, 2010:89; Vanwesenbeeck, 2011:292; Yu et al., 2008). 
Likewise, and especially where AIDS has become generalised, high-road approaches are also 




needed to ensure overall public health in a country. Unfortunately, South Africa under Thabo 
Mbeki’s presidency is an example of the dire consequences of avoiding high-road solutions 
altogether, in this case the access to and distribution of ART (Chigwedere et al., 2008:412).  
Fundamentally, both high-road and low-road solutions are needed to fight HIV and AIDS; the 
binary between them is constructed by ideas of what AIDS is. The ART breakthrough in 
1996, where findings of how combinations of ART drugs can slow down the development of 
HIV in the body was presented at the International AIDS Conference in Vancouver, changed 
the future for numerous HIV infected people. What had been a death sentence now for many 
turned  into  a  chronic  disease.  Also,  “[i]n 2011, for the first time, a majority (54%) of people 
eligible for antiretroviral therapy in low- and middle-income   countries   were   receiving   it”  
(UNAIDS, 2012:51). The hope for finding a cure in the future is kept alive by intense 
scientific work and medical breakthroughs. These developments had not been possible 
without a high-road focused approach. However, although the global scale-up of ART has 
been impressive, a lot of people are still in need of treatment (Bongaarts & Over, 2010:1359; 
Horton & Das, 2008:421-422;;  UNAIDS,  2012:50).  Significantly,  saving  people’s   lives  does  
not take away the structural challenges that might have contributed to the acquiring of the 
virus in the first place. As already mentioned, there has been increasing attention and concern 
tied to sexual violence and its link to the pandemic (Vanwesenbeeck, 2011:292). Although the 
lifesaving qualities of ART are unquestionably appreciated in these instances as well, there 
are certain types of pathologies that these drugs, and other high-road solutions, are not able to 
address. Here, a rights-based low-road approach sensitive to context and discrimination 
proves its significance.  
Not surprisingly, considered that models are simplifications of reality, high-road and low-road 
approaches are not as black and white as initially portrayed. There are also approaches that 
can be argued to be in a grey zone. For instance, Vanwesenbeeck (2011:290) classifies the 
distribution of condoms as an obvious low-road approach, whereas Parker (2013) refers to 
condoms as a form of biomedical (thus, high-road) prevention. Similarly, Vanwesenbeeck 
(2011:291) implies that microbicides – a gel currently under development where the aim is to 
apply it before sexual intercourse and lower the risk of HIV infection – is a high-road 
approach, despite it being designed for sexual purposes. Also, microbicides are believed to 
empower women who are not in a position to negotiate condom use with their partners, 
meaning that it is gender sensitive.  




At first glance it can almost seem as if condoms and microbicides are one and the same: 
constructed items one needs to put on in order to protect oneself. However, the fact that 
microbicides can be hidden from sexual partners during intercourse – which is good if one is 
out of other options – also undermines the more general importance of sexual and 
reproductive health. It, for instance, does not challenge the possible abusive situation the user 
is in. In other words, it is a short-term solution. Condoms, on the other hand, although 
constructed and not necessarily always adapted to the abusive reality many people find 
themselves in, are so visible and (unfortunately often viewed as) awkward that it has to be 
somewhat negotiated. Also, the condom is an extremely effective and sexualised prevention 
method, an important part of sexual and reproductive health as it stops pregnancy and other 
sexually transmitted infections, often distributed along with sexual education and can be 
cheap and easily accessible. Therefore, distribution of condoms is here still viewed as a low-
road approach, whereas microbicides is, despite its gender sensitivity, still understood as a 
high-road solution because of its short-term scope, biomedical base, and that it cannot be 
applied to the overall context of sexual health.  
As of yet, there has not been any scholarly comment or criticism directed towards 
Vanwesenbeeck’s   (2011) model in itself, possibly because her article is still too recent. 
However, in acknowledging that how AIDS is problematised and understood globally is 
affecting multilateral policy outcomes identified in various contested constructs of AIDS as a 
policy  problem,  Vanwesenbeeck’s  model  of  the  binary  between  different  problem  definitions  
and response mechanisms can potentially clarify the recent paths that global AIDS responses 
have taken. This is important because it questions how and why certain approaches are 
neglected in the light of others. It raises significant questions about who has the power to 
make such decisions  and  define  others’  fate.  The  next  section  discusses  the  ideas  and  norms  
that Vanwesenbeeck believes are fundamental for high-road prioritisation.  
2.3.3 Underlying social forces, ideas and norms 
Indeed, despite the recognition by global actors and scholars of the significance of low-road 
approaches (Berer, 2011:6; Boyce et al., 2007:1; Germain et al, 2009:840; WHO et al, 
2009:1),   Vanwesenbeeck   (2011:290)   argues   that   “in   the   case   of   HIV/AIDS,   the   balance  
[between high-road and low-road solutions] seems to be increasingly lopsided towards 
technological,   biomedical   solutions”.   The   claims   are   that   sexuality   and   sexual   and  
reproductive health and rights (SRHR) have been taken out of the overall global AIDS agenda 
– for instance when separating HIV and SRHR in the MDGs – with an increasing focus on 
clinical solutions and treatment at the expense of prevention of sexual transmission (Biehl, 




2007:1085; Germain et al., 2009:840-842; Knight, 2008:172; Vanwesenbeeck, 2011:291-
292).  
This prioritisation of high-road over low-road solutions, Vanwesenbeeck (2011:293) argues, 
is  due  to  “socio-political,  moral  and  economic  forces  and  mechanisms”,  represented  by  ideas  
of   “morals,  medicalisation  and  markets”.   In  other  words,   the  problem  contestation  between  
high-road and low-road solutions is due to how AIDS has been understood and problematised 
within certain ideas, norms and assumptions. Figure 2.1 is an illustration  of  Vanwesenbeeck’s 
model. It demonstrates the mutually affecting relationship between global AIDS agendas and 
multilateral AIDS responses, as well as high-road and low-road  approaches’  relationship  with 
medicalised, market-driven and moralistic ideas and norms. Vanwesenbeeck argues that 
biomedical high-road approaches are prioritised at the expense of contextual and sexual low-
road approaches because ideas of the market, medicalisation and morals are more aligned 
with the former than the latter. An understanding of these factors emphasised by 
Vanwesenbeeck is essential in order to further highlight the strengths and weaknesses of the 
model, and to later evaluate whether it can be identified in the discourse around the 1996-
2012 International AIDS Conferences. This is discussed in the remaining part of this chapter.  
 
 
Figure  2.1:  Vanwesenbeeck’s  model 
The morals that Vanwesenbeeck (2011) refers to are mainly ideas and norms with a 
disapproving view of sexuality and sexual practices, especially among young adults. These 
norms affect how donors and policymakers understand AIDS as a problem and how they 
choose   the   ‘appropriate’   response.   They   also   reflect   global   ideational   power   relations   by  




demonstrating whose norms are accumulated. Examples of influential global norm 
entrepreneurs who have been criticised for their moralism and anti-sex approaches are the 
Vatican and   the  President’s  Emergency  Plan   for  AIDS  Relief   (PEPFAR)  under  George  W.  
Bush (Berer, 2011:7; Vanwesenbeeck, 2011:293).  
The   US   government   backed   PEPFAR,   has   proved   to   be   “one   of   the   largest   and   most  
influential  donor  programmes  of  recent  years”  (Vanwesenbeeck, 2011:291) with a total sum 
of $63 billion pledged to fight the pandemic. In a high-road/low-road  framework,  PEPFAR’s  
approach is undoubtedly high-road. The programme is mainly focused on pharmaceutical and 
biomedical solutions, for the most part treatment and to a lesser extent also biomedical 
prevention programmes. In many ways, PEPFAR has been a success. With the first $15 
billion   pledged   PEPFAR   managed   to   “provide[…]   treatment   to   two   million   people   in   15  
focus   countries,   12   of   which   were   African”   before the end of 2008 (Fourie, 2013:1). 
However, the initial policies associated with the organisation, especially the moral ones, have 
been controversial. The comparably smaller amount of the PEPFAR budget spent on 
prevention of sexual transmission has been accused of being moralistic because it is 
concentrated around abstinence of sexual activity (Bliss, 2012:15). Although sexual 
abstinence   would   drastically   decrease   one’s   chances   of   getting   infected   with   HIV,   critics  
argue that such moral approaches are unrealistic and depraving because they fail to 
acknowledge the normality of sex and sexuality, thereby also undermining the work of 
approaches focusing on this (Boyce et al., 2007:13-14; Vanwesenbeeck, 2011:291-292). 
Accordingly, PEPFAR initially failed to provide the facts about how one can protect oneself 
and  was   therefore   “endangering   the   lives   of   the   people   they’re   supposed   to   be   protecting”  
(Population Action International, 2007:1-2).   PEPFAR’s   early   focus   mirrored   government  
supported abstinence-only programmes  in  the  US.  These  policies  are  kept  despite  the  critics’  
claims   that   the   approach   is   unsustainable,   ineffective   and   “promote[s]   myths   and  
misconceptions   about   sexuality   and   sexual   behaviour”   (Marques   &   Ressa,   2013:124).  
PEPFAR’s  global  AIDS  policies are therefore an example of how a locally inter-subjective 
ontology and norms can play out in global agenda-setting and responses.  
Further, ideas of medicalisation fit well with moralist norms because they allow for 
approaches that are more focused on science than the overall sexual context of HIV. 
However, medicalisation in itself does not emanate from moralistic preferences; the increased 
medicalisation Vanwesenbeeck (2011:293) refers to is a result of a (Western) need to quickly 
discover and evaluate solutions to challenges. Over the years there have been growing 
demands to evaluate the effectiveness of donor money (Austveg, 2011:27). This can be 




associated   with   the   growth   of   neoliberalism,   privatisation   and   the   “[r]einvention   of  
[g]overnance”   (Power, 1999:41) in the 1980s and beginning of 1990s, where much of the 
focus was on productive and cost-effective solutions, exemplified by ideas such as New 
Public Management. In order to evaluate productivity, it had to be measured. Through these 
evaluations organisational  activity  and  policymaking  could  be  legitimised,  ensuring  ‘value  for  
money’  and  ‘quality’.  This  development  is  thus  rooted  in  an  epistemological  assumption  that  
evaluations and revisions are effective tools to make sure goals are reached (Power, 1999:10-
11, 42, 52).  
Following this logic, easy-to-measure biomedical high-road solutions are possibly more 
attractive in order to demonstrate effective use of time and money, so that the donors know 
they are supporting an approach that works. A popular way of figuring out what works, also 
when   it   comes   to   “defin[ing]   the  evidence  base   for  HIV  prevention  programs  and  policies”  
(Padian et al., 2010:622), is to use evidence-based research through several Randomised 
Controlled Trials (RCT), also known as the  metric  ‘gold  standard’.  These  are  scientific  trials  – 
based in positivism – aiming at eliminating the context in order to see the effect of what is 
researched (Fineide, 2013:133; Kippax & Holt, 2009:5). When it comes to biomedicine, focus 
on evidence-based   research   is   a   reasonable   development:   “[i]n   health   care,   evidence-based 
medicine  came  as  a  reaction  to  the  use  of  interventions  that  were  ineffective  or  even  harmful”  
(Austveg, 2011:27; see also Fineide, 2013:121). The encouraging biomedical discovery that 
ART can reduce the chances of getting infected through sexual transmission has also 
contributed to a medicalisation of the AIDS pandemic, arguing how biomedical approaches 
can be mainstreamed (Bliss, 2012:16; WHO, 2012:6). The particular challenge with the AIDS 
pandemic, however, is that it is not exclusively biomedical. 
While  ‘easy   to  measure’  sounds   like  an  exclusively  positive  characteristic,   it  can  also  be  an  
example  of  how  dynamics  “difficult   to  measure   [….]  [are]  pushed  aside  for  methodological  
reasons”  (Finnemore  &  Sikkink,  1998:889).  Taking  it  one  step  further,   this  can  be  linked  to  
Power’s   (1999:51-52) claim that what is understood as effective in the end is socially 
constructed by the methodologically exclusive evaluation process itself. In other words, only 
measurable   approaches   can   be   labelled   ‘effective’.   The   effects   of   approaches   directed   at  
preventing sexual transmission of HIV, together with other culturally complex low-road 
approaches, have been difficult to measure (Horton & Das, 2008:421-422; Knight, 2008:78; 
Vanwesenbeeck, 2011:293). Hence, medicalisation of the AIDS pandemic is an issue of 
epistemological and methodological importance. This is a challenge because AIDS responses 
are thus chosen on the basis of how the pandemic has been problematised and defined within 




the contemporary (scientific) framework. Already at the 2006 International AIDS Conference 
in   Toronto,   there   were   “warn[ing   signals]   of   a   trend   towards   the   ‘medicalization’   of  
prevention   as   a   ‘quick   technical  magic   solution’”   (IAS,   2007:13).   The   consequences   of   an  
overly medicalised framework are that human rights-based, sexual, contextual and long-term 
low-road solutions are not prioritised although they are recognised as important for overall 
wellbeing and crucial to comprehensively combat the pandemic and to protect vulnerable 
people (Boyce et al., 2007:9; Vanwesenbeeck, 2011:293).  
In their study done on HIV prevention research and RCTs, Padian et al. (2010:624, 627) 
found, not surprisingly, that RCTs give significant results for biomedical interventions, but 
have difficulties in measuring (low-road) behavioural approaches. These scholars believe that 
this   is   “attributable,   at   least   in  part,   to   issues   related   to   trial   design   and/or   implementation”  
(Padian et al., 2010:631). This relates to the distinction that Kippax & Holt (2009:5) make 
between   “what   works”   and   “what   works   in   practice”;;   it   is   the   efficacy   and   not   the   actual  
effectiveness of the approaches that are measured through RCTs. In other words, that some 
responses do not show any effect in RCTs does not mean that they do not have any effect in 
real life. This is important because research should be about finding out what can actually 
improve health and quality of life in reality, and not only what works on paper (Austveg, 
2011:27; Fineide, 2013:122).  
Vanwesenbeeck’s   last   theme,  markets,   is   presented   as   equivalent   to   the   “neoliberal   global  
political   economy”   (Vanwesenbeeck,   2011:293),   which   she   argues   is   served   by   recent  
developments within global policy agendas. The argument is that biomedical high-road 
solutions are much more compatible with the interests of pharmaceutical companies. Because 
“[t]here   is   much   more   money   to   be   made   on   the   high-road”   (Vanwesenbeeck,   2011:293),  
initiatives focusing more on care and general health are neglected on behalf of money-making 
drugs.  This   perception   of   the  market’s   influence   on   the  AIDS   agenda   reflects   the   idea   that  
“[t]hose  who  have  the  gold,  make  the  rules”  (Fylkesnes  et al., 2011:1911). The discussion of 
the   market’s   presence in the AIDS pandemic is neither new nor unconventional. Despite 
cooperation from the pharmaceutical industry in reducing drug prices during the Accelerating 
Access Initiative (AAI), and their constrained obligations under the Doha Declaration, they 
are often accused of only bothering to invest where they can earn profit (Berer, 2011:6). 
Especially since the introduction of ART as a viable alternative to save HIV positive lives, the 
pharmaceutical industry has been the object of harsh critiques, activism and demonstrations, 
accused of profiting on the back of the pandemic. The International AIDS Conferences are 
good examples of occasions when such demonstrations have taken place (Bliss, 2012).   




Although the role of the pharmaceutical industry and its greedy reputation should not be 
underestimated,  by  stating  that  “[t]here  is  not  much  money  to  be  made  with  a  human  rights  
agenda”,   Vanwesenbeeck   (2011:293)   underplays   the   benefits   of   high-road solutions that 
many scholars, people living with HIV, and policymakers believe in. It is important here to 
draw a distinction between the pharmaceutical industry and other actors encouraging high-
road solutions. To imply that high-road approaches are focused exclusively on money is too 
simplistic in a pandemic where the key  efforts   are  on  saving   and   improving  people’s   lives.  
Also,   it   is   important   to   recognise   the   pharmaceutical   industry’s   contributions   in   the   AIDS  
pandemic. For instance, big pharmaceutical companies, among them GlaxoSmithKline, Pfizer 
and Roche, are often some of the largest donors for the International AIDS Conferences (IAS, 
2004:43). That said, these financial contributions might also affect the conferences as a 
whole, for instance through PR events and marketing. This is a topic for coming chapters to 
explore further.   
Apart from a possible penchant for simplification, another significant limitation to 
Vanwesenbeeck’s  (2011)  model  is  that  she  emphasises  the  material  power  of  the  market,  yet  
she does not refer to the Global Financial Crisis that impacted most of the world since 2008. 
Funding for the Global Fund decreased drastically after 2008. In 2010 almost $400 million of 
what had been pledged to the organisation was not paid, and in 2011 this amount grew to 
$575 million. The United States, the Global Fund’s  largest  donor,  was  in  2011  responsible  for  
$423,355,000 of this amount (Bernescut, 2012:24-25). The conclusion that the global 
recession also affected the HIV pandemic financially is therefore not an unreasonable one 
(WHO et al., 2011:8). Although this fact might not change the overall model, it might have 
explanation value for why high-road solutions have been more popular after the Global 
Financial Crisis, even though they are more expensive. This is because in times of crisis, it 
seems logical to follow the solutions that are viewed as easier, more straightforward, and 
where the expenses can be justified in evidence-based research. As the preceding discussion 
stressed, these are current characteristics of high-road solutions. Furthermore, 
Vanwesenbeeck (2011) fails to see the ideational importance of the market. Neoliberalism is 
about more than making money; as an ideology it contains ideational as well as material 
power. This negligence of the ideological importance of the market is further elaborated upon 
in Chapter 4. 
The underlying ideas and norms discussed here – the market, medicalisation and morals – and 
the fundamental ideas they accumulate and allocate are used for identifying high-road and 
low-road   approaches   and   illuminate   Vanwesenbeeck’s   (2011) model in the discourse and 




developments around the International AIDS Conferences between 1996 and 2012. More 
specifically, the principles and actors of the neoliberal market and its complex role in the 
pandemic are investigated. The Global Financial Crisis is important in this regard, and used to 
highlight the relationship between neoliberalism and AIDS. The demands for evidence-based 
and scientific research, as well as the role of actors and donors with so-called moralistic 
objectives, are also examined and discussed in an attempt to identify the prominence of 
medicalisation and moralism. Importantly, what has been neglected from the overall discourse 
around the specific conferences is as significant as what has been prioritised. Here, activist 
opinions, demonstrations and criticism become especially important.     
2.4 Conclusion 
This  chapter  has  discussed  Vanwesenbeeck’s  (2011)  model,  the  general  differences  between  
high-road and low-road approaches, the ideas and norms she believes are fundamental for 
high-road prioritisation, as well as some of the strengths and weaknesses of her argument. The 
first  part  of  this  chapter  aimed  to  theoretically  contextualise  and  illuminate  Vanwesenbeeck’s  
model within ideational and structural approaches of public policy problematisations and IR 
constructivism. The former emphasises how policies are necessarily and unintentionally 
problematised  and  constructed  by  assumptions  of  what  the  initial  ‘problem’  is  believed  to  be.  
The latter focuses on ontological and epistemological assumptions at the global level, and 
how inter-subjective ideas and norms shape the interests and decisions of policymakers. 
Together these theories highlight how ideas and norms construct the worldviews of 
policymakers and norm entrepreneurs, thereby   shaping   ‘appropriate’   policy   outcomes   and  
epistemological   preferences.   In   the   case   of   Vanwesenbeeck’s   model,   ideas   of   moralism,  
medicalisation and the market are believed to shape multilateral AIDS responses by 
prioritising biomedical, non-contextual, and vertically distributed high-road solutions over the 
more human rights-based, contextual, and sexual and reproductive health-oriented low-road 
solutions. This is because, according to Vanwesenbeeck, high-road approaches match the sex 
negative, market-driven and quantitatively measurable preferences of current ideas and norms 
better than low-road approaches. As such, low-road approaches can be understood as too 
sexual, too unquantifiable, and too independent of the pharmaceutical industry – all in all too 
‘difficult’   – to be prioritised by policymakers and donors. This chapter has discussed the 
relevance  of  these  ideas,  but  also  limitations  in  Vanwesenbeeck’s  model.  Being  a  model,  the  
high-road/low-road differentiation is inherently too simplistic. Besides this, Vanwesenbeeck 
does   not   adequately   consider   the   impact   of   the   Global   Financial   Crisis   on   policymakers’  
choices   and   ideas   of   ‘appropriate   solutions’.   These   elements   are   considered   in   the   further  




analysis,   which   explores   whether   Vanwesenbeeck’s   model   can identify and illuminate the 
developments of global AIDS responses in the discourse around the International AIDS 
Conferences   between   1996   and   2012.   The  main   analysis   of   Vanwesenbeeck’s   model   only  
appears in Chapter 4. Before this, Chapter 3 necessarily provides an historical overview of the 
key developments and tendencies before, during and after the biennial International AIDS 
Conferences emphasised in this study. Hence, the subsequent chapter provides the essential 
historical outline for the forthcoming analysis in Chapter 4. 
  




Chapter 3: Historical outline, 1996-2012 
3.1 Introduction 
As   previous   chapters   have   shown,   Vanwesenbeeck’s   (2011)   model   of   the   binary   between  
high-road and low-road approaches claims that global and multilateral AIDS responses have 
become increasingly biomedical, vertically distributed and clinically individualised since the 
mid-1990s. This, she claims, is because of constructed ideas of the neoliberal market, morals 
and medicalisation, and how these norms are less compatible with sexualised, rights-based 
and socially dependent low-road approaches. The previous chapter discussed 
Vanwesenbeeck’s   model   of   these   ideas   as   well   as   the   theoretical   background   of   policy  
problematisations and socially constructed worldviews and epistemological preferences. This 
study  aims   to   test   the  utility  of  Vanwesenbeeck’s  model   for   identifying   and  explaining  key  
events and developments around the biennial International AIDS Conferences between 1996 
and 2012, however, the main analysis of Vanwesenbeeck’s   model   in   relation   to   these  
historical tendencies only appears in Chapter 4. The aim of this chapter is thus to first provide 
the historical outline necessary for the further analysis in the succeeding chapter. In doing so, 
different frameworks are discussed for trying to highlight various viewpoints and descriptions 
of how the global AIDS response has developed since 1996. The chapter starts with a brief 
contextualisation of AIDS responses before 1996, before discussing the periods recognised in 
Tables 1.1 and 3.1 – most  specifically  the  ‘building  of  institutions’,  ‘increased  funding’  and  
the  ‘remedicalisation  and  eventual  funding  cuts’  – in more detail.   
3.2 Before 1996 
This study focuses on the events around the International AIDS Conferences from 1996 – the 
year scientists at the International AIDS Conference in Vancouver presented the discovery 
that a combination of antiretroviral therapy (ART) drugs can hinder the development of HIV; 
a development claimed by some scholars to subsequently lead to an increased multilateral, 
monetised and medicalised AIDS response. Before focusing on the key happenings and 
discourses since then, however, this section briefly reviews global AIDS responses before 
1996, to outline the context.  
After AIDS first publicly manifested in 1981, the first International AIDS Conference was 
held in 1985 in Atlanta, as a scientific meeting. Science was at the core of the agenda until the 
International AIDS Society (IAS) was established in 1988 to coordinate and co-host the 
conferences. However, the pandemic was political from the start, absurdly exemplified by the 
lack of political reaction and discrimination against communities predominantly affected by 




the disease at the time, such as men who have sex with men (MSM) and injecting drug users 
(Bliss, 2012:4-7; Kallings & McClure, 2008:10). Critics claim that the initial political neglect 
was in fact directly linked to this discrimination, as AIDS was associated  with  “people   that  
were  already  stigmatized”  (Ingram,  2013:438)  and  that  the  main  interest  therefore  was,  in  the  
previous  US  Secretary  of  Health  and  Human  Services’  own  words,  to  “’stop[…]  AIDS  before  
it spreads outside the risk groups, before it becomes  an  overwhelming  problem’”  (Margaret  
Heckler,   quoted   in   Bliss,   2012:5).   Hence,   the   general   population’s   safety   seemed   more  
important than to help the ones already infected (Bliss, 2012:5).  
Apart from blunt discrimination, Ingram (2013:439) argues that AIDS was neglected as part 
of domestic and international organisational changes brought forward by neoliberal ideas and 
values  in  the  1980s  and  1990s  where  health  in  general  was  deprioritised.  Neoliberalism’s  role  
in global AIDS responses is a prominent and complex one and is discussed in greater detail 
below. However, in the 1980s and early 1990s, there were certainly also other sources 
influencing AIDS responses. The lack of scientific success to find a treatment or a cure 
sparked reactions within communities to modify behaviour and to effectively reduce risk and 
prevent the spread of HIV. Examples of such culturally attuned reactions are the development 
of  ‘safe  sex’  approaches  and  efforts  to  rejuvenate,  even  “eroticising”,  male  condoms  (Parker,  
2013; Rochel de Camargo et al., 2013:780). Later on, focus on and theories regarding sexual 
behaviour became influential, ranging from comprehensive sex education to programmes on 
abstinence (Giami & Perrey, 2012:353, 355; Parker, 2013).  
Importantly, the International AIDS Conference in Stockholm in 1988 was the first to 
recognise these more social sides of HIV by going beyond an exclusively biomedical content. 
This  was  in  line  with  the  IAS’  mission  to  include  international  and  multilateral  approaches  on  
human and legal rights, politics, economics, discrimination and prevention on the agenda at 
the   conferences.   In   the   years   following   the   IAS’   establishment   the   conferences   were  
characterised by reactions to and the consequences of controversial policies, protests and 
activism, scientific engagement and frustration. With an effective cure still out of sight, both 








3.3 The International AIDS Conferences (1996-2012) and surrounding discourse 
Table 3.1: IAS conference trends and key events – expanded 
Year Conference trends Outside events High-road Low-road Tendencies 
1996 Vancouver - ART breakthrough 
- Call for resources 
- Mobilisation of activists 
- The situation in the 
developing world 
- Critique of pharmaceutical 
companies 
- UNAIDS’  first  meeting 
  
B
uilding of institutions 
1997    
1998 Geneva - The Geneva Principle 
- Treatment vs. prevention 
- Side effects of treatment  
- North-South divide in access 
to ART 
  
1999  - The  World  Bank’s  
Multi-Country HIV/AIDS 




2000 Durban - Developing world 
- Access to treatment 
- Call for resources 
- Denialism and the scientific 
link between HIV – AIDS 
- Link between AIDS and 
governance 
- Accelerating Access 
Initiative (AAI) 
- Cheaper drugs 
- MDG 
- AIDS discussed in 
UNSC  Resolution 
1308 and securitisation 
 




- Funding starts to 
increase 
- Doha Declaration – 
TRIPS 




2002 Barcelona - Access to treatment 
- WHO  ‘3  by  5’:  3  million  on  
ART by 2005 
- Treatment vs. prevention 
- Increased participation by 
prominent leaders 
- Call for resources 





2003  - PEPFAR’s  first  launch:  
$15 billion 
 
2004 Bangkok - Women in focus 
- Universal access to 
treatment, care and prevention 
- Call for funding  The 
Global Fund 
- First time for the Global 
Village, the Leadership 
Programme and the Youth 
Programme 
- Call for more scientific 
content   
- Call for evidence-based 
policies 
  
2005    
2006 Toronto - Treatment vs. prevention  
treatment as prevention 
(TASP) 
- UN General Assembly 
Political Declaration on 
HIV/AIDS  access to 
 




- Prevention technologies – 
male circumcision 
- Pressure on pharmaceutical 
companies 
- Call for more scientific 
content 
- Gender sensitive 
- Discrimination 
- Strengthening of health 
systems 
- Human rights 
treatment, prevention and 
care for all by 2010 
2007  - Male circumcision 
recommended by WHO 
and UNAIDS for 
prevention purposes 
2008 Mexico City - Universal access to 
treatment 
- Discrimination and stigma 
- Combination prevention 
- TASP 
- Against criminalisation 
- Global Financial Crisis 





edicalisation and eventual funding cuts 
2009    
2010 Vienna - The Vienna Declaration – 
injecting drug users 
- TASP 
- Prevention technologies 
- Treatment 2.0  
- Human Rights 
- Discussion of and reaction 
to funding cuts 
- Global Fund 
replenishment meeting 
 
2011  - HPTN 052 trial: TASP 
- UN General Assembly 
Political Declaration on 
HIV/AIDS  access to 
treatment, prevention and 




- The Washington D.C. 
Declaration: end AIDS   
- Scientific developments  
TASP  eradication of AIDS 
- Human rights 
- Call for resources  
  
 
As Table 3.1 suggests it is possible to identify three main tendencies in global AIDS 
responses between 1996 and 2012 – ‘building   of   institutions’,   ‘increased   funding’   and  
‘remedicalisation   and   eventual   funding   cuts’   – although it should be noted that these 
tendencies are somewhat overlapping and not mutually exclusive. After the important 
biomedical discovery of highly active antiretroviral therapy (HAART) in 1996 there was 
increased emphasis on the structural global inequalities amplified by the pandemic, and 
particularly with regards to access to ART. Civil society activists pushed for a global response 
to this challenge. Table 3.1 also indicates that the period between 1996 and 2002 showed an 
increased political engagement towards AIDS. This is demonstrated by the institutionalisation 
of global AIDS responses, such as with the establishment of UNAIDS, the incorporation of 
AIDS in the Millennium Development Goals (MDG) and the UN General Assembly Special 
Session (UNGASS) on HIV/AIDS in 2001.  




From 2002 towards 2008 this political engagement and global social justice activism reaped 
results in form of increased funding for global AIDS responses. Some expressed concerns that 
most of these funds were directed towards treatment efforts, especially as further biomedical 
discoveries came to the fore, consequently overshadowing focus on prevention of sexual 
transmission of HIV. Table 3.1 further indicates that these concerns were justified as the years 
after 2007 saw a remedicalisation – back to the initial scientific focus in the 1980s – of the 
pandemic,  where  biomedical   prevention   technologies   and   ‘treatment   as   prevention’   (TASP)  
became substantial parts of multilateral prevention efforts. This remedicalisation seems to 
have continued even after funding for global AIDS responses flatlined and decreased after 
2008 and the Global Financial Crisis. These main trends and tendencies are important for 
analysing   Vanwesenbeeck’s   (2011)   model   in   Chapter   4,   and   are   explored   in   fuller detail 
below.      
3.3.1 Building of institutions, 1996-2001 
As indicated, 1996 was a significant year of change for the AIDS pandemic. There was finally 
a breakthrough in scientific research, presented at the XI International AIDS Conference in 
Vancouver: highly active antiretroviral therapy (HAART) was discovered. These 
combinations of ARTs demonstrated the potential of slowing down the development of HIV 
in the human body, and even averting the emergence of AIDS. Following this astonishing 
information the conference experienced a revived sense of optimism. At the same time, many 
attendees were concerned with the high prices of the drugs and the inability for many people, 
especially from the developing world, to access them. Activists demanded more involvement 
and funding from international policymakers,  and  questioned  the  pharmaceutical  companies’  
materialistic objectives (Bliss, 2012:11; Kallings & McClure, 2008:28).  
Some scholars view this breakthrough in ART research as the start of a more biomedical 
global response to the pandemic, a response they claim is viewed by scientists as the more 
obvious solution to AIDS after a (too long) pit stop with behavioural approaches and their 
limited triumphs (Giami & Perrey, 2012:355; Rochel de Carmargo et al., 2013:780). Parker 
(2013), however, although also under the understanding that AIDS responses increasingly 
became more biomedical, argues that behavioural AIDS approaches were initially replaced 
with more structural explanations in the first part of the 1990s. Underlying a structural 
approach is the idea that inequalities are caused by external factors. According to this view 
the unequal global spread of AIDS – negatively affecting the developing world – was affected 
and amplified by structural vulnerability and violence. The additional unequal global 
distribution of lifesaving HAART sparked a humanitarian global justice movement in the 




fight for equal access to these drugs. Governments in the developing world, such as those in 
India and Brazil at the time, challenged pharmaceutical companies and their understanding of 
the patents laws agreed upon in the World Trade Organisation’s Agreement on Trade-Related 
Aspects of Intellectual Property Rights (TRIPS) in order to ensure cheaper drug access to 
their HIV-positive citizens (Harrelson, 2001:190-192; Marques et al., 2005:472-474). Similar 
moves were also recognisable in civil society engagement. For instance, the South African 
Treatment Action Campaign (TAC), which had access and rights to ART on its main agenda, 
was established in 1998 (Fourie, 2006:130; Low et al., 2010:3). As such, structural 
inequalities and unequal access to ART sparked activism in the developing world and 
globally. Thus, global justice and medicalisation in the form of increased allocation of drugs 
went hand-in-hand, indicating that biomedical high-road approaches were intertwined with 
rights-based low-road approaches. This has explanation value because it can give a more 
nuanced picture of why multilateral AIDS policies eventually became more medicalised than 
simply the development of biomedical solutions such as ART.  
There are indeed signs from the first half of the 1990s that more structural explanations and 
solutions   started   to   gain   popularity.   The   UN   Development   Programme’s   (UNDP)   Human  
Development Report from 1994 suggested a shift from national to human security; a people-
focused approach that emphasises structural threats, like environmental change and disease, 
and  their  potential  to  disrupt  human  beings’  wellbeing  and  even  put  them  in  danger  (UNDP,  
1994:22-23). The year 1994 was also when the International Conference on Population and 
Development (ICPD) was arranged in Cairo, leading to the recognition of the Cairo Agenda 
in 1995. This agenda emphasised the complex relationship between development and the state 
of the world population,  arguing  that  overall  human  wellbeing  and  the  right  to  lead  one’s  own  
life enhances development. In this case, AIDS was placed within the greater context of sexual 
and reproductive health and rights (SRHR), especially with regards to women and family 
planning (Germain et al., 2009:840; Greer et al., 2009:674; MacIntosh & Finkle, 1995:225; 
Vanwesenbeeck, 2011:290-291). At the time, the agenda was widely acknowledged by the 
179  governments  participating,  and   it  was  expressed   that   the   ICPD  “had  been  a   conference  
with  no  losers”  (MacIntosh  &  Finkle,  1995:224).     
With these structural developments and apparent satisfaction with the ICPD conference in 
mind, Germain et al.  (2009:841)  state  that  “[t]he  timing  was  certainly  perfect”  when  UNAIDS  
was established in 1996 to use the Cairo Agenda as a basis for a global AIDS response. 
However,  “AIDS  advocates  and   researchers  had   long  been  committed   to  a  different  agenda  
and  UNAIDS  was   to   go   its   separate  way”   (Germain   et al., 2009:841), avoiding horizontal 




health care approaches and sexual and reproductive health in their framework from 2001, and 
consequently contributing to the de-sexualisation  of  HIV.  This  statement  of  UNAIDS’  almost  
anti-structural approach is not supported by Parker (2013), who claims that UNAIDS, among 
other organisations at the time, had people supporting structural approaches amongst its staff. 
These different perceptions of UNAIDS might reflect the controversy around the 
establishment of the organisation itself. By 1996 many UN agencies had their own distinct 
AIDS policies. An agency to coordinate these efforts, one of the purposes of UNAIDS, was 
thus necessary. However, this also led to conflict and institutional jealousy between the 
agencies  UNAIDS  was  supposed  to  coordinate,  as  “UN  agencies  were  not  interested  in  being  
‘coordinated’  or  managed  by  an  upstart,   new-fangled  program  with   few   resources   to  offer”  
(Behrman,  2004:170).  Efforts  to  coordinate  UN’s  approaches  to  the  pandemic  were  thus  slow  
in  the  first  couple  of  years  after  UNAIDS’  establishment,  leading  to  inconsistent  or  confusing  
messages from and between UNAIDS and various other UN agencies (Behrman, 2004:171). 
Hence, Germain et al.’s   (2009)  claim   that  UNAIDS  embarked  on  a  de-contextual approach 
might also reflect the compromises UNAIDS officials had to make in order to achieve respect 
and allocate funding for the organisation and the pandemic, such as pushing the challenge of 
AIDS in the UN Security Council (UNSC) and thereby framing AIDS as an urgent security 
issue rather than one of global health. The significance of AIDS being discussed in the UNSC 
is further explored below.  
Nevertheless, Germain et al.,   (2009)   do   have   a   point   in   the   sense   that   “funding   for  
reproductive  health   as   a  proportion  of  health   aid  dropped   from  30%   to  12%”   (Greer   et al., 
2009:674; see also Greene et al., 2012:90) from 1994 to 2008, just as money started rolling in 
for the global AIDS response. One of the main objectives with this chapter is to interrogate 
developments like these in global AIDS responses between 1996 and 2012 and to put them 
into context. The information obtained here is then used as background material for the 
analysis  of  Vanwesenbeeck’s  (2011)  model  in  Chapter  4.   
Despite   the   Vancouver   conference’s   good   news   regarding   HAART,   the   mood   at   the   XII  
International AIDS Conference in Geneva in 1998 was more sober. This was due to the 
realisation of the many side effects of ART as well as an overall discussion about the 
developing  world’s  lack  of  access   to   these  expensive  drugs,  accompanied  by  depressing  but  
important statistics from UNAIDS revealing the spread and extent of HIV (Behrman, 
2004:176; Knight, 2008:86-88; Pavia, 1998; Volberding, 1998). Approaches directed towards 
prevention of sexual transmission were still believed to be effective and important responses 
to AIDS, especially while HAART was still in its nascent phase. However, there was a 




recognition that these types of contextual approaches were more difficult to research and 
prolong, as they need to take culture and sex into consideration. Thus, already a fear was 
expressed that an increased focus on ART post-1996 would overshadow the importance of 
prevention efforts (Bliss, 2012:11-12; Knight, 2008:87). Hence, despite the Geneva 
Principle’s  emphasis  on  combining  science  and  community  approaches  (Kallings  &  McClure,  
2008:28), a constructed treatment vs. prevention binary was starting to take form. This 
supports  Vanwesenbeeck’s  (2011)  model  because  the  concern  that   treatment   is  prioritised  at  
the  expense  of  prevention  of  sexual  transmission  efforts  mirrors  Vanwesenbeeck’s  claim  that  
high-road approaches outshine low-road approaches.   
The inequality between the global north and the global south with regards to access to ART 
stressed  both  in  Vancouver  and  in  Geneva  is  essential  in  Parker’s  (2013)  understanding  of  the  
structural approach towards AIDS and further developments in global AIDS responses. This 
is because the emphasis on the structural injustice of the world created an environment where 
straightening out these inequalities in access to drugs became top priority for many activists 
and members of national and transnational civil society. That these global inequalities were 
enhanced by principles of the neoliberal market – for instance how patents for ART drugs 
were owned by pharmaceutical companies in the developed world, making it difficult for low-
income countries to access them – did not make the case better. The idea that someone was 
profiting from other people’s tragedies  was,  and  still  is,  a  provoking  one.  Thus,  “[a]ccess   to  
ART   quickly   became   a   flashpoint   for   international   mobilization”   (Ingram,   2013:439) and 
eventually   laid   the   grounds   for   the   “scale-up”   of   global   funding   towards   AIDS   responses  
(Parker, 2013).    
The XIII International AIDS Conference in Durban in July 2000 is acknowledged as a crucial 
point towards this development. More than ever the conference highlighted the dire situation 
of the pandemic in the developing world and the needs and possibilities to improve global 
access to ART. The topic sparked strong engagement and activism – with the South African 
activist group Treatment Action Campaign (TAC) in front – and encouraged cooperation 
across north-south divisions. While prevention had remained at the forefront for many actors 
and donors even after the ART breakthrough, the conference in Durban made the need to 
escalate global ART access more visible and better understood (Abdool Karim, 2006:N7; 
Bliss, 2012:13; Knight, 2008:110, 112).  
The conference in Durban therefore led to a re-evaluation of the international handling of 
AIDS,  as  it  was  recognised  that  “AIDS  is  a  crisis  of  governance” (UNAIDS, 2001:7). In other 




words,  it  was  made  clear  that  it  is  the  leaders  on  various  governance  levels’  responsibility  to  
make sure that all efforts are made to curb the pandemic. Indeed, in the setting around the 
Durban conference, this became underscored in two ways: first through criticism of the South 
African   government’s   handling   of   the   pandemic,   and   second   through   the   international  
society’s   increased  engagement. The following part first discusses the former, and then the 
latter of these situations, both of which might have contributed to or can serve as examples of 
eventual high-road prioritisation. 
Poor  leadership  claims  were  raised  when  Thabo  Mbeki,  South  Africa’s  president  at  the  time  
of the Durban conference, and his Minister of Health, Manto Tshabalala-Msimang, 
infamously questioned the link between HIV and AIDS, and therefore also the effect and 
relevance of ART. This so-called AIDS denialism has later been estimated to have cost 
thousands of South African lives (Chigwedere et al., 2008:412), not only because the 
government rejected to distribute ART but also because of the inaccurate ideas about AIDS 
that they spread. In response to their policies, the Durban Declaration, stressing that the 
“empirical   evidence   for   the   link   between   HIV   and   AIDS   was   ‘clear-cut, exhaustive, and 
unambiguous’”  (Knight,  2008:110),  was  issued  and  signed  by  5,000  HIV  researchers.  AIDS  
denialism does not only reflect the importance of leadership, however. It also is a good 
example of the importance of science. Denialists had supporters from far outside South Africa 
and  in  2007  Pedro  Cahn,  then  president  of  the  IAS,  stated  that  the  IAS  “supports  an  evidence-
based  approach”  and  therefore  “has  a  unique  responsibility”  (Cahn,  2007:2)  to  defy  the  claims  
and actions put forward by AIDS denialists. Hence, just like evidence-based research is 
important in medicine in order to avoid harmful practices (Austveg, 2011:27) it has been used 
within AIDS research to avoid and delegitimise harmful approaches. This increasing need for, 
and subsequently also the legitimisation of, evidence-based research in multilateral AIDS 
responses can illuminate why quantifiable and measurable high-road approaches have been 
increasingly prioritised at the expense of more complicated low-road approaches, as the 
former are easier to monitor and evaluate through evidence-based research than the latter. 
Furthermore,  it  also  supports  Vanwesenbeeck’s  (2011)  claim  that  medicalised  ideas  – such as 
the focus on evidence-based research to monitor and evaluate approaches in the first place – 
have contributed to this development.  
Although not evident during the conference in Durban, it is worth mentioning here that during 
the same period the IAS went through some changes. Their election in 2000 resulted in the 
first Governing Council to consist of more clinicians than people of basic science or social 
science   background,   “reflecting   the   new   era   of   [ART]   after   1996”   (Kallings   &   McClure,  




2008:15). Also, in 2001 they arranged their first conference on Pathogenesis and Treatment, 
attracting more than 3,000 medical scientists (Susman, 2001:N19). In contrast to the 
International AIDS Conferences these conferences are exclusively scientific, and included 
also biomedical prevention into their scope from 2007 onwards (Cahn & McClure, 2006). 
Hence, although still focused on low-road approaches around 2000, the increased 
legitimisation and importance of evidence-based research and biomedicine is unmistakable.  
As for the global response to AIDS, many interesting and significant changes happened at the 
time of the Durban conference. Certain initiatives specifically addressed the global 
inequalities regarding access to ART, such as the Accelerating Access Initiative (AAI) from 
May 2000 and the 2001 Doha Declaration. The AAI, an outcome of negotiations between UN 
agencies and five pharmaceutical corporations, drastically reduced the costs of ART to 
developing countries hard hit by AIDS. This pressure on the pharmaceutical industry was 
further enhanced by the Doha Declaration, which emphasised that the WTO TRIPS 
agreement should not be a hindrance to public health, and therefore that production of generic 
AIDS drugs should be allowed and more readily available despite patent ownerships (Knight, 
2008:122, 125). The Doha Declaration – directly   challenging   the  pharmaceutical   industry’s  
patents – was thus crucial as the industry was reluctant to approve the production of cheaper 
generic products, despite the scale of the AIDS pandemic. This pharmaceutical resistance can 
be   exemplified   by   how   the  South  African   government’s  Medicines   and  Related  Substances  
Control Amendment Act of 1997 (Republic of South Africa, 1997:5), which would enable 
parallel-import of medicines and local production of cheaper generic ART drugs, was met 
with a lawsuit by several pharmaceutical companies despite being allowed for in the initial 
WTO TRIPS agreement (Fourie, 2006:148-149). The lawsuit charges were eventually 
dropped in 2001, after immense public protests (Alsegård, 2004:16; Ingram, 2013:439-440).  
A commitment to AIDS in general was also discussed at the highest international levels. 
These   include   the   World   Bank’s   (WB)   Multi-Country HIV/AIDS Programme for Africa 
(MAP) of 1999 (Ingram, 2013:441; World Bank, 2013), the 55/2 United Nations Millennium 
Declaration from September 2000 (UN General Assembly, 2000) – what later became 
publicly known as the Millennium Development Goals (MDGs) – and  the UN General 
Assembly Special Session (UNGASS) on HIV/AIDS from 2001. UNGASS is a good example 
of how political commitment to the AIDS pandemic reached new heights. The Declaration of 
Commitment, being the forerunner of the 2006 Political Declaration on HIV/AIDS, engaged 
international   and   multilateral   actors   to   “prevent   new   HIV   infections,   expand   health   care  
access  and  mitigate   the  epidemic’s   impact”   (UNAIDS,  2007:9),  working   towards   the  MDG 




deadline in 2015. Although cooperation towards such a high-profile commitment proved 
challenging  taking  into  consideration  some  of  the  actors’  moral  judgements  regarding  sex  and  
sexuality (Knight, 2008:133), UNGASS has been said to be, together with the later 
establishment of the Global Fund in 2002, one of the most important factors leading to 
increased global funding for AIDS (Fylkesnes et al., 2011:1911). Thus, the period of 
institution building with regards to the AIDS pandemic does not only illustrate the increased 
political engagement for the AIDS pandemic, it was also significant for the development and 
funding of future global and multilateral responses. Table 3.2 provides an overview of many 
of the most significant institutions established between 1995 and 2003 with regards to the 
AIDS pandemic.  
Table 3.2: AIDS-related institutions established between 1995 and 2003  
Institutions Year 
WTO TRIPS 1995 
UNAIDS 1996 
World Bank MAP 1999 
Accelerating Access Initiative 2000 
MDG 2000 
The Gates Foundation  2000 
UNGASS 2001 
Doha Declaration 2001 
The Global Fund 2002 
PEPFAR 2003 
 
These developments – activism and success against the neoliberal pharmaceutical market 
industry and increased international political commitment – are seen as an essential part of the 
search for increased funding to curb the pandemic (Ingram, 2013:440; Kallings & McClure, 
2008:36; McInnes & Rushton, 2011:123; Parker, 2013). Parker (2013) emphasises the 
humanitarian vision of the access to treatment movement and the consequent global 
understanding of the link between AIDS, vulnerability and inequality. While Ingram 
(2013:440-442) understands that this sort of mobilisation can be understood as an attack on 
the neoliberal system itself in the quest for health and welfare, he adds the irony that these 
AIDS activists have simultaneously re-legitimised the system by using neoliberal values by 
enhancing market competition in order to access health. Neoliberal responses would still be 
used to respond to and finance AIDS through market dynamics, multilateral, philanthropic 




and non-governmental organisations and corporations, making it acceptable to supporters of 
the market to view AIDS as something that needs to be dealt with outside of current 
neoliberal norms. In global responses to AIDS, the market has indeed been an important, but 
also necessary, actor. This supports  Vanwesenbeeck’s  (2011)  claim  that  market  forces  shape  
multilateral AIDS responses because, according to this view, no matter the humanitarian 
intentions the pandemic is still undeniably dependent on the neoliberal market. 
Simultaneously, then, the pandemic must also be tied to the financial status of this market, 
something Vanwesenbeeck does not mention despite the significance of the Global Financial 
Crisis. These issues are further elaborated upon in Chapter 4.   
According to some scholars, however, it was  not  only  AIDS’  position   in,  or  outside  of,   the  
neoliberal market that helped the funding flow. In 2000, AIDS was discussed in the UN 
Security Council (UNSC), leading to the adoption of Resolution 1308. In this meeting and the 
following resolution, the UNSC discussed AIDS as a threat to national security – in other 
words as a problem with implications beyond human security (McInnes & Rushton, 
2011:121). The symbolic meaning of this event is significant, and exemplifies a shift where 
the discussion was not   only   about   the   structural   effects   on   AIDS,   but   AIDS’   effect   on  
structure. To get the message of the possible implications of the pandemic across, AIDS was 
linked to political instability and its negative effect on states, social wellbeing and the 
economy. This framing of AIDS as a security issue was put forward by high-profiled people, 
among  them  UNAIDS’  Peter  Piot,  to  underscore  the  need  for  a  comprehensive  reaction  to  the  
pandemic. AIDS was therefore more easily accepted as an exceptional emergency than a 
disease within sexual health. This is exemplified by how the securitisation of AIDS was 
reflected at the UNGASS meeting the following year, and was widely adopted by many actors 
in the international community (Ingram, 2013:440-441; McInnes & Rushton, 2011:121-122). 
Importantly, therefore, is not only the notion of how AIDS is positioned within the neoliberal 
market, but also the recognition that how AIDS has been problematised has affected how and 
when international responses came. In this case, the treatment of AIDS as something 
exceptional laid the grounds for increased funding for ways to deal with it.      
This is significant, because so-called   ‘HIV-exceptionalism’  enhances high-road approaches, 
linked to how the pandemic is separated from sexual and reproductive health in the MDGs 
and treated in the same funding stream as other non-sexual diseases – more specifically 
tuberculosis and malaria – through the Global Fund (Germain et al., 2009:842; 
Vanwesenbeeck, 2011:291). The way HIV-exceptionalism developed as indicated above 
might therefore suggest one way high-road approaches have been forced on global AIDS 




responses while trying to accumulate much needed funding. As Table 3.1 indicates, the 
securitisation of AIDS happened before funding for AIDS responses started to drastically 
increase around 2001-2002, which supports the argument that the securitisation of AIDS was 
a necessary and/or contributing factor to increased funding. This is further discovered in 
Chapter 4.  
3.3.2 Increased funding, 2002-2007 
At the XIV International AIDS Conference in Barcelona in 2002, calls for more resources to 
increase access to treatment in the developing world was still a hot topic, and the US 
government was especially pressured by activists to get more involved. The political 
commitment to the pandemic continued to grow, and more high-profile political leaders 
started to attend the conferences. Earlier that year the Global Fund to fight AIDS, 
Tuberculosis and Malaria was established, which, although actual funding was slow in the 
beginning, proved in the following years to be an effective multilateral funding mechanism. 
Now,  at   the  Barcelona  conference,   the  WHO  announced  its  ‘3  by  5’  initiative,  aiming  for  3  
million people on ART by 2005 (AIDS 2002 Conference News, 2002; Bliss, 2012:13; 
Kallings & McClure, 2008:36). This overall focus on treatment made commentators remind 
people of the still many serious side effects with ART (Zuger, 2002), and that prevention 
programmes are both working, needed and should not compete with treatment (Knight, 
2008:166; Piot, 2002).  
After the conference, at the beginning of 2003, the United States launched PEPFAR – “the  
largest   bilateral   aid   programme   in   the   world   to   fight   HIV/AIDS”   (Kallings   &   McClure,  
2008:36) – promising $15 billion to the pandemic and thereby forcing other countries to step 
up their game as well (Bliss, 2012:14). With the development of MAP, the Global Fund, and 
now PEPFAR, as well as the commitments and pledges made by many world leaders, funding 
for AIDS responses became easier and started to increase drastically. However, scholars claim 
that when distributing these funds treatment was usually the main priority, and prevention 
efforts were increasingly left behind (Bertozzi et al., 2008:841; Germain et al., 2009:842). 
Again, there is a sign that a binary between high-road and low-road approaches is emerging. 
PEPFAR’s  contribution  to  get  more  people  on treatment is undisputed – it has helped millions 
of people to access ART (Fourie, 2013:1) – yet the programme has been criticised for its 
controversial and moralistic policies (Bliss,  2012:15).  PEPFAR’s  funds  are mainly distributed 
through bilateral agreements, and the organisation has a lot to say in terms of how its donor 
money is spent by the receiving country. Religiously rooted, the first launch of PEPFAR was, 




apart from its main priority in non-sexual biomedical interventions, focused on abstinence in 
its prevention programme. Critics claim that programmes based on abstinence  denies not 
only sexual health and rights, but also the reality that for many women sex is not always 
negotiable (The Lancet, 2004:303-304; Population Action International, 2007). It must be said 
that PEPFAR funds have been used to distribute a significant amount of condoms (Knight, 
2008:171), however, these are claimed to have been stigmatised by reserving them for people 
engaging   in   ‘high-risk   activities’   (Population   Action   International,   2007). What is 
questionable and relevant for this research study, and is further elaborated upon in the 
subsequent chapter, is not the values of PEPFAR itself (although controversial), but rather 
how much this proclaimed moralism has affected trends and events within the global AIDS 
agenda over time. Considering that moralistic approaches are believed by many to be less 
effective, the continued existence of such approaches within a framework where evidence-
based research is increasingly demanded can highlight how certain ideas and power-positions 
affect AIDS agendas.  
Far away from PEPFAR and claims of moralism, the XV International AIDS Conference in 
Bangkok   in   2004   was   a   celebration   of   Thailand’s   prevention   programme,   which   had  
successfully reduced a substantial number of new HIV infections with its campaigns 
promoting consistent condom use and enhanced public information and awareness. The Thai 
government at the time also initiated access to ART and programmes focused on prevention 
of mother-to-child transmission (PMTCT) (Kallings & McClure, 2008:38). While, as Chapter 
2 indicates, condoms can be viewed as a biomedical intervention, their sexualised nature 
validates their placement within the cluster of low-road approaches. Thailand could thus show 
to a prevention programme focused on both low-road and high-road approaches. At the 
conference,   women’s   vulnerable   position in the pandemic was a topic of great concern. 
Furthermore, acknowledging the major developments made in the global AIDS response since 
Durban, the Bangkok conference was focused on continuing to push for worldwide access to 
treatment, care and prevention. In doing so, more funding was called for, but this time more 
specifically to the multilateral Global Fund. Heated protests again emerged over overpriced 
drugs   and   the   newly   established   PEPFAR’s   controversial   policies   (Bliss,   2012:15;;   IAS,  
2004:35; Kallings & McClure, 2008:39). Emphasising the importance of connecting the 
conferences with the local community, engaging leaders, and including young people in 
discussions, the conference in Bangkok was the first to arrange the Global Village, the 
Leadership Programme, and the Youth Programme. This commitment underscores the 
conference’s  holistic  approach.   In   fact,   the  subsequent  conference  report  says   that  “[o]ne  of  




the   great   lessons   [from   Bangkok]   was   that   ‘one   size   does   not   fit   all’,   that   treatment   and  
prevention   plans   have   to   be   tailored   to   local   conditions”   (IAS,   2004:49).   The   need   for  
cooperation between diverse AIDS responses was also stressed by high-profile AIDS figures 
Peter Piot and Helene Gayle (IAS, 2004:19).  
Although some commentators noted that the development of the conferences from scientific 
meetings   to   a   “political   circus”   (Altman,   2004)   was   a   necessary   good,   not   everyone   was  
pleased  with  Bangkok’s  political  focus.  Some  scientists  disagreed  with  what  they  perceived  as  
a chaotic development of the   conferences,   claiming   that   “this   large   forum   appears   to   have  
become  irrelevant  to  the  science  of  AIDS”  (Laurence,  2004).  Indeed,  some  scientists  started  
to become attracted to other, more scientific, AIDS meetings instead (Kallings & McClure, 
2008:28), despite the fact that important scientific discussions – for instance about emerging 
biomedical prevention approaches – were present at the conference (IAS, 2004:12). Because 
of the believed importance of a contextual image of the pandemic, the conference report states 
that  “while  a  few  commentators  expressed  disappointment  at  the  prominence  of  ‘politics  over  
science’   in   Bangkok,   they   may   have   been   missing   an   important   point”   (IAS,   2004:4).  
Considering these features of the Bangkok conference, it did not seem as if high-road 
approaches were going to squeeze out low-road approaches any time soon.  
Simultaneously, the increased involvement of different governments and actors created a fear 
of duplicated responses towards AIDS. While an increased amount of actors were necessary 
to accumulate enough money to deal with the pandemic comprehensively, this also eventually 
sparked the need for some kind of coordination of approaches in order not to create more 
harm than help, and for funds not to be wasted (Garrett, 2007:14-15). Hence, a UN based 
standardisation was requested in order to get an overview of cost and efficiency of approaches 
(Bliss, 2012:14), and there was also an increased demand for links between evidence and 
policies (IAS, 2004:12-13). Importantly, efforts to curb the pandemic were (and still are) 
donor dependent. This, according to Garrett (2007:21-23), promotes approaches that are 
specifically   directed   at   sensational   diseases   stirring   strong   emotions,   and   are   thus   “tied   to  
short-term numerical targets”   (Garrett,   2007:15)   undermining   the   importance   of   the   overall  
health system. While these multiple disease specific efforts certainly needed coordination to 
ensure efficiency, such standardisation can also be argued to be shaped by ontological and 
epistemological understandings, especially as donors prefer short-term targets and feel more 
comfortable knowing that their funds are spent wisely and based on evidence, like suggested 
above. Both disease specific and evidence-based approaches are more aligned with 
quantifiable high-road approaches and are further discussed in Chapter 4.  




Figure 3.1 indicates financial pledges from donor countries and actual disbursements between 
2002 and 2012. As the figure shows, funds pledged and disbursed grew drastically after 2002, 
illustrating the need for coordination of efforts. Significantly, the figure also indicates how 
actual distributions flatlined and decreased after the implications of the Global Financial 
Crisis reached the pandemic after 2009, a development which is further explored below and 
important for the analysis of Vanwesenbeeck’s  (2011)  model.     
 
Figure 3.1: International HIV assistance from donor governments: commitments and 
disbursements, 2002-2012 (Kates et al., 2013:2). 
With AIDS already high up on the emergency and security agenda, the United Nations 
General Assembly High-Level Meeting on AIDS was arranged in the beginning of June 2006. 
Here, the UN General Assembly Political Declaration on HIV/AIDS was adopted. This 
declaration reiterated the MDGs from 2000 and the Declaration of Commitment on 
HIV/AIDS from the UNGASS meeting in 2001, and emphasises the vulnerable position of 
women and children in the pandemic, the importance of human rights and sexual and 
reproductive health, the structural implications of poverty and the need for international, 
multilateral  and  domestic  engagement  and  political  commitment.  The  declaration’s  objective  
was   to   encourage   the   global   community   to   ‘scale-up’   their   efforts   and   achieve   worldwide  
availability to treatment, care and prevention by 2010 (UN General Assembly, 2006). It also 
“[r]eaffirm[s]  that  the  prevention  of  HIV  infection  must  be  the  mainstay  of  national,  regional  
and international responses to  the  pandemic”  (UN  General  Assembly,  2006:4).   
Later that year, in mid-August, the XVI International AIDS Conference was arranged in 
Toronto. Similar to the Political Declaration on HIV/AIDS, the Toronto conference presented 
a comprehensive and multifaceted picture of the AIDS pandemic and the global response. The 




conference was gender sensitive; the links between gender inequalities, violence and 
transmission of HIV were widely discussed and recognised, although some attendees claimed 
that little was said on how to care for vulnerable women already infected (IAS, 2007:12-13). 
At the same time, biomedical discussions were more prominent than in a while due to recent 
developments in scientific research – more specifically the posted possibility of using 
treatment as prevention (TASP). ART use by people living with HIV was discovered to 
reduce the chance of transmitting HIV sexually. By scaling up treatment efforts the 
constructed binary between treatment and prevention was thus in the scope of being bridged, 
according to TASP enthusiasts (Bliss, 2012:16; IAS, 2007:11-12). With this in mind the 
possibility   that   “[p]roviding   universal   treatment   access   could   potentially   save   billions   of  
dollars  over  time”  (IAS,  2007:12)  was  one  of  the  arguments  to  encourage  further research on 
the topic.  
Referring more to the new TASP regime than an integration of various approaches, prominent 
world figures Bill and Melinda Gates of the Gates Foundation talked about the importance of 
realising the symbiosis between prevention and treatment in the fight against AIDS. Showing 
how  the  conference’s  gender  sensitive  and  biomedical   focus  coincide,  Melinda  Gates  spoke  
out for the many vulnerable women in risk of infection and how continued development of 
biomedical microbicides can help empower them. Furthermore, the Toronto conference 
highlighted new evidence-based studies on how male circumcision (MC) can lower the risk of 
contracting and passing on the HI-virus (IAS, 2007:10). These findings led to a 
recommendation by WHO and UNAIDS in 2007 to implement the practice (Giami & Perrey, 
2012:356).  Hence,  although  “many  conference  delegates  and  members  of  the  media  [viewed  
the   International   AIDS   Conference   in   Toronto   as]   the   conference   of   prevention”   (IAS,  
2007:10), discussions on prevention had started to take a new turn and were more concerned 
with the current and future situation of prevention technologies (IAS, 2007:10-11). This is 
important, because the emergence of the TASP model is a strong indicator of a more 
biomedical approach and the increasing appearance of high-road solutions.  
Indeed, several scholars see the development of TASP and MC as a clear sign of an 
increasingly medicalised AIDS response. Using MC as an example, critics argue that the 
approach   is   ‘top-down’   – as high-road solutions are – in the sense that the medical 
intervention   is   “carried   out   on individuals   and   societies   […]   as   opposed   to   with those 
affected”  (Rochel  de  Camargo  et al.,  2013:780,  original  emphasis),  effectively  removing  “the  
‘human   factor’”   (Giami   &   Perrey, 2012:357) and thereby increasing the reliability of the 
intervention. Unlike behavioural solutions, biomedical approaches are not dependent on 




human’s  sexual  modification.  Hence,  MC  is  not  as  effective  as  condoms  but  the  approach  is  
easier to control (Giami & Perrey, 2012:358). This is linked to how medical research and 
RCT aim to remove the effect of context, as emphasised in Chapter 2. Similarly, biomedical 
approaches are also easier to implement than trying to change structural conditions of AIDS, 
such as inequality and sexual violence (Parker, 2013). The notion that de-contextualised and 
de-sexualised biomedical approaches are easier to measure should therefore not be 
underestimated, especially, as is discussed later, when funding suddenly becomes scarce. 
Absurdly, however, is the good point that biomedical approaches also are dependent on a 
change in behaviour in order for people to actually access and use them. Behavioural and 
biomedical approaches are therefore somewhat united in individualism (Giami & Perrey, 
2012:357-358), as opposed to structural explanations (Parker, 2013).   
Expressing similar views, not everyone in Toronto agreed with TASP and MC being 
exclusively positive developments. Some researchers and actors of civil society expressed a 
fear that prevention technologies would be the easy individualised solution that in effect 
would   ignore   vulnerable   populations’   need   for   empowerment   and   create   a   trend   where  
political and structural difficulties in AIDS responses are not effectively dealt with at the 
hands of medicalisation (IAS, 2007:13-14).  However,  in  addition  to  the  conference’s  focus  on  
the feminisation of the pandemic and gender sensitivity, and despite the discussions on 
prevention mainly being biomedical, there were visibly other low-road approach focused 
discussions.  For   instance,  concerns  were   raised  over  HIV’s  exceptional  position   in   scale-up 
efforts, and the possible negative effects this could have on funding for other diseases and 
resources left to focus on general health. Indeed, binaries between short-term, vertical and 
HIV specific vs. long-term, horizontal and cohesive services in health were recognised, 
although optimists highlighted how an HIV-specific approach is dependent on a strengthening 
of health infrastructure in general and therefore might not be harmful (IAS, 2007:22-23). 
Nevertheless, despite the diverse topics at the conference, or perhaps because of it, the content 
was criticised by actors who requested more scientific presentations in both quantity and 
quality (Bliss, 2012:16). 
The efforts made to scale-up global funding for AIDS and access to treatment reaped benefits. 
Between 2003 and 2005 people accessing ART in the developing world grew from 400,000 to 
1 million (Abdool Karim, 2006:N7), and more than $30 billion had been pledged to the 
Global Fund between 2002 and 2011 (UN General Assembly, 2011:3).   
 




3.3.3 Remedicalisation and funding cuts, 2008- 
The year 2008 started well in terms of funding: PEPFAR announced to commit $48 billion in 
its second round (Bliss, 2012:17). At the XVII International AIDS Conference in Mexico City 
later that year discrimination and stigma among people living with HIV was on the agenda, as 
well as a continued emphasis of the need for universal access to treatment (Bliss, 2012:17; 
Kort et al.,   2008:5).   Due   to   the   close   2010   deadline   of   ‘universal   access’,   participants  
suggested how the International AIDS Conferences could monitor the progress and hold 
policymakers accountable for their promises (Kort et al., 2008:6). Continuing the health 
systems debate from Toronto, most speakers in Mexico City argued that approaches 
specifically addressing HIV are strengthening the rest of the health system in general, thereby 
concluding that HIV-exceptionalism in health care did not affect other health issues 
negatively – rather the opposite (Kort et al., 2008:5). From this point of view, 
Vanwesenbeeck’s  (2011)  emphasis  on  the  difference  between  vertically  distributed  high-road 
approaches and horizontal low-road approaches might not be real in terms of neglecting 
infrastructure for health. However, although certainly affecting each other, it might be useful 
in this debate to separate between strengthening infrastructure and improving health care. In 
the light of the top-down medical interventions discussed above regarding de-contextualising 
interventions, vertically distributed solutions might improve infrastructure, but also change 
how health systems work and what they prioritise. If they are becoming increasingly 
biomedical this is   supporting   Vanwesenbeeck’s   point   in   the   sense   that   short-term and 
individualised approaches are prioritised on behalf of making local health services self-
sustainable and adapted to their local context.  
Also significant for the conference in Mexico City  was  the  coining  of  the  term  ‘combination  
prevention’  and  the  emphasis  on  combining  behavioural,  structural  and  biomedical  prevention  
approaches. According to the IAS report after the conference, this prevention strategy aims at 
taking structural factors,   “such  as  gender   inequality,  homophobia  and   the  criminalization  of  
drug   use   and   sex   work”   (Kort   et al., 2008:5) into consideration with behavioural and 
biomedical solutions in the designing of a more long-term approach towards HIV prevention. 
At first sight this seems like the combination of high-road and low-road solutions that 
Vanwesenbeeck (2011) requests. Parker (2013) and Giami and Perrey (2012:356-357), 
however, argue how combination prevention efforts are constructed within overall biomedical 
approaches and the belief that these can deal with structural factors as well, such as how 
microbicides empower vulnerable women without actually taking care of the structural 
situation. Supporting their argument about biomedicalised combination prevention is the 




increased focus on RCTs confirming the effects of TASP, and the notion that the 2008 
conference   “became   known   for   the   ‘marriage’   of   treatment   and   prevention”   (Kort   et al., 
2008:5). However, this development might less be a consequence of a rational choice based 
neglect of structural, cultural and sexual approaches in general as much as there is an 
ideational change in what is perceived as constructive solutions exemplified by an increase in 
demands for measurement, accountability and evidence-based research, which, as already 
argued, is difficult to use on contextual approaches.      
At the XVIII International AIDS Conference in Vienna, discussions evolved around human 
rights for injecting drug users – emphasised in the Vienna Declaration – and further 
development of prevention technologies (Bliss, 2012:18). In efforts to scale-up funding for 
the latter, Treatment 2.0 was launched with emphasis on the implementation and further 
development of TASP, prevention technologies and prevention of mother-to-child 
transmission (IAS, 2010:23). 
Hence, concerns were raised at the conference about funding, but within a different context 
than   earlier   as   “[a]lthough   2008   saw   the   highest   levels   of   resource   allocation   for  HIV   and  
AIDS yet, donors are now curtailing or flat-lining  HIV  funding”  (IAS,  2010:2).  By  the  end  of  
2008, the Global Financial Crisis was a fact (Germain, 2010:xi, 19), and its implications on 
funding for health and HIV is recognised by several actors (Fourie, 2013:3; IAS, 2010:8; UN 
General Assembly, 2011:3; WHO et al., 2011:7-8). Important actors were hit hard. The 
Global Fund, for instance, had to have a replenishment meeting in October 2010 as a 
consequence of not receiving all the money they had been pledged (UN General Assembly, 
2011:3-4). Having less money to work with, how the existing funds are distributed becomes 
an issue of concern (Fourie, 2013:3). How these resources are distributed in the end is, 
according   to   Ingram   (2013:448),   affected  by   neoliberal   principles   of   ‘scarcity’   in   the   sense  
that funding for AIDS approaches need to be rationalised by their efficacy and comparability 
– in other words how cost-effective they are. 
With this in mind, high-road   approaches’   eligibility   with   neoliberal   principles   of   efficacy,  
quantifiable measurement and need for monitoring and evaluation, might be able to explain 
why easier-to-measure biomedical high-road approaches have been prioritised during a time 
of economic crisis, despite them being more expensive in the outset. Vanwesenbeeck (2011), 
in this view, is not emphasising the importance of the Global Financial Crisis enough in her 
model.  On  the  other  hand,  Ingram’s  (2013:446)  argument  is  based  on  a  belief  that  the  tensions  
between developmental and biomedical approaches did not become a problem until resources 




became scarce. Hence, if arguing that the separation between high-road and low-road 
approaches happened much earlier, the Global Financial Crisis or neoliberal scarcity in 
general cannot explain why high-road approaches seemed to be dominant when resources 
were still abundant, or even increasingly influential as resources increased as well. Here, 
Vanwesenbeeck’s   more   ideational   understanding   of   how   global   AIDS   agendas   are   shaped  
might have more explanation value, keeping in mind that neoliberalism is more than just a 
financial strategy, and that ideas of moralism, medicalisation and the market are believed to 
influence each other as well as the more physical outcomes of these ideas and norms. For 
instance, and also recognised by Ingram (2013:444), how AIDS was framed as an exceptional 
emergency and a threat to national security might therefore not only have influenced the 
increased resources rolling in at the beginning of the millennia, but also why funds started to 
decrease as the effect of HIV-exceptionalism was questioned and the security complications 
of AIDS re-evaluated. As McInnes and Rushton (2011:131) argue, this process was not only 
based in so-called empirical evidence but also how the securitisation/de-securitisation of 
AIDS was constructed, presented and received.  
In 2011, between the conferences in Vienna and Washington D.C., two significant events 
took place: the findings from the HPTN 052 trial on TASP, and the 2011 Political Declaration 
on HIV and AIDS. The HPTN 052 trial found that early treatment of HIV-positive people 
decreases sexual transmission of the virus with as much as 96 per cent (Granich et al., 
2012:2). This sparked further belief and hailing of the TASP model (WHO, 2012:5-6). 
Around the same time the 2011 Political Declaration was adopted by the General Assembly in 
July.  Reaffirming  the  2001  Declaration  of  Commitment  and  the  2006  Political  Declaration’s  
commitment   to   accomplish   “universal   access   to   comprehensive   treatment   programmes,  
treatment,   care   and   support”   (UN  General   Assembly, 2011:2), it also came with a clearer 
message of eradicating AIDS once and for all.  
This optimistic commitment was repeated at the XIX International AIDS Conference in 
Washington D.C. in 2012. The Washington D.C. Declaration is specifically aimed at ending 
AIDS (IAS et al., 2012), which is deemed possible with the many biomedical interventions 
now in place (The Lancet Infectious Diseases, 2012). Therefore, a topic at the conference was 
again calling for more funding in order to reach this goal and the engagement of the private 
sector and faith-based organisations was encouraged. The need to strengthen human rights 
and fight discrimination and stigma within the development, distribution and implementation 
of biomedical approaches was also frequently discussed (IAS, 2012:8-9).  The  goal  of  ‘ending  
AIDS’  is  significant.  It  would  indeed  be  optimal  if  the  pandemic  could  be  curbed.  Yet  the  idea  




of   ending   AIDS   and   the   “AIDS-free   generation”   (PEPFAR,   2012:4)   proposed   by   Hillary  
Clinton is not within sight with current strategies. The approach is first of all dependent on a 
new major scale-up in global funding, especially considering that previous targets for 
universal access are yet to be met (The Lancet, 2012), and secondly framed within a reliance 
on biomedical approaches and prevention technologies (Parker, 2013). Hence, despite a focus 
on human rights, the idea of high-road biomedical and vertical approaches seems to be the 
dominant one when the last International AIDS Conference was arranged in 2012.  
3.4 Conclusion 
This chapter has presented an historical overview of key events at and around the nine 
International AIDS Conferences arranged between 1996 and 2012. The main analysis of 
Vanwesenbeeck’s   (2011)   model   of   high-road and low-road approaches only appears in 
Chapter 4, where it is explored whether her arguments holds in relation to the International 
AIDS Conferences, and how influential ideas of the market, morals and medicalisation are in 
shaping global AIDS agendas. The aim of this chapter has, therefore, been to shape the 
historical outline necessary for the further analysis. This has been done within frameworks 
that can highlight different sides of developments within multilateral AIDS responses and of 
Vanwesenbeeck’s  model   itself.  More   specifically,   these have been frameworks focused on 
neoliberalism’s   role   in   the   pandemic,   HIV-exceptionalism and securitisation, and the 
construction of medicalisation and its relationship to humans, culture and sex. Examining 
what has been discussed at the conferences and the surrounding events, there are clear signs 
of certain moralist approaches, top-down interventions, problematisations of AIDS, increased 
focus on evidence-based approaches, increased belief in biomedical solutions, and 
dependency of the neoliberal market, which indicate an ideational preference for high-road 
approaches.   Hence,   elements   of   Vanwesenbeeck’s   model   can   certainly   be   identified.  
However, the model shows signs of incoherence in some parts and it is not clear what has 
affected these  various  historical  developments.  Therefore,  Vanwesenbeeck’s  argument  of  the  
ideational effects of the market, medicalisation and morals on global AIDS agendas is still to 
be fully discovered and discussed, especially in relation to the more materialistic effects of 
neoliberalism and rational reactions towards decreased amounts of resources. This is further 
explored in Chapter 4.  
  




Chapter  4:  Analysis  of  Vanwesenbeeck’s  model 
4.1 Introduction 
In light of the background theories of public policy problematisations and IR constructivism 
explored  in  Chapter  2,  Vanwesenbeeck’s  model  aims  to  interrogate  how  ideas  and  norms  have  
affected how AIDS is globally problematised and responded to. As such, Vanwesenbeeck 
argues that there is a binary between biomedical and vertically distributed high-road 
approaches and the more contextual and sexually determined low-road approaches. This, she 
claims is because current ideas and norms of the market, morals and medicalisation are 
prioritising high-road approaches because of their de-sexual and de-contextual characteristics. 
The  aim  of   this   study   is   to   investigate   and   test  whether  Vanwesenbeeck’s   (2011)  model  of  
high-road and low-road solutions can be identified in and illuminate the policy ideas, problem 
definitions and political binaries that play out in the discourse surrounding the biennial 
International AIDS Conferences between 1996 and 2012.  
Chapter 3 provided an historical outline of the key events and tendencies regarding global 
AIDS policies during this time. It concluded that overall trends, such as increased emphasis 
on evidence-based research, presence of moralistic approaches, dependency of the neoliberal 
market and prominence of biomedical solutions indicate a prioritisation of high-road 
approaches   since   1996.   Chapter   3   thus   suggests   that   features   of   Vanwesenbeeck’s   (2011)  
model can be recognised in multilateral AIDS governance since 1996. As already mentioned, 
Vanwesenbeeck’s  model  suggests  that  ideas of medicalisation, moralism and the market have 
influenced this high-road prioritisation. However, as Chapter 3 indicates, there can also be 
other explanations for this development. For instance, measurable biomedical high-road 
solutions could also have gained prominence due to the changed economic landscape after the 
Global   Financial   Crisis   and   such   approaches’   alignment   with   rational   principles   of   cost-
efficiency and evaluation. In this case, high-road prioritisation could be a reaction to the 
material need to evaluate the efficacy of donor money after resources became scarcer, instead 
of a consequence of current ideas and norms of moralism, medicalisation and the market.  
This is one of the arguments that this chapter explores further for the purpose of analysing the 
utility  of  Vanwesenbeeck’s  model  for  explaining  multilateral  AIDS  agendas.   
This   chapter   aims   to   analyse  Vanwesenbeeck’s  model  of   the  binary  between  high-road and 
low-road approaches by discussing indicators of these approaches and exploring the 
explanation value of ideas of morals, medicalisation and the market. More specifically this 
involves an analysis of the prominence of moralistic policies and policymakers, the 




understanding of evidence and knowledge, HIV-exceptionalism, the role of social justice and 
human rights, the complex protagonist of the neoliberal market, and the understanding of 
sexual   and   reproductive   health.   Identification   of   and   engagement   with   Vanwesenbeeck’s  
model, its limitations and alternative explanations for the development of multilateral AIDS 
responses are essential for this analysis. 
4.2  The  utility  of  Vanwesenbeeck’s  model 
As  Chapter  3  already  indicates,  elements  of  Vanwesenbeeck’s  (2011)  model  of  high-road and 
low-road approaches can certainly be recognised in the events and developments surrounding 
the International AIDS Conferences between 1996 and 2012. What is not clear, however, is 
what kind of underlying factors have contributed to this development. Vanwesenbeeck argues 
that ideas and norms – a reverberation of   constructivists’   notion   of   ‘norm   cascades’  
(Finnemore & Sikkink, 1998) – of medicalisation, morals and the market are affecting high-
road prioritisation. There can be, however, several other explanations or ideas behind an 
increasingly biomedical pandemic, such as financial consequences after the Global Financial 
Crisis, humanitarianism and the framing of AIDS as a security issue. The analysis in this 
chapter  seeks  to  critically  analyse  the  utility  of  Vanwesenbeeck’s  model  by  discussing  high-
road and low-road indicators and the effect of ideas of moralism, the market, medicalisation 
and the alternative ideas on these indicators. This discussion is complemented with insights 
from a personal semi-structured interview with Nathan Geffen, a key informant with long 
work experience from the Treatment Action Campaign (TAC) and the former AIDS Law 
Project (ALP) who attended many of the International AIDS Conferences under scrutiny in 
this study. 





High-road approaches Low-road approaches 
Moralistic values and policymakers Sexual and reproductive health 
Evidence-based research, science and de-
sexual approaches 
Social and political science 
Market dependency Social justice and human rights 
HIV-exceptionalism Horizontal health approach 
 
Table 4.1 provides an overview over the main indicators used to identify the presence of high-
road and low-road approaches in the following analysis. It must be noted that not all of these 
indicators have their separate subheading, as they are discussed together with and compared 
to other indicators in the table. Importantly, this overview is also not an outline of everything 




that this chapter discusses, as limitations and new suggestions to the model are also elaborated 
upon.  
One   of   Vanwesenbeeck’s   (2011)   suggestions   for   high-road prioritisation in global AIDS 
agendas is the prominence of moralistic norms and values and the influence such ideas pose 
on pushing de-sexualised responses to the pandemic. The following section explores this 
argument by exploring the prominence of these ideas, especially with regards to the US based 
PEPFAR programme under George W. Bush. 
4.2.1 Prominence of moralistic values and policymakers 
As Chapter 3 indicates, moralistic values – the conservative inter-subjective norms shaping 
some  prominent  actors’  policies  – have certainly been present in AIDS discourses after 1996. 
The Vatican, for instance, has kept a conservative stance when addressing the pandemic, 
preaching sexual abstinence   and   implying   that   the   use   of   condoms   and   women’s   rights   to  
sexual and reproductive health involves immoral behaviour that cannot be accepted (Adolphe, 
2011).  PEPFAR’s   initial  policies  under  George  W.  Bush,  known  as  PEPFAR  I,  had  similar  
moralistic attitudes:  the  smaller  bulk  of  the  programme’s  finances  that  were  addressing  sexual  
transmission of HIV were ideationally and financially prioritising programmes focused on 
abstaining   from   sexual   intercourse.   Similar   to   the   programme’s   predominantly   biomedical 
focus these mentioned anti-sex characteristics are typical of high-road approaches. Other 
types of prevention of sexual transmission, for instance low-road approaches such as condom 
education and distribution, were saved for people engaging in so-called  ‘high-risk  activities’  
(The Lancet, 2004:303; Office of the United States Global AIDS Coordinator, 2005:18-23). 
Akin to the very beginning of the pandemic the US government seemed uncomfortable with 
AIDS’   sexual   contents,   expressing   views   of   the   many   Christian conservatives in the US 
(Barnett & Parkhurst, 2005:590; Epstein, 2005). As stressed in previous chapters, such de-
sexualising problematisations of AIDS are more aligned with biomedical and asexual high-
road approaches than sexually contextualised low-road approaches. Considered that a large 
and significant programme such as PEPFAR I reflected these disapproving inter-subjective 
understandings of the sexual aspects of AIDS, it is not unreasonable of Vanwesenbeeck 
(2011) to suggest that morals have affected global AIDS agendas and governance.  
At International AIDS Conferences, PEPFAR I – despite major successes in distributing ART 
– was met with protests and resistance for this conservative approach (Bliss, 2012:15; IAS, 
2004:12; Rivers, 2004). Moralistic policymakers, and particularly PEPFAR I, have indeed 
been widely criticised for pushing an agenda that disregards scientific evidence, is unrealistic, 




spreads misinformation, violates human rights and sexual and reproductive health and ignores 
structural challenges and restrictions on individual sexual agency (Barnett & Parkhurst, 
2005:591; Cohen & Tate, 2005:67-70; Goldstein, 2011; The Lancet, 2004:303; Population 
Action International, 2007). Therefore, if one believes that the acceptance of ideas and norms 
are reflected in how they are taken for granted and thereby not criticised, the lack of 
acceptance of moralistic ideas and policies raises questions of how widespread moralistic 
norms actually are and whether Vanwesenbeeck (2011) overstates the ideational influence of 
moralism.  
Nevertheless,  although  scholars   tend  to  disagree  on  whether  PEPFAR’s  initial  policies  were  
fruitful (Halperin et al., 2004:1913) or not (Cohen & Tate, 2005:1) they all seem to imply that 
the  programme’s  involvement  has been somewhat influential. For instance, the ones arguing 
that   the   sudden   increase   in   Ugandan   HIV   infections   “[i]s   attributed   to   the   [Ugandan]  
government’s   move   away   from   condom   promotion   and   distribution   and   substantial   U.S.  
assistance for abstinence-only  activities  that  has  distorted  Uganda’s  once-balanced  approach”  
(Population Action International, 2007) are certainly indicating the impact of moralistic ideas 
on policy implementation albeit not agreeing with them. 
With this in mind, the crucial need and timing   of   PEPFAR   I’s   initial   $15   billion   budget  
should not be underestimated, as it appeared at a time when scaling up of funds to AIDS was 
essential  for  the  future  global  response  to  the  pandemic.  Thus,  the  impact  of  the  programme’s  
moralistic policies can be argued to rather be based in its financial authority as in the 
acceptance   of   its   moralistic   ideas.   This   distinction   is   not   pointed   out   in   Vanwesenbeeck’s  
(2011)  model.  Certainly,  an  important  criticism  of  PEPFAR  I  was  that  it  “exert[ed]  too  much  
control   over   the   design   and   emphasis   of   local   HIV/AIDS   programs”   (Garrett,   2007:30)  
through its bilateral agreements. This indicates that the programme used its financial 
superiority to implement its own inter-subjective ideas where they perhaps had not been as 
readily accepted were it not for the need for financial support. Supporting this argument is 
how PEPFAR I also inserted its moralistic norms outside its own programme by making 
restrictions on what other organisations could purchase with PEPFAR funds. For instance, the 
Global Fund was not allowed to support family planning efforts – an essential part of low-
road clustered sexual and reproductive health – with money from PEPFAR (Cleland & Ali, 
2006:1792). Indeed, in 2004 an editorial in the respected journal The Lancet claimed that 
PEPFAR’s  financial  position  was  an  upper  hand  that  made  some  prominent  actors  – including 
the   Global   Fund’s   Executive   Director   at   the   time,   Richard   Feachem   – not reproach the 
programme’s   policies,   believing   that   “the   size   of   the  US investment into AIDS render[ed] 




President   Bush   immune   from   criticism”   (The   Lancet,   2004:304).   That   PEPFAR   I’s  
contributions have made the overall programme more legitimate is reflected in Nathan 
Geffen’s  comment   from  a  personal   interview,  where  he  explains   that  although  he  has  “been  
involved  in  […]  criticisms  [of  PEPFAR]  over  the  years  [….]  on  balance  PEPFAR  has  been  
predominantly  something  that  saved  lives”  (Geffen,  2013).   
With the example of PEPFAR I, it can seem as if widespread acceptance of moralistic ideas 
contribute less to high-road prioritisation than the material strength and legitimacy of moral 
policymakers. While this can highlight the impact moralistic policies have had in global 
responses   to  AIDS,   supporting  Vanwesenbeeck’s   (2011)  argument  of their influence, it still 
does  not  support  Vanwesenbeeck’s  indication  of  widespread  moral  ideational  ‘forces’,  as  the  
acceptance of moralistic ideas lies within certain policymakers and not the global AIDS 
community as a whole. Thus, the actual effect of moralistic ideas might not have been that 
significant  had  it  not  been  for  moralistic  policymakers’  financial  muscles. 
Simultaneously, the ideational scope of moralism must not be underestimated, as moralistic 
policymakers are not rational interest seekers operating in a vacuum unaffected by ideas and 
norms. Although the moralistic ideas these policymakers are expressing are inter-subjective 
rather than objective, this still suggests the presence of a moralistic ontology in some circles. 
Furthermore, despite criticism of moralistic ideas and norms, it is difficult to see how 
moralistic policies could have been implemented without any ideational legitimacy. This can 
be   viewed   in   the   light   of   Finnemore   &   Sikkink’s   (1998)   idea   of   ‘norm   cascades’   in  
international relations, where norms are accepted based on international pressure despite them 
not necessarily expressing domestic values. In this case, the ideational legitimacy of PEPFAR 
as a programme representing the US President should be considered an important factor in the 
acceptance of its moralistic ideas.  
Furthermore, moralistic ideas and norms are still expressed in global discourses on AIDS. The 
Vatican, for instance, has pronounced a clear de-sexualised interest during meetings regarding 
future global AIDS responses, such as the high-level meeting resulting in the 2011 Political 
Declaration on HIV and AIDS (Goldstein, 2011). As a consequence of the UN system where 
various interests have to be taken into account, these meetings can easily turn into 
negotiations over values and religion, which again is reflected in the politically correct end 
result. Also, as Chapter 2 indicates, people living with HIV, and especially the communities 
particularly hard hit by the pandemic, have been alienated since AIDS was discovered in the 
1980s. As such, stigmatisation and discrimination are to this day prominent issues posing 




several challenges, which have been vigorously discussed at several International AIDS 
Conferences, especially from 2006 onwards. This can mean two things: first of all, there are 
still  certain  “value-based  judgments”  (IAS,  2007:33)  stigmatising  people  living  with  HIV  and  
the so-called   ‘high-risk   groups’  of   infection,   for   instance  by  moralistically   linking  AIDS   to  
acts of promiscuity and irresponsibility (IAS, 2007:33; Kort et al., 2008:25). In other words, 
moralistic ideas and norms are still prominent, as Vanwesenbeeck (2011) suggests. Second, 
and on the other hand, the fact that stigma and discrimination are met with resistance and 
action supports the abovementioned argument that the impact of moralistic norms are limited, 
as moralistic ideas are neither accepted nor taken for granted. Furthermore, the indication that 
human rights issues are discussed at the International AIDS Conferences suggests a presence 
of rights-based low-road   approaches   that   are   not   reflected   in  Vanwesenbeeck’s  model.  The  
role of this more recent rights-based focus is further explored in Sections 4.2.3 and 4.2.4. Yet 
still, as argued above, moralistic policymakers are part of shaping global AIDS policies. 
It  can  thus  be  argued  that  moralistic  policymakers’  – such as PEPFAR under George W. Bush 
– executive ability is found somewhere in the nexus between materialism and ideas, where 
(desperately needed) financial authority is linked to somewhat acceptance of moralistic ideas 
through   normative   power   and   traditional   legitimacy.   IR   constructivists’   emphasis   on   this  
nexus of how ideas and materialism are reinforcing each other, as explored in Chapter 2, can 
elucidate and support Vanwesenbeeck’s (2011) model here. Moralistic policies and material 
outcomes do not  exist  in  a  vacuum,  thus,  moralistic  policymakers’  financial  influence  must  be  
understood in the light of the inter-subjective ideas encouraging them to enforce this 
influence. Similarly, the acceptance of moralistic policies in donor receiving countries must 
be  based  in  somewhat  acceptance  of  the  ideas  that  they  hold.  This  supports  Vanwesenbeeck’s  
model of the impact of morals on multilateral AIDS governance. 
Interestingly, however,   is  how  Vanwesenbeeck’s   (2011)  model   indicates   that  moralistic  and  
medicalised ideas have affected high-road prioritisation simultaneously. Certainly, the de-
contextualised and de-sexualised elements of medicalisation fit moralistic ideas well, as 
Vanwesenbeeck  suggests.  However,  as   indicated   in  Chapter  3,  moralistic  policies’   link  with  
evidence-based research is dubious at best (amfAR, 2007; Campbell & Shaw, 2008:691; El-
Sadr & Hoos, 2008:553; IAS, 2007:15; Nguyen et al., 2011:292; PEPFARwatch, s.a.). 
Considering that evidence-based research is, as Chapter 2 also reports, an important element 
of medicalised ideas and suggested high-road prioritisation, moralistic norms and medicalised 
ideas do not necessarily complement each other as well as Vanwesenbeeck suggests. It is 
therefore paradoxical that ideas of moralism have gained prominence at the same time as the 




need for evidence-based research has grown. As suggested in Chapter 3, this can highlight 
how certain positions of power and moralistic ideas play out in shaping policies and 
distributing funds. In terms of the nexus between ideas and materialism, moralistic beliefs and 
financial superiority might therefore not only have allowed moralistic actors to ignore 
criticism of their conservative policies, but also convincing results from evidence-based 
research suggesting the actual ineffectiveness of moralistic policies. Indeed, this idea that 
“even   the   best   scientific   evidence   does   not   sway   governments”   (Nguyen   et al., 2011:292) 
supports   Vanwesenbeeck’s   argument regarding the influence of moralistic ideas. This is 
further elaborated upon in Section 4.2.4. However, this mismatch between moralistic and 
medicalised ideas can also indicate that moralistic ideas and norms have been less influential 
than Vanwesenbeeck gives them credit for, something that would be more explicated as 
medicalised ideas and evidence-based research have come to the fore. 
In fact, evidence-based research has been used to counter moralistic policies, just like it has 
protected against harmful approaches in medicine and in countering inaccurate claims from 
AIDS denialists. The debate regarding needle exchange for injecting drug users is a good 
example here. While such harm reduction has been viewed as normatively or morally not 
acceptable by some policymakers, the much presented evidence-based research of the 
approach’s  effectiveness  was  so  strong  that  “[t]he  debate  was  [declared]  over”  (IAS,  2007:37)  
at the International AIDS Conference in Toronto in 2006. Accordingly, at the International 
AIDS Conference in Vienna in 2010 former US President Bill Clinton, an opponent of harm 
reduction efforts while in office, expressed that he had suddenly changed his mind (Schleifer, 
2010). Similarly, already at the International AIDS Conference in Bangkok  in  2004  “a   'new  
realism'  [….]  [was  expressed]  on  the  part  of  many  countries  to  put  evidence  based  prevention  
programmes   in  place  despite   their  political,   religious  and  moral  sensitivity”  (IAS,  2004:12).  
This indicates that medicalised ideas have gained prominence at the expense of moralistic 
norms.   This   development   is   not   reflected   in   Vanwesenbeeck’s   (2011)   model,   which  
emphasise the concurrent existence of moralistic and medicalised ideas. 
Accordingly, PEPFAR, which was reauthorized in 2008 under the Obama administration with 
a significantly higher $48 billion budget, went through some interesting changes. First of all, 
where PEPFAR I required that 33 per cent of the funds allocated at preventing sexual 
transmission had to be used on promoting abstinence, PEPFAR II removed this requirement. 
Second, the reauthorisation of PEPFAR focused more on gender disparities, the strengthening 
of local capacities and extended the amount of countries eligible for support. Thus, in many 
respects, PEPFAR II is more aligned with low-road approaches than its predecessor. PEPFAR 




II’s  seemingly  move  away  from  moralistic   ideas  and  policies  is  supported  by  key  informant  
Nathan  Geffen  who   stated   in   a   personal   interview   that   “there   have   been   several   important  
battles over the way PEPFAR  has  restricted  funding,  which  I  think  we  largely  won”  (Geffen,  
2013). Interestingly, then, is it that PEPFAR II is also more medicalised than its predecessor, 
with more focus on prevention technologies and measurable targets (Kaiser Family 
Foundation, 2008:2-5).  
These changing characters of PEPFAR II can both support and argue against 
Vanwesenbeeck’s  (2011)  model.  They  can  suggest  that  the  new  and  more  liberal  changes  in  
PEPFAR II are still adjusted to moralistic ideas. Table 3.1 indicates that these changes 
certainly came at a time when scientific developments provided alternative de-sexualised 
opportunities for policies that moralists and more liberally inclined actors eventually could 
agree  upon.   Indeed,   in  Obama’s  Global  Health   Initiative   (GHI)   for the years between 2009 
and   2014   only   “5%   is   reserved   for   family   planning   and   reproductive   health”  
(Vanwesenbeeck, 2011:292), suggesting that sexual health might still be an issue although 
some moral restrictions have been removed. This supports Vanwesenbeeck’s  model  because  it  
suggests that moralistic and medicalised ideas simultaneously impact multilateral AIDS 
responses. Together these ideas would agree upon more de-contextual and de-sexual high-
road approaches. This is further explored in Section 4.2.4. On the other hand, the changes in 
PEPFAR II can also again suggest that moralistic ideas are not as strong as Vanwesenbeeck 
claims, because they are inconsistent, outdated and disapproved of by increasingly popular 
ideas of medicalisation. High-road prioritisation would, according to this view, be more 
affected by medicalised than moralistic ideas. As such, the explanation value of ideas and 
norms of medicalisation the development of multilateral AIDS responses is explored in the 
following section.   
4.2.2 Evidence-based research, monetisation and scientific legitimacy  
As the previous section and chapters stress, evidence-based research has been significant in 
order to counter harmful approaches in medicine and inaccurate claims about AIDS and has 
also been used to argue against unsustainable value conservative approaches. As Chapter 2 
points out, evidence-based research is also linked to medicalised neoliberal principles of 
monitoring and evaluation to ensure cost-efficiency and legitimate use of donor money. 
Vanwesenbeeck’s   (2011)   model   suggests   that   high-road approaches are prioritised at the 
expense of low-road approaches because the de-contextualised characteristics of the former 
make those approaches easier to evaluate and demonstrate effectiveness. This section explores 
the prominence of evidence-based research and biomedical science as indicators of 




medicalised ideas and their impact on global AIDS agendas and other epistemological 
understandings of knowledge. 
At the International AIDS Conference in Vancouver in 1996 the demonstration of the 
lifesaving combination of ART drugs made researchers interrogate the cost and cost-
efficiency of distributing these medications. The original price of ART was so high that most 
people and even most governments would not be able to purchase them (Berger, 1996:719-
720). This can be linked to the rise of the global justice movement challenging the 
pharmaceutical companies and their unreasonable prices, which is further explored in the 
following section. However, this scientific breakthrough can also be said to have monetised 
the pandemic in the sense that neoliberal norms of cost-efficiency became more pronounced. 
Efforts   to   monitor   and   evaluate   AIDS   responses   became   important,   as   these   “allow  
programme managers to calculate  how  to  allocate  resources  to  achieve  the  best  overall  result”  
(UNAIDS, 2000:4). Contextual low-road approaches are challenging to quantify, monitor and 
evaluate. ART – a high-road  approach  according  to  Vanwesenbeeck’s  (2011)  model  – are on 
the other hand more aligned with these neoliberal and medicalised principles. 
Vanwesenbeeck’s   model   argues   that   the   increased   prominence   of   ART   and   high-road 
solutions as such is thus based in how these approaches can more easily be measured 
according to standards reflecting already existing norms demanding a demonstration of 
efficiency.  
However, as Chapter 3 indicates, despite the concerns that emerged after the Vancouver 
conference over a treatment vs. prevention binary, the 2004 International AIDS Conference in 
Bangkok’s   holistic   agenda   is   a   demonstration   of   how   low-road approaches were still 
prominent long after the discovery of HAART. Indeed, the conference report indicates that 
the discovery of HAART opens up the opportunity to direct attention towards other pressing 
issues,   such   as   social   drivers   of   the   pandemic   (IAS,   2004:4).   The   Bangkok   conference’s  
political  focus  does  not  support  Vanwesenbeeck’s  (2011)  model  of  a  de-prioritisation of low-
road approaches or that the pandemic was steered by clinical forms of science. Nevertheless, 
Chapter  3’s  mentioning  of  how  the  Bangkok  conference  was  criticised  for  being  too  political  
and how scientists escaped to other more biomedical conferences are interesting notions in 
this regard. Hence, although the conference organisers in Bangkok were confident about their 
holistic agenda, the conference might also represent the beginning of a crossroad where 
different problematisations of AIDS enhanced a binary between low-road and high-road 
approaches.  




In a report Kippax and Holt (2009:3) made for the International AIDS Society they express 
that  the  “[a]ppreciation  of  the  significant  role  that  the  social  and  political  sciences  have  played  
in HIV prevention, treatment and care has declined as the focus on treatment and biomedical 
prevention   technologies   has   grown   stronger.”   Especially   the   development   of   prevention  
technologies is important here because, as Table 3.1 indicates, such approaches to prevention 
were presented for the first time at the International AIDS Conference in Toronto in 2006, 
simultaneously as high-road approaches became increasingly pronounced. The prominence of 
high-road approaches can thus be explained by increased biomedical solutions to traditionally 
non-biomedical fields. This suggests that the binary between political/social science and 
basic/clinical science visible in Bangkok deepened after the development of biomedical 
solutions to prevention. The fact that some scientists hoped this would bridge the divide 
supports  Vanwesenbeeck’s  (2011)  argument  of  medicalisation because it reflects a belief that 
‘everything’   can   be,   and   should   be,   explained   through   evidence-based research. The 
development of prevention technologies, thus, can be seen as a saviour from the traditional 
approaches towards prevention and their   ‘inefficiency’,   or   lack   of  measurement   of   such   at  
least.  Thus,  when  Nathan  Geffen   expressed   in   a  personal   interview   that   “both   [politics   and  
science]  are   important  and   [….]  good  evidence  provide   the  stuff  you  need   to   form  political  
opinion”   (Geffen, 2013) this can be argued to still be framed within medicalised 
problematisations  of  AIDS.  This  medicalisation  of   research  and   ‘knowledge’   is   reflected   in  
the  norm  that  “you  can’t  make  confident  good  decisions  without  evidence”  (Geffen,  2013).   
Supporting this argument is how increased demands for evidence-based research only became 
explicitly pronounced during the 2000s, after prevention technologies had started to come to 
the fore. For instance, while the 2001 Declaration of Commitment on HIV/AIDS does not 
mention   the  word   ‘evidence’  once   in   its   52-page document (UN General Assembly, 2001), 
the 2011 Political Declaration on HIV and AIDS shows a drastically changed rhetoric, as 
‘evidence’  is  referred  to  as  much  as  twelve  times  in  the  declaration’s  17  pages  (UN General 
Assembly, 2011). Furthermore, where scientific evidence and evidence-based research is 
mentioned, it is with regards to prevention efforts and cost-efficiency. For instance, point 45 
of   the   2011  Political  Declaration   states   “that   programmes  must become more cost-effective 
and evidence-based and deliver better value for money,   and   that   [….]   a   lack   of   proper  
governance and financial accountability impede   progress”   (UN  General  Assembly,   2011:7,  
emphasis added).  
Although it is reasonable for donors not to want their contributions to go to waste and 
evidence-based research is important for the further development of medical approaches to 




the pandemic, these developments suggest a global AIDS response where quantitatively 
measurable approaches are preferred in order to evaluate their effect, ensure cost-efficiency 
and increase legitimacy through transparent accountability. This is important because while 
there are clear benefits with evidence-based research, an overly dependency on evidence-
based approaches indicates an epistemological preference benefiting high-road approaches, 
which then also will have material proof to back up their plea for funding. The neoliberal 
norms   to  monitor  and  evaluate  and  ensure  value   for  money   thus  supports  Vanwesenbeeck’s 
(2011) claim that medicalised ideas are enhancing high-road prioritisation.  
Indeed,   prevention   technologies,   such   as   ‘treatment   as   prevention’   (TASP),   are   still   not  
acknowledging the mutual importance of both social and basic science. Prevention 
technologies frame solutions that traditionally were low-road approaches within a biomedical 
framework where evidence-based research is the appropriate way of accumulating knowledge. 
Furthermore, this epistemological framing of knowledge and efficiency suggests that the 
demand for evidence-based research has become so dominant that only approaches that can be 
measured  by   the  metric  ‘gold  standard’  of  RCTs  can  possibly  be  declared  effective.  Nathan  
Geffen’s   statement   that   “whatever   works,   works   [….].   I’m   not   really   aware of any 
behavioural   prevention   mechanisms   that   have   been   proven   to   work”   (Geffen,   2013)   in   a  
personal  interview  reflects  how  “[t]he  demand  for  immediate  empirical  evidence  for  success  
[has  become]  the  norm”  (Garrett,  2007:34),  despite  that  many  scholars find RCT results to be 
“misleading”   (Nguyen   et al., 2011:291). This indicates that Vanwesenbeeck (2011) has a 
point when claiming that norms of medicalisation have contributed to high-road prioritisation 
because medicalised norms of what  ‘evidence’  and  ‘knowledge’  are have disregarded social 
scientists’   understanding   of   epistemology,   methodology   and   how   to   address   structural  
challenges within the AIDS pandemic. 
Although the prominence and ideological importance of science and evidence-based research 
thus seems significant for epistemologically framing global AIDS agendas – an issue explored 
further in Section 4.2.4 regarding the medicalisation of sexual and reproductive health – other 
ideas can also be said to have contributed to an increasingly biomedical focus on AIDS. The 
following section explores the importance of global justice in the distribution of ART, which 
is not covered by Vanwesenbeeck’s  (2011)  model.     
4.2.3 Social justice and human rights 
Chapter 3 indicates that after the discovery of HAART – the combination of ART drugs that 
can avert the development of HIV in the human body – and its announcement at the 




International AIDS Conference in Vancouver in 1996, high-road and low-road approaches 
were simultaneously expressed in global AIDS responses, as the struggle to allocate funding 
for and universalise access to ART (a high-road approach) became a global justice issue (a 
low-road approach). Accordingly, the attitude towards AIDS changed from one of despair to 
“a   question   of   resources”   (Schechter, 1996:54). Particularly at the International AIDS 
Conferences in Vancouver, Geneva and Durban this was explicitly expressed, as even in the 
nascent phase of HAART it was clear that the access to these absurdly expensive medications 
would be determined by geographical position and wallet size (Berger, 1996:720; Walters, 
1996:712-713).  
Reflecting  the  Vancouver  conference’s  theme  of  “One  World,  One  Hope”,  some  governments  
and activists became engaged in challenging what they believed were the contributing factors 
to such an unequal distribution of drugs within a pandemic that were already structurally 
discriminating vulnerable people and populations. Large activist groups, such as the AIDS 
Coalition to Unleash Power (Act Up), were significant for protesting against the 
pharmaceutical   companies’   monopoly   already   at   the   International   AIDS   Conference   in  
Vancouver (Walters, 1996:713). As mentioned in Chapter 3, the fight for social justice and its 
successes can also be recognised in the establishment and engagement of the Treatment 
Action  Campaign  (TAC)  in  South  Africa,  the  Indian  and  Brazilian  governments’  battle  with  
pharmaceutical patent laws to ensure cheaper drugs for their citizens, and the curbing of the 
pharmaceutical  industry’s  decision  making  power  in  the Accelerating Access Initiative (AAI) 
and the Doha Declaration. Another successful outcome of such mobilisation for social justice 
is  illustrated  by  how  the  pharmaceutical  companies’  lawsuit  of  the  South  African  Medicines  
and Related Substances Control Amendment Act (Republic of South Africa, 1997) was 
dropped in 2001 after immense public protests (Fourie, 2006:149). In many ways, these were 
direct attacks on the global neoliberal regime (Ingram, 2013), which in this case was 
amplified by the monopolised position of pharmaceutical companies. As Nathan Geffen 
expressed  in  a  personal  interview  “it  was  critical  to  winning  our  battles  that  we  took  [human  
rights and social justice] into account, that those concepts were at the forefront of our 
struggle”  (Geffen, 2013).    
Thus, although the focus on the distribution of drugs worldwide have contributed to an 
increased focus on biomedical high-road approaches in global AIDS responses – supporting 
the claim of a medicalisation of sexuality explored in Section 4.2.4 – there are clear social 
justice and rights-based low-road aspects with this development. As Chapter 3 indicates, this 
is emphasised by Parker (2013) and his focus on the mid-1990s’   structural   explanations   to  




AIDS, as this humanitarian engagement and mobilisation of civil society and political 
involvement was essential for future responses and allocation of funds to the global AIDS 
pandemic. This more nuanced picture of the medicalisation of the pandemic through 
“scientific   activism”   (IAS,   2004:71)   for   global justice and universal human rights is not 
reflected  in  Vanwesenbeeck’s  (2011)  model.  The  model  suggests  a  binary  between  low-road 
and high-road approaches where the prioritisation of one is occurring at the expense of the 
other, which is not the case if one takes into consideration the global justice fight for universal 
access to drugs. This existence of a humanitarian grey zone between low-road and high-road 
approaches also suggests that ideas of moralism, medicalisation and the market cannot alone 
elucidate how global AIDS agendas have developed, as global justice and human rights rather 
work on ideas and principles of equality, humanitarianism and global solidarity. The 
increased focus on biomedical high-road approaches since 1996, then, can be argued to be a 
consequence of, and dependent on, the low-road initiative of a human rights-based approach 
to AIDS rather than being influenced by medicalised, moralistic or monetised ideas. Thus, 
Vanwesenbeeck’s  (2011)  model  has  limitations  when  trying  to  explain this era in the history 
of   AIDS.   This   argument   of   humanitarianism   is,   however,   challenged   by   Ingram’s   (2013)  
understanding  of  the  neoliberal  market’s  re-legitimisation through humanitarian approaches to 
the  AIDS  pandemic.  Ingram’s  argument,  which  supports Vanwesenbeeck’s  understanding  of  
the power of the market, is further elaborated upon in Section 4.2.6. Furthermore, the 
securitisation of AIDS in the early 2000s can illuminate yet another explanation of the 
political engagement and scale-up of funds to the pandemic. This is discussed in Section 
4.2.5. 
As Section 4.2.1 indicates, human rights have been specifically addressed at the International 
AIDS   Conferences,   most   particularly   from   2006   onwards,   and   linked   “to   achiev[ing]  
universal access goals, including addressing workplace discrimination, travel restrictions, and 
the   denial   of  women’s   property   and   inheritance   rights”   (Kort,   2008:5).   Furthermore,   at   the  
2012   International   AIDS   Conference   in   Washington   D.C.   “[t]here   was   consensus   among  
conference participants that a real need exists to fight prejudice, stigma, discrimination, 
exclusion,   and   criminalization”   (IAS,   2012:8).   Thus,   universal   access   to   treatment   has  
remained a human rights issue to this day, incorporating also the more contextual need for 
human rights in order to reach vulnerable people and populations.  
The apparent need to still address issues such as discrimination and stigma at the conferences 
suggests, as Section 4.2.1 indicates, the continued presence of moralistic norms leading to 
such violation of human rights even as late as 25-30 years into the pandemic, which supports 




Vanwesenbeeck’s  (2011)  model.  However,   the  fact   that  human  rights  are  actually  addressed  
at  the  International  AIDS  Conferences  does  not  support  the  model’s  claim  that  human rights 
are marginalised (as a part of the low-road approach cluster) in global AIDS agendas. Indeed, 
as Table 3.1 suggests, the focus on such rights-based low-road approaches seems to even have 
expanded from focusing on global access to drugs – with the high-road approach consequence 
of a medicalised pandemic – to also include social and legal rights, effectively fighting stigma 
and discrimination of vulnerable people and enhancing the prominence of contextualised 
human rights-based low-road approaches.  
This  development  does  not  coincide  with  the  Vanwesenbeeck  (2011)  model’s  binary  between  
high-road and low-road approaches because not only are some low-road approaches essential 
for the attention given to high-road approaches themselves, as the abovementioned historical 
development suggests, but they are also independently presented at the International AIDS 
Conferences in the form of efforts to curb stigma and discrimination. Although, as Table 3.1 
indicates, high-road approaches started to become more prominent around the International 
AIDS Conference in Toronto in 2006, this development of high-road prioritisation is, 
according to this view, linked to and in company of rights-based low-road approaches. This 
is, in other words, another indication of how  Vanwesenbeeck’s   model   does   not   take   grey  
zones between high-road and low-road approaches into consideration, which limits the 
model’s   explanation   value   in   terms   of   which   ideas   might   have   contributed   to   high-road 
prioritisation.  
However, instead of being an indication of a faulty claim of high-road prioritisation on 
Vanwesenbeeck’s  (2011)  behalf,  the  presence  of  a  human  rights  agenda  simultaneously  as  the  
AIDS pandemic became remedicalised can also suggest that in practice low-road approaches 
are more split than they appear on paper. While human rights are an important part of low-
road approaches the wide reaching scope of human rights themselves opens up the possibility 
that some aspects of human rights – the de-sexualised ones – might be preferred as they are 
more aligned with norms of moralism, medicalisation and the market than others. For 
instance, at the International AIDS Conference in Vienna in 2010, the conference theme was 
settled  on  human  rights;;  however,  the  conference’s  rights  based  focus  was  aimed at injection 
drug use (Bliss, 2012:18). While the Vienna conference made great and important progress in 
spreading consensus and information regarding injecting drug  users’  human  rights,  this  is  an  
example of how human rights can be addressed while still adjusting to norms of quantification 
and moralism. From this point of view, it can be argued that only human rights that conform 
to medicalised and moralistic ideas are the ones addressed at the International AIDS 




Conferences. Thus, although this disparity within low-road approaches is not mentioned in 
Vanwesenbeeck’s  model,  which  indeed  is  a  limitation  in  terms  of  the  model’s  simplicity,  this  
argument  is  supporting  the  model’s  emphasis  on  the  influence  of  moralistic  and  medicalised  
ideas.  
The role of sexual and reproductive health and rights in global AIDS responses and discourses 
can thus stand as a crucial indicator for how multilateral AIDS governance and high-road 
prioritisation have developed and why. This is because approaches with a sexual and cultural 
focus – an important element of low-road approaches – are poorly aligned with the de-
contextual and de-sexual preferences of both moralistic and medicalised ideas. The 
prominence of sexual and reproductive health is therefore an important indicator for the 
explanation   value   of   Vanwesenbeeck’s   (2011)   model   and   ideas   of   moralism   and  
medicalisation. Sexual and reproductive health is therefore further explored in the following 
section. 
4.2.4  Sexual  and  reproductive  health….  and  rights? 
As previous chapters stress, a focus on sexual and reproductive health (SRH) is significant for 
a comprehensive global AIDS response. SRH is contextually focused on AIDS, recognising 
the  pandemic’s  sexual  nature  and  links  with  discrimination,  power  and  violence.   In  an  SRH  
framework empowerment of women and their right to decide over their own bodies is seen as 
a significant factor in addressing AIDS and improving overall global health. This contextual 
emphasis  is  aligned  with  Parker’s  (2013)  understanding  of  the  structural  explanations to AIDS 
that gained prominence around the mid-1990s. Indeed, when UNAIDS was established in 
1996 the UN Population Fund (UNFPA) – an institution focused on sexual and reproductive 
health working towards the acclaimed Programme of Action from the 1994 International 
Conference on Population and Development (ICPD) – was a natural cosponsor of the new 
AIDS institution. After the review of the ICPD in 1999 clear targets were set between the two 
institutions in order to coordinate efforts on AIDS and sexual and reproductive health (SRH) 
(Knight, 2008:82). Furthermore, as Chapter 3 indicates, the International AIDS Conference in 
Bangkok in 2004 acknowledged both the importance of condoms – an essential tool in 
securing family planning and sexual and reproductive health – and  women’s  empowerment  in  
confronting the AIDS pandemic. In 2005 access to reproductive health was included in the 
Millennium Development Goals (MDGs), stressing the importance of SRH in order to meet 
the rest of the MDG targets (Greer, et al., 2009:674). Also the 2006 Political Declaration on 
HIV/AIDS expresses the importance of gender equality and sexual and reproductive health 
(UN General Assembly, 2006:5). All these factors indicate that sexual and reproductive health 




has been acknowledged   in   global   AIDS   agendas,   not   supporting   Vanwesenbeeck’s   (2011)  
claim that SRH has been marginalised by moralistic and medicalised ideas.  
As mentioned in Chapter 3, however, sexual and reproductive health and rights (SRHR) are 
claimed to be deprioritised compared to the attention given to AIDS alone. Since the 
biomedical HAART breakthrough in 1996 the concern of an emerging treatment vs. 
prevention (of sexual transmission) binary, benefitting the former at the expense of the latter, 
was expressed at several International AIDS Conferences. As Chapter 3 indicates, this 
concern was articulated as early as the International AIDS Conference in Geneva in 1998, and 
amplified as funding for AIDS responses started to increase. Prevention of sexual 
transmission of HIV is connected to the overall agenda of sexual and reproductive health, and 
the marginalisation thereof can thus indicate that SRH has indeed been overshadowed by the 
global initiatives focused on treatment. Indeed, the money distributed to SRH drastically 
decreased around the same time as funding for biomedical AIDS responses increased and 
peaked (Greer et al., 2009:674; Greene et al., 2012:90; Vanwesenbeeck, 2011:291).   
The previous section argues the link between low-road and high-road approaches in the global 
justice aim for access to treatment; a link that is not recognised in the Vanwesenbeeck (2011) 
model’s   claim   that   medicalisation,   morals   and   the   market   are   the   ideas   contributing   to  
biomedical high-road prioritisation. Similar to this argument, the treatment vs. prevention 
binary and marginalisation of SRH compared to AIDS can also be claimed to be affected by 
the sense of urgency around the human right to access AIDS treatment. Thus, 
Vanwesenbeeck’s  ideas  of  moralism,  medicalisation  and  the  market can also be said to have 
limitations for explaining the marginalisation of SRH in global AIDS agendas. Section 4.2.5 
explores yet another idea beyond humanitarianism that also could have contributed to the 
prioritisation of high-road  approaches’  short-term and vertical solutions to AIDS, and that is 
not   taken   into   consideration   in   Vanwesenbeeck’s   model.   However,   as   the   former   section  
points out, an increasingly de-sexualised high-road initiative in global AIDS responses can 
still be valuably elucidated   by   the   Vanwesenbeeck   model’s   focus   on   moralistic   and  
medicalised   ideas.   This   is   because   these   ideas’   alignment   with   de-contextualised and 
moralistically refined high-road approaches might elucidate why biomedical solutions are 
preferred as viable options to low-road  approaches   in  order   to  meet  donors’   requirement  of  
cost-efficiency while simultaneously avoiding culturally sensitive issues.  
Supporting  Vanwesenbeeck’s   (2011)   argument   are   the   scholars   pointing   out   the   perplexing  
decision to leave sexual and reproductive health out of the original MDG targets, despite the 




widely  recognised  Cairo  Agenda’s  emphasis  to  work  towards  universal  access  to  reproductive  
health by 2015 (Fathalla et al., 2006:2098). The exclusion of SRH and the Cairo Agenda from 
international and domestic programmes in general, and the MDGs in particular, are claimed 
by some to be due to moralistic norms and conservative values. These moralistic inclinations 
have, according to this view, made some policymakers – such as PEPFAR I, the Vatican and 
some conservative nations in the developing world – actively campaign against SRH and 
family planning in multilateral agendas regarding AIDS and health. The reproductive right to 
abortion, for instance, seems to be one of the more sensitive issues making moralistically 
inclined policymakers back away from anything regarding sexual and reproductive health 
(Buse et al., 2006:2101; Crossette, 2005:72, 76; Greer et al., 2009:674). From this point of 
view,  PEPFAR  I’s   requirement   that   the  majority  of   its funds had to be spent on biomedical 
treatment efforts (Kaiser Family Foundation, 2008:2) can be argued to be based in moralistic 
norms and the consequent inclination to de-sexualise the AIDS agenda by avoiding low-road 
approaches focused on sexual and reproductive health. Within sexually conservative cultures, 
biomedical high-road approaches must be a safe haven where a sexually transmittable 
infection  can  actually  be  addressed  without  addressing  ‘the  sex’.  Thus,  moralistic  norms  could  
have contributed to the mentioned treatment vs. prevention binary rather than, or in addition 
to,  the  humanitarian  need  to  ensure  universal  access  to  drugs.  This  supports  Vanwesenbeeck’s  
emphasis on the impact of moralistic norms.  
Also interesting for the explanation value of  Vanwesenbeeck’s   (2011)  model   is   the   role   of  
measurable targets in the development of the MDGs. Apparently the drafters of the MDGs, 
although   acknowledging   the   importance   of   reproductive   health,   “wanted   goals   that   were  
quantifiable   [….]   [and  were  under   the understanding] that reproductive health could not be 
quantified  in  any  way”  (Crossette,  2005:76).  This  reflects  the  claim  from  Section  4.2.2  that  a  
norm   of   medicalisation   affects   the   global   AIDS   agenda,   and   supports   Vanwesenbeeck’s  
argument that medicalised ideas contribute to high-road prioritisation because of the 
challenge to quantitatively measure, evaluate and raise funds for sexual and contextual low-
road approaches.  
Structural solutions, such as the ones based in sexual and reproductive health, to the AIDS 
pandemic have indeed been viewed as challenging to define, target, change and evaluate 
(Gupta et al., 2008:764, 770-771; Parker, 2013). As such, structural solutions to prevent 
transmission of HIV – addressing structural and sexual violence – have been marginalised due 
to lack of funding (Piot et al.,  2008:845).  While  this  supports  Vanwesenbeeck’s  (2011)  idea  
of medicalisation, as explored in Section 4.2.2, it also elucidates how AIDS responses are 




dependent on the choices of the donors, which is further elaborated upon in Section 4.2.6. 
Regardless of these challenges, SRH and structural emphases were, as mentioned above, still 
recognised around 2005-2006, with the inclusion of SRH in the MDGs and the 
acknowledgement in the 2006 Political Declaration. Therefore, with regards to 
Vanwesenbeeck’s   model,   the   evolvements   around   and   after   the   International   AIDS  
Conference in Toronto in 2006 are interesting, especially because, as Table 3.1 indicates, de-
sexual high-road approaches started to become increasingly dominant around this time.  
As indicated in Chapter 3, while the International AIDS Conference in Toronto in 2006 
shared   the   Bangkok   conference’s   gender   sensitive   approach,   recognising   the   link   between  
gender discrimination and HIV transmission, it was also the conference first emphasising 
biomedical   prevention   efforts   and   TASP.   The   conference’s   encouragement   for   further  
development of biomedical approaches, such as microbicides, was addressed within the 
framework that such discoveries can help people in vulnerable situations and thereby also the 
structure that they are in. Also in Toronto the promising results of TASP made some scholars 
consider the treatment vs. prevention binary as bridged due to the biomedical prevention 
benefits with expanded treatment  efforts.  The  coining  of  the  term  ‘combination  prevention’  at  
the International AIDS Conference in Mexico City two years later also promised more 
straightforward solutions to initial complex structural challenges. Combination prevention is 
aimed at applying a variety of approaches – structural as well as behavioural and biomedical – 
and adjust these to different settings in order to reach vulnerable people and address the 
further approach needed to lower the chances of HIV transmission (IAS, 2010:17; Kort et al., 
2008:5; Parker, 2013). Combination prevention was believed to address the importance of 
structure and make up for the otherwise marginalised efforts to prevent sexual transmission of 
HIV (Merson et al., 2008:485). Prevention technologies, TASP and combination prevention 
were thus important discoveries for multilateral AIDS responses because – among other 
things – they were set at eliminating the challenges that up until then were associated with 
structural approaches.  
Indeed, at first glance, this is a holistic development suggesting less prominence of 
medicalised and moralistic ideas than Vanwesenbeeck (2011) claims. Combination prevention 
could  represent  what  Vanwesenbeeck  calls  for:  a  ‘combination’  of biomedical high-road and 
contextual low-road approaches. However, TASP, prevention technologies, combination 
prevention and even the more recent call to end the AIDS pandemic presented at the 
International AIDS Conference in Washington D.C. in 2012 (IAS, 2012:48) and by 
organisations   such   as   UNAIDS   and   PEPFAR   can   be   argued   to   be   based   in   a   “biomedical  




triumphalism”   (Nguyen   et al., 2011:291), as they essentially are dependent on ART 
distribution or other clinical solutions to the pandemic (Giami & Perrey, 2012:357; Montaner, 
2008:2; Stein, 2011). HIV prevention within these approaches is thus framed and even 
dependent on the existence of biomedical high-road approaches. Importantly, sexual and 
reproductive health is rarely mentioned as a part of combination prevention and the seemingly 
structural elements of combination prevention remains de-contextualised from overall health 
initiatives, such as securing maternal health. Sexual and reproductive health is thereby 
supposedly dealt with by biomedical interventions without actually being addressed. This 
“medicalization  of  sexuality”  (Giami  &  Perrey,  2012:357)  can  be  argued  to  be  based  in  a  wish  
to make initial contextual and structural elements easier to control and measure, which 
suggests the appearance of a biomedical ontology oblivious to what more contextual 
approaches focused on sexual and reproductive health are about. Making targets more 
straightforward so that they are easier to reach and demonstrate might look good for donors, 
but as long as they do not deal with essential underlying challenges nothing will change. 
Vanwesenbeeck’s argument that medicalised ideas are enhancing high-road prioritisation can 
illuminate this development, because taken-for-granted norms and epistemological 
understandings of what makes AIDS responses effective reflect a problematisation of AIDS 
that underscores the appropriateness of biomedical and/or quantifiable high-road solutions. 
This need to fix AIDS the biomedical way turns a blind eye towards the challenges 
biomedical high-road approaches, including combination prevention, cannot solve alone.  
On the other hand, Vanwesenbeeck (2011:294-295) herself is optimistic about recent 
developments regarding sexual and reproductive health. Indeed, contributions to the UNFPA 
have increased from $783 million in 2009, to $870 million in 2010 and $981 million in 2012 
(UNFPA, 2011:29; UNFPA, 2013:44). Although this amount is still small compared to the 
$7,9 billion disbursed specifically to the AIDS pandemic in 2012 (Kates et al., 2012:2) it is 
interesting that this increase in funds for UNFPA has occurred simultaneously as funds for 
AIDS has decreased – which has seemingly been because of the Global Financial Crisis. This 
is explored further in Section 4.2.6. It is not yet clear, however, how much of the funds for 
UNFPA will be coordinated with responses to AIDS. In a UNAIDS report from 2011 it was 
reported that of all the resources allocated to AIDS, 53 per cent were still focused on 
treatment and care, 22 per cent went to prevention efforts (including biomedical prevention 
technologies) and only 1.2  per  cent  was  reserved  for  “social  protection  and  social  services”  
(UNAIDS, 2011:154). In terms of global AIDS responses, thus, SRH still seems to be 




deprioritised compared to biomedical interventions,  which  supports  Vanwesenbeeck’s  model,  
but not her optimism.  
As  Section  4.2.3  indicates,  while  human  rights  in  terms  of  “structural  inequalit[ies]  based  on  
race, class, gender, age and   sexual   orientation”   (Kort et al., 2008:25) are addressed at 
International AIDS Conferences, the direct addressing of sexual and reproductive health 
(SRH)   can   be   argued   to   be   merely   “a   rhetorical   necessity”   (Giami   &   Perrey,   2012:357).  
Indeed, although SRH is a human right, it seems as if its presence still has to be justified (see 
Greene et al., 2012:iv-v). Furthermore, the few times SRH is actually addressed in the 
conference report following the International AIDS Conference in Washington D.C., no 
strategy is communicated on how to effectively deal with the lack of access to it, despite the 
issue being characterised as essential. Thus, despite the focus on human rights, discrimination 
and stigma at recent International AIDS Conferences, sex still seems to be an issue that is 
brushed under the carpet. This is supported by the fact that PEPFAR II, despite having less 
direct moralistic requirements than PEPFAR I, necessitates that the US Congress must be 
made  aware  “if  less  than  half  of  prevention  funds  in  any  host  country  go  to  abstinence,  delay  
of sexual debut, monogamy,   fidelity,   and   partner   reduction”   (Kaiser   Family   Foundation,  
2008:4). Hence, PEPFAR II still pressures the importance of moralistic approaches at the 
expense of approaches aimed at safe sex and condom distribution, which is amplified by the 
latter being restricted with an age limit (PEPFARwatch, s.a.). PEPFAR II has also kept its 
predecessor’s   restrictions   against   supporting   organisations   working   with   family   planning  
and/or do not explicitly state that they are against prostitution (Kaiser Family Foundation, 
2008:4).  
Perhaps the biomedical developments within prevention technologies since 2006, then, has 
allowed for low-road approaches dealing with human rights to enter AIDS agendas and 
discourses because the actual addressing of other contextual factors,  such  as  the  ‘sex  thing’,  
can now more easily be avoided by being handed over to biomedical solutions, such as TASP, 
male circumcision and microbicides. Thus, SRH can be dealt with without actually discussing 
sensitive political and cultural issues. In other words, by framing structure within biomedical 
terms, SRH can be separated from human rights because biomedical solutions are seemingly 
already   about   to   address   the   problem.   This   supports   Vanwesenbeeck’s   (2011)   claim   that  
morals are affecting multilateral AIDS agendas, and that medicalised and moralistic ideas 
have indeed developed simultaneously around the common ground of de-contextual and de-
sexual high-road approaches, as one of the arguments in Section 4.2.1 suggests. However, it 
also supports the point,   as   suggested   in   Section   4.2.3,   that   Vanwesenbeeck’s   (2011)  




demonstration of low-road approaches is too simplistic. Since some low-road approaches are 
floating in a grey zone between high-road and low-road approaches, low-road approaches can 
be argued to be more split in reality than on paper.   
In terms of the development of sexual and reproductive health, not everyone agrees with the 
idea  that  the  1994  ICPD’s  broader  SRH  development  agenda  necessarily  contributed  to  long-
term benefits for the distribution of all SRH goals. Cleland et al. (2006:1811, 1823) argues 
that the ICPD undermined the importance of family planning by disconnecting it from overall 
economic development, framing the issue as less urgent. While these scholars paradoxically 
disregard the importance of linking family planning with gender equality and sexual and 
reproductive rights, their argument can illustrate two important insights. First of all, urgency 
is key for prioritisation in global politics. This is further explored in the following section. 
Second, economic development is considered urgent. The role of the neoliberal market is 
discussed in Section 4.2.6. 
4.2.5 HIV-exceptionalism 
HIV-exceptionalism is the idea that since AIDS, due to its widespread political, social and 
economic implications, has consequences beyond health and medicine it is a disease that 
requires an exceptional response. In the earlier phases of the pandemic, HIV-exceptionalism 
was closely linked to the frightening and fatal consequences of HIV, the distinctive needs of 
vulnerable communities and the struggle for social justice for people living with HIV (Smith 
& Whiteside, 2010:1-3). After the HAART breakthrough in 1996, the possibility of treating 
AIDS  made  HIV   less   threatening   and   “AIDS   exceptionalism   came   to   refer   to   the   disease-
specific  global  response”  (Smith  &  Whiteside,  2010:1)  amplified  by  “fevered  aid”  (Smith  &  
Whiteside, 2010:1) for the pandemic.  
Vanwesenbeeck’s  (2011)  model  suggests  that  HIV-exceptionalism is a characteristic of high-
road approaches, affected by moralistic de-sexual preferences as well as medicalised and 
monetised principles to vertically target and measure solutions for ensuring cost-effectiveness 
(Garrett, 2007:34). As the previous section suggests, monetised targets, de-sexualised morals 
and medicalised vertical distribution can all have explanation value for understanding the 
development of a global AIDS response where AIDS specific services are the objectives of 
prioritisation, as compared to overall health systems. Importantly, as Chapter 3 indicates, the 
link between short-term measurable targets and donor prioritisation is profound (Garrett, 
2007:15), which suggests how medicalised needs to monitor and evaluate approaches can 
contribute to the prioritisation of quantifiable high-road approaches. Thus, although 




Vanwesenbeeck’s  model  does  not  take  into  consideration  the  global  justice  and  human  rights  
elements that have contributed to a more de-contextual and biomedical global approach to the 
pandemic, as previous sections suggest, HIV-exceptionalism as an indicator of high-road 
prioritisation  can  in  some  respects  be  explained  by  the  Vanwesenbeeck  model’s  emphasis  on  
the de-contextual preferences of the market, moralistic and medicalised ideas.  
For instance, at the International AIDS Conference in Mexico City in 2008, the claimed 
implications of vertical HIV-exceptionalism on the rest of the health system discussed at the 
conference in   Toronto   two   years   earlier   was   declared   “a   ’false   debate’”   (Kort,   2008:5)   by  
scientists who argued that vertically distributed AIDS specific services would rather improve 
health systems. However, as indicated in Chapter 3, the idea that AIDS specific services are 
strengthening general health systems is based on the understanding that health care and health 
infrastructure is the same thing; while in many respects these are separate. The positive 
findings presented at the International AIDS Conference in Mexico referred to a strengthening 
of   health   infrastructure   dependent   on   donors’   AIDS   specific   vertical   distribution   of  
biomedical high-road approaches. The findings did not take into consideration a general 
health focus on local capacity building and horizontally distributed health care. Thus, while 
health infrastructure might be improved by AIDS specific services, the consequent de-
contextualising of the pandemic still ignores the link between AIDS and general health and 
wellbeing (Garrett, 2007:32-33) which is  one  of  Vanwesenbeeck’s  (2011)  arguments  against  
high-road prioritisation and HIV-exceptionalism.  
These different perceptions of what a strengthened health system contains are valuably 
elucidated  by  Vanwesenbeeck’s  (2011)  model  because  the  idea  that  health infrastructure is the 
same as health care reveals a biomedical ontological understanding where vertically 
distributed AIDS specific services is the norm and low-road approaches are deprioritised. Just 
as the previous section argues that the de-contextual and de-sexual preferences of 
medicalised, monetised and moralistic ideas have affected SRH marginalisation, these ideas 
can have contributed to HIV-exceptionalism. In the example of the health systems debate at 
the International AIDS Conferences in Toronto and Mexico City, medicalised ideas can be 
argued to be particularly evident, as the arguments pro HIV-exceptionalism at the Mexico 
City conference were relying on the findings from evidence-based research and ignoring the 
many African leaders that reported coordination problems between AIDS specific services 
and the overall health system (Kort, 2008:5).     




However,  Vanwesenbeeck’s  (2011)  model  does  not  indicate  any  alternative  explanations  for  
HIV-exceptionalism. The model implies that HIV-exceptionalism and AIDS specific services 
are a consequence of overall de-contextualisation and de-sexualisation of AIDS responses 
following the scale-up for AIDS, rooted in medicalised, monetised and moralistic ideas. As 
indicated in Chapter 3, other scholars have argued that HIV-exceptionalism is not necessarily 
only a symptom of scale-up and particularly medicalised ideas, but also something essential 
for the scale-up to occur in the first place. This can be linked to neoliberal re-legitimisation, 
which is discussed in Section 4.2.6.  Moreover, HIV-exceptionalism can also be linked to how 
AIDS was framed as an emergency and security threat, which is explored in the remaining 
part of this section.  
As indicated in Chapter 3, AIDS was deliberately framed as something exceptional before the 
scale-up for funds materialised. Significantly, at the UN Security Council (UNSC) meeting in 
2000, and in the subsequent Resolution 1308, AIDS was framed as a threat to national 
security. UNAIDS was a part of this framing process (Behrman, 2004:175-176; Ingram, 
2013:440; McInnes & Rushton, 2011:122; Smith & Whiteside, 2010:3). This is interesting for 
several reasons. First of all, it illuminates alternative explanations to high-road prioritisation, 
because the responses to an emergency would be that of a fire fighter: short-term drastic 
solutions to deal with the most apparent and urgent factors. Thus, HIV-exceptionalism, short-
term solutions, vertical distribution and the urgent need for evidence-based research and 
access to ART – all indicators of high-road approaches – could be direct urgent responses to 
the idea of AIDS as a national security threat, rather than ideas of moralism, medicalisation 
and the market, as Vanwesenbeeck (2011) argues, or humanitarianism, as this study stresses. 
This supports the insight from Cleland et al.’s  (2006:1811,  1823)  argument   in  Section  4.2.4  
on how family planning has been deprioritised   after   being   taken   off   the   ‘high   politics’  
economy agenda and thereby deemed less urgent. Since urgent cases are prioritised in global 
politics, an AIDS emergency can also explain the de-prioritisation  of  the  ‘less  urgent’  sexual  
and  reproductive  health.  This  is  not  reflected  in  Vanwesenbeeck’s  model. 
Second, the framing of AIDS strengthens the constructivist argument that ideas and 
materialism are reinforcing each other. The idea of AIDS as a security threat, as compared to 
solid material evidence (McInnes & Rushton, 2011:125; Smith & Whiteside, 2010:4), was 
enough for policymakers to start pouring money in to the pandemic. This securitised idea was 
enhanced  by  Western,  and  particularly  the  US’,  focus  on  security,  especially  after  the  terrorist  
attacks   11   September   2001.   The   idea   that   “the   ‘high   politics’   of   health   issues   that   is,   their  
security   aspects   rather   than   ‘low politics’   in  which  health   issues   are   seen  as   a   reflection  of  




human   dignity”   (Fourie,   2013:3)   needs   to   be   emphasised   in   order   to   trigger   a   response   is  
depressing from a global health perspective. However, this view calls for a re-evaluation of 
the importance of ideational framing in material responses in global politics.  
These  points  imply  that  something  is  lacking  from  Vanwesenbeeck’s  (2011)  model.  An  idea  
or  norm  of  ‘sensationalism’  to  describe  the role of multilateral actors in framing emergencies 
in order to allocate attention and funds, and the security and/or sensational preferences of 
policymakers that use this sort of framing to legitimise their engagement, could perhaps be 
valuable  for  the  model’s  interrogation  of  high-road prioritisation.  
Peter Piot, previous Executive Director of UNAIDS, understood the importance of getting 
AIDS discussed in the UNSC in order to increase much needed attention for the pandemic 
(Berhman, 2004:175; Cleland et al., 2006:1823). As a security issue, AIDS is exceptional and 
separated from its overall context for targeted emergency measurements. While targeted and 
urgent short-term responses to the AIDS pandemic can be understood from a medicalised 
point of view for the importance of monitoring and demonstrating effective use of donor 
money, they are also important attention seekers for engaging donor contributions in the first 
place.  Although  Vanwesenbeeck’s  (2011)  ideas  of  the  market,  medicalisation  and  moralism,  
in addition to humanitarianism, can explain some parts of high-road prioritisation, these ideas 
cannot   elucidate   why   “donations   are   propelled   by   mass   emotional   responses”   (Garrett,  
2007:21). In the latter case, issues are prioritised based on how much attention they can get – 
how sensational they are and urgent they are portrayed – and not whether they are the largest 
killer. In this sense, HIV-exceptionalism and high-road prioritisation can be elucidated by 
how  AIDS  was  seen  as  sensational  although  “the  top  three  killers  in  most  poor  countries  are  
maternal death around childbirth and pediatric respiratory and intestinal infections leading to 
death  from  pulmonary  failure  or  diarrhea”  (Garrett,  2007:23).   
The point here is not that AIDS as a pandemic does not have serious, even exceptional, 
widespread consequences that deserve high-profiled   political   attention.   Indeed   “after   three  
decades   [the   pandemic]   is   still   unfolding”   (Smith   &   Whiteside,   2010:6).   Furthermore,   as  
Nathan  Geffen  (2013)  pointed  out  in  a  personal   interview,  “[if]  there  weren’t  seven  or  eight  
million people  on  treatment  across  the  world  I  think  you’d  find  that  many,  many  more  people  
would   die   of  HIV   than   any  other   diseases”.  The   point,   thus,   is   rather   that   there   are   certain  
ideas shaping global AIDS agendas based on how AIDS has been problematised. In order to 
ensure a comprehensive response, these ideas and processes ought to be understood. 
Vanwesenbeeck’s  (2011)  model  can  elucidate  some  of  these  processes,  but  not  all.  In  addition  




to an insight of the humanitarian aspects of scale-up for global AIDS responses, an idea 
entailing how de-contextual high-road approaches has been necessary parts of ensuring this 
scale-up  in  the  first  place  is  also  an  important  aspect  lacking  from  Vanwesenbeeck’s  model.   
Another   limitation   to   Vanwesenbeeck’s   (2011)   model   is   how it does not mention the 
depletion of the market during the Global Financial Crisis while simultaneously emphasising 
the influence of the market and the medicalised ideas at the ground for demands of cost-
efficiency, productivity, accountability and legitimacy. Interestingly, the remedicalisation of 
the pandemic recognised in Table 3.1 came around the time as funds started to decrease. 
Another explanation for high-road prioritisation and remedicalisation of the AIDS pandemic 
can therefore be found in a material need to ensure productive allocation of a tight budget 
rather than medicalised norms. This is further explored in the following section.    
4.2.6 The complex role of the neoliberal market 
In the current neoliberal world market dynamics play a significant role, also when it comes to 
global health. For instance, in bilateral funds for the AIDS pandemic, North-America and 
Western Europe alone distributed $5.5 billion to regions such as Latin America, Northern 
Africa and the Middle East, sub-Saharan Africa, Russia and Asia in 2008 (UNAIDS, 
2010b:10), suggesting a large flow and allocation of resources. Regarding the pharmaceutical 
industry  “global  pharmaceutical  sales   reached  $602  billion”  (Biehl, 2007:1097) in 2005. As 
Chapter 3 indicates, people living with HIV are dependent on ART drugs to survive and 
market actors, the pharmaceutical industry in particular, have been criticised for their cynical 
or  greedy  approach  to  the  AIDS  pandemic.  As  such,  Vanwesenbeeck’s  (2011)  model  claims 
that market forces have been significant in encouraging high-road prioritisation, as these 
biomedical approaches opens up for more money-making opportunities than low-road 
approaches.  
A  significant   limitation   to  Vanwesenbeeck’s   (2011)  model,   as  Section  4.2.3   indicates,   is   its 
failure to elucidate the grey zone between low-road and high-road approaches, exemplified by 
how the low-road based global justice campaign was essential for securing access to high-
road   ART   drugs.   Furthermore,   the   model’s   emphasis   on   the   influence   of   moralistic, 
monetised and medicalised ideas ignores the humanitarian idea behind this scale-up. 
Countering the argument from Section 4.2.3 that this humanitarianism has disempowered the 
neoliberal market by curbing the pharmaceutical industry, however, is Ingram’s   (2013:440-
441) claim that this fight for global justice effectively re-legitimised the market by engaging 
market principles and dynamics in order to improve global health. The quest for universal 




access to ART could therefore be accepted by market enthusiasts on the premise that market 
dynamics and actors, such as multilateral and philanthropic organisations and corporations, 
would be used in responding to the crisis.  
This can be illustrated by Biehl (2007:1084, 1095-1096), who argues that in the background 
of  Brazil’s  decision  to  challenge  the  pharmaceutical  industry  by  making ART a public good 
was an army of market principles deeming supply and demand. While Brazil is almost 
completely independent of international investments in terms of the AIDS pandemic, its 
biomedical problematisation of AIDS has made the country overly dependent on ARTs in 
order to address their domestic situation (UNAIDS, 2011:154). To sustain this, coalitions 
between government, civil society and the pharmaceutical industry had to eventually be made 
in order to ensure access to the drugs that could not be cheaply generically produced in 
accordance with the WTO TRIPS agreement. Such coalitions become especially important in 
order to ensure back up medication for the citizens that get resistant to their generically 
produced ART drugs (Biehl, 2007:1100). Thus, where Vanwesenbeeck (2011) argues that the 
market is avoiding human rights-based approaches because of the lack of financial 
opportunities,   Ingram’s   (2013)   argument   can   elucidate the opposite. This suggests that 
Vanwesenbeeck’s  model  has  a  point  in  terms  of  the  impact  of  the  market.  Furthermore,  it  can  
also explain why human rights have entered the official programme at the International AIDS 
Conferences simultaneously as the pandemic has become increasingly remedicalised, as 
humanitarian spread of biomedical solutions serves the market.  
While the humanitarian efforts behind the distribution of drugs for the AIDS pandemic must 
not be underestimated, the strong links between access to ART, human rights and the 
pharmaceutical industry can illustrate the ability of the neoliberal market to adapt and reinvent 
itself (Biehl, 2007:1099-1100).   This   can   “indicate[…]   the   possibilities   that   may   exist   for  
working creatively with neoliberalism  [….]  to  expand  welfare”  (Ingram,  2013:442),  however,  
it can also illustrate an increased dependency on the market. Thus, in support of 
Vanwesenbeeck’s   (2011)   claim   that   market   forces   are   shaping   global   AIDS   agendas   and  
contributing to high-road prioritisation is the idea that the neoliberal market, with the 
pharmaceutical   industry   in   front,   has   cooped   the   ‘universal   access’   paradigm   from   overall  
humanitarian  principles.  From  this  point  of  view,  Vanwesenbeeck’s  emphasis  on  the  greedy  
market can elucidate the increasingly biomedical solutions to the pandemic. Especially the 
TASP   paradigm   deemed   necessary   to   ‘end   AIDS’   and   the   biomedical   elements   of  
combination prevention aimed at sorting out even structural challenges are based in 
biomedical ideas the market would benefit from as an increasing amount of people start using 




these drugs. Since  the  market  prefers  targeted,  measurable,  ‘quick-fixes’  and  profitable  high-
road approaches, increased dependency ignores the non-pharmaceutical low-road responses to 
the pandemic. While more people on treatment might reduce the chances of passing on the 
HI-virus, as is the idea behind TASP, it will also increase the number of people getting 
resistant to ART, which again increases demands for new medications. This downward spiral 
of   supply   and  demand   in   the  AIDS  pandemic   supports   both  Vanwesenbeeck’s   argument  of  
how the market and biomedicine enhance each other towards high-road prioritisation, and the 
claim that a purely high-road approach to AIDS is unsustainable.  
Simultaneously, it might be more the hope entailed to ending the pandemic that drives market 
dynamics and high-road prioritisation than greedy actors of themselves. In the aftermath of 
numerous behavioural and structural approaches with limited effect according to evidence-
based research – reflecting the trust in medicalised ideas – biomedical approaches present an 
idea of controllable and seemingly effective solutions to the pandemic (Giami & Perrey, 
2012:357).   In  this  case,   it   is   less  the  direct   ‘evilness’  of  market actors and more the web of 
ideas and belief that the pandemic is best fought through market dynamics, that drive high-
road prioritisation. Vanwesenbeeck (2011) might therefore exaggerate the greediness of 
market actors, or at least their impact on AIDS agendas, and not elaborate enough on the 
ideational factors of the market and the ideas of freedom and hope it entails.  
Nevertheless, perhaps the most significant demonstration of how the market affects global 
AIDS responses is how the pandemic is still dependent on donor contributions. Even the 
International AIDS Conferences, as Chapter 3 indicates, are supported by and dependent on 
the financial contributions of the pharmaceutical industry. In a pandemic that affect the most 
vulnerable people in this world hardest, both individually and internationally, donor 
preferences towards AIDS specific, biomedical and vertically distributed high-road 
approaches can be argued to increase global inequalities by making countries in the 
developing world dependent on developed countries – despite whatever humanitarian 
reasoning  behind  this.  The  influence  of  market  dynamics  and  the  pandemic’s  dependence  on  
funds become visible when the money for the vertical tap of funds stop flowing in and no 
local capacity has been built (Garrett, 2007:30, 38). Thus, the impact the flatlining and 
decreasing funds had on the AIDS pandemic after the Global Financial Crisis is a clear 
demonstration of donor and market dependency.  
Interestingly, for a model that acknowledges both the growth  of  medicalised  ideas’  focus  on  
cost-efficiency and the   AIDS   pandemic’s   dependency   on the   market,   Vanwesenbeeck’s  




(2011) model does not take into account the Global Financial Crisis although its impact on the 
pandemic is widely recognised (Ahmed et al., 2009:9; Fourie, 2013:3; IAS, 2010:8; UN 
General Assembly, 2011:3; WHO et al., 2011:7-8). With regards to donor dependency and 
priorities,   Nathan   Geffen   rationalises   the   Global   Financial   Crisis’   impact   on   global   AIDS  
responses  with  the  belief  that  “[r]ich  people are a lot more likely to give their money to poor 
people  when  things  are  going  well”  (Geffen,  2013).  Furthermore,  the  Global  Financial  Crisis  
is   significant   for   the   analysis   of   Vanwesenbeeck’s   model   because,   although   it   supports  
Vanwesenbeeck’s   argument by demonstrating the influence of the market, it provides yet 
another explanation apart from moralistic, medicalised and market-driven ideas for why 
global AIDS agendas have become increasingly remedicalised and focused on high-road 
approaches. Indeed, with less money to distribute for AIDS approaches, Ingram (2013:447) 
suggests that neoliberal principles focused on cost-efficiency  and  ‘value  for  money’  came  to  
the fore, consequently increasing the demand for approaches that can be legitimated through 
evidence-based research, which, as this study has articulated, are usually high-road 
approaches.  
Furthermore, the impact of the Global Financial Crisis on global AIDS responses and high-
road prioritisation suggests that there might be a purely rational and material explanation for 
the prioritisation of high-road approaches at the expense of low-road approaches. This 
undermines   the  entirety   of  Vanwesenbeeck’s   (2011)  model,   as   it   stresses   the   importance  of  
how ideas and materialism reinforce each other. However, the Global Financial Crisis cannot 
explain why increased focus on science, medicalised approaches and evidence-based research 
became increasingly pronounced as the early 2000s went by or why, as Table 3.1 indicates, a 
binary between high-road and low-road approaches emerged around the time of the 
International AIDS Conference in Toronto in 2006. During this time, resources for the AIDS 
pandemic  were  abundant  and  still  growing,  which  undermines  Ingram’s  (2013)  argument  that  
neoliberal   principles   of   ‘scarcity’   impacted   global   AIDS   agendas.   In   fact,   as   Chapter   3  
indicates,  medicalised  ideas  of  ‘value  for  money’,  cost-efficiency and biomedical approaches 
were increasingly pronounced as the scale-up for funds became abundant. This supports 
Vanwesenbeeck’s   (2011) model because it suggests that high-road prioritisation did not 
happen as a reaction to scarce material resources, but rather to medicalised ideas and norms. 
Again the framing of AIDS, or sensationalism, comes up as a lacking factor in 
Vanwesenbeeck’s model.  
The securitisation of AIDS explored in the previous section can also serve as an argument 
against the impact of the Global Financial Crisis on high-road prioritisation. This is because 




the de-securitisation of AIDS – occurring after it became more “clear   that  AIDS   and  other  
diseases are not the cause of   global   insecurity   and   state   failure”   (Fourie,   2013:3,   original  
emphasis) – happened just before the Global Financial Crisis and funds for AIDS responses 
decreased. Just as the Global Financial Crisis, the de-securitisation of AIDS – consequently 
reversing HIV-exceptionalism – might have contributed to less funds for the pandemic as the 
matter was declared less urgent (Ingram, 2013:446-447; McInnes & Rushton, 2011:118). 
While the Global Financial Crisis is believed to have had a major impact on decreased funds 
for   the   pandemic,   if  AIDS  was   still   perceived   as   a   security   threat  worthy   of   ‘high-politics’  
attention, the funds for the pandemic might not have decreased as much as they did. 
Supporting this argument is how funding for UNFPA increased at the same time as funding 
for AIDS decreased, as Section 4.2.4 indicates. This is important because, although 
Vanwesenbeeck (2011) does not mention the framing of AIDS in her model, it illustrates the 
importance of ideas in global AIDS governance, which in the end is part of the important 
contribution Vanwesenbeeck is making.  
Curious is it then that Vanwesenbeeck (2011) herself does not explicitly elaborate on the 
ideational and ideological link between the market and medicalisation. While the capitalist 
market has existed for a long time, it has since the 1980s been particularly affected by 
neoliberal   financial   principles.   Medicalisation’s   emphasis   on   cost-efficiency,   ‘value   for  
money’,  monitoring   and   evaluations is also, as Chapter 2 indicated, based on a neoliberal 
ideology restructuring governments around the same time. This is significant because the 
ideational link between these, the link Vanwesenbeeck forgets to emphasise, is actually 
supporting her argument. The increasingly medicalised AIDS pandemic despite abundant 
resources can therefore be illuminated by a neoliberal belief in how market money is best 
allocated – cost-efficiently – and can also explain why these neoliberal principles became 
more explicit as   funds   decreased.   Ingram’s   (2013)   principles   of   ‘scarcity’   after   the  Global  
Financial Crisis are thus still relevant because they are, according to this view, based on 
norms already present that became increasingly visible as funding stopped. This is, again, an 
illustration of the nexus between materialism and ideas.  
4.2.7  The  Vanwesenbeeck  model’s  explanation  value 
As   this   chapter   has   aimed   to   demonstrate,  Vanwesenbeeck’s   (2011)  model   has   explanation  
value beyond illuminating the prioritisation of high-road approaches at the expense of low-
road  approaches.  The  model’s  emphasis  on  ideas  and  norms  of  morals,  medicalisation  and  the  
market can highlight certain developments around the International AIDS Conferences 
between 1996 and 2012, albeit not all.  




The   model’s   focus   on   ideas   of   the   market,   moralism   and   medicalisation   certainly   has  
explanation value for why high-road approaches have become increasingly prominent. 
Moralistic ideas and policymakers have been, and are still, evident. This study argues that 
because of the financial supremacy some moralistic policymakers have, combined with these 
policymakers’  legitimacy  – as  reflected  in  the  constructivist  notion  of  ‘norm  cascades’  – and 
the ideas believed to affect these policymakers themselves and the inhabitants of receiving 
donor countries, the impact of moralistic norms must be found in the nexus between 
materialism   and   ideas.   This   supports   the   Vanwesenbeeck   (2011)   model’s   insight   for   how  
ideas  and  materialism  reinforce  each  other  and  the  model’s  claim  that moralistic norms have 
contributed to high-road prioritisation. Furthermore, the continued significance of moralistic 
ideas   become   especially   pronounced   in   PEPFAR   II’s   continued   sex   negative   or   asexual  
policies and how sexual and reproductive health as part of a broader human rights agenda at 
more recent International AIDS Conferences has been avoided. While the latter points out a 
limitation   to  Vanwesenbeeck’s   (2011)  model,   that   is   that   this   incoherence  within   low-road 
approaches is not expressed, the fact that sexual and reproductive health is ignored can be 
explained by continued presence of moralistic ideas.  
Medicalised ideas, although incoherent with moralism in terms of evidence-based research, 
can also be identified in increased demand for evidence-based research and promotion of 
biomedical   approaches   believed   to   ‘solve’   very   complex   social   and   structural   issues.   Thus,  
although there is a mismatch between the increased prominence of moralistic ideas and 
evidence-based research – because the former is often not supported in the latter – the focus 
on prevention technologies since 2006 can signify a good compromise between moralistic and 
medicalised ideas, as they avoid culturally sensitive and/or moralistic discussions as well as 
contextual and unquantifiable approaches. Such measurable approaches are well aligned with 
the increased demand for evidence-based research and medicalised principles of cost-
efficiency and evaluation. The development of prevention technologies, TASP and 
combination prevention and their supposed ability to address non-biomedical contexts and 
structure also suggest the presence of a biomedical ontology where a positivist inclined 
epistemology is preferred, or even taken for granted, for accumulating knowledge, at the 
expense of social   and   political   sciences’   understandings   of   epistemology   and  methodology.  
This  supports  Vanwesenbeeck’s  (2011)  claim  of  the  prominence  of  medicalised  ideas,  as  well  
as  these  ideas’  co-existence with moralistic norms.  
The development of such biomedical prevention technologies also benefits the market, 
because of the increased pharmaceutical distribution and the downward spiral of dependency 




this entail. The complex role of the market in the AIDS pandemic – both at the heart of global 
justice struggles to distribute lifesaving medications and as contributor to donor dependency – 
supports  Vanwesenbeeck’s  (2011)  emphasis  on   the   influence  of   the  market  on  global  AIDS  
agendas and high-road prioritisation, although this impact might be less materialistically 
inclined than Vanwesenbeeck recognises. Indeed,  Vanwesenbeeck’s suggestion that ideas of 
the market, moralism and medicalisation have enhanced high-road prioritisation is reasonable 
because in the complicated nexus between these ideas, high-road approaches are perhaps the 
only thing that can actually be agreed upon. 
Thus, the high-road/low-road model elucidates much of the problematisations AIDS has gone 
through in recent years. However, while a model is a necessary simplification of reality, there 
are contestations within low-road   approaches   that   indicate   that   Vanwesenbeeck’s   (2011)  
binary between high-road and low-road approaches is too pronounced. First of all, 
Vanwesenbeeck fails to see the significance of the global justice movement on the focus on 
and distribution of biomedical solutions and thereby also humanitarian ideas for high-road 
prioritisation. This humanitarian idea indicates a grey zone between high-road and low-road 
approaches   that   is   not   expressed   in   Vanwesenbeeck’s   model,   and   which   can   give a more 
nuanced picture of how the pandemic has become more biomedical. In this sense, 
Vanwesenbeeck’s  binary  is  too  pronounced.   
Second, Vanwesenbeeck does not recognise other ideas than moralism, medicalisation and the 
market for HIV-exceptionalism. Where the model implies that HIV-exceptionalism is a result 
of these ideas and the scale-up of funds for the AIDS pandemic, many scholars argue that 
HIV-exceptionalism and the framing of AIDS as a national security emergency – removing it 
from its overall context – were necessary for the scale-up to happen in the first place. HIV-
exceptionalism is therefore not only an indicator of high-road approaches, but also a 
contributor to high-road prioritisation on the whole. This study argues, thus, that an idea or 
norm  of  sensationalism  could  with  benefit  be  added  to  Vanwesenbeeck’s  model,  as  this  would  
help illuminate the significance of framing issues as urgent in global policymaking and the 
emotional drive this provokes at the hands of the donors. 
Lastly, Vanwesenbeeck (2011) does not recognise the ideological link between the market 
and medicalisation, which are both based on neoliberal norms and principles. This becomes 
particularly explicit when she fails to incorporate the impact the Global Financial Crisis had 
on funding for AIDS. Although the Global Financial Crisis cannot explain high-road 
prioritisation and the increased prominence of medicalised ideas of cost-efficiency before its 




occurrence, it can elucidate why high-road approaches and neoliberal principles became more 
pronounced as funds decreased, as high-road prioritisation would merely be a natural reaction 
to already existing neoliberal ideas and norms. Thus, had Vanwesenbeeck recognised the 
ideational link between the market and medicalisation, an implementation of the Global 
Financial Crisis would have made her argument stronger, as it all the more clearer 
demonstrate the ideational importance of neoliberalism – as compared to purely material 
responses – and thereby also both medicalised and market-driven ideas.  
4.3 Conclusion 
Chapter  3   argues   that  Vanwesenbeeck’s   (2011)  distinction  between  high-road and low-road 
approaches can be recognised in the events and discourses surrounding the biennial 
International AIDS Conferences between 1996 and 2012, albeit with some incoherencies, 
limitations and unclear underlying ideas. Thus, the aim of this chapter has been to analyse 
Vanwesenbeeck’s  model  to  explore  whether  the  model  can  valuably  explain  and  simplify  the  
complex situation and development of recent and current multilateral AIDS agendas. 
Vanwesenbeeck claims that biomedical high-road solutions are currently prioritised at the 
expense of more contextual and sexual low-road solutions due to moral, medicalised and 
monetised preferences of donors and policymakers. These ideas have some clear limitations 
for explaining global AIDS policies and the prioritisation of high-road approaches, such as 
how they ignore the significance of humanitarianism in the distribution of lifesaving 
medications and thus also the existence of a grey zone between low-road and high-road 
approaches. Furthermore, the ideological link between the market and medicalisation is not 
directly emphasised, neither is the impact of the Global Financial Crisis, and, finally what 
appears to be a norm of sensationalism in global policymaking. Nevertheless, this study 
argues   that   Vanwesenbeeck’s   model,   despite   its   limitations,   can   both   be   recognised   and  
valuably illuminate the events and political discourses around the International AIDS 
Conferences between 1996 and 2012. This is because ideas of morals, medicalisation and the 
market still seem to have prominence and affect multilateral AIDS agendas, albeit perhaps not 
as strong as Vanwesenbeeck initially claims. Moralistic ideas and norms are still visible in 
global AIDS agendas. Ideas of medicalisation are evident in the emphasis on evidence-based 
research and cost-efficiency, which appeared before the Global Financial Crisis hit. Finally, 
the AIDS pandemic is dependent on the market, which in many senses is necessary yet also 
destructive. In many ways, de-sexualised, measurable, biomedical and profitable high-road 
approaches are the only solutions that can be agreed upon in the idea space between these 
norms.  This  is  expressed  in  Vanwesenbeeck’s  model. The following chapter summarises the 




main points of this study, answers the research questions, and provides suggestions for future 
research on the topic.     
  




Chapter 5: Conclusions, and Future Agendas 
5.1 Introduction 
Global, multilateral, medical and societal actors and responses to the AIDS pandemic have 
been plentiful since AIDS was first identified in 1981. These multiple engagements have been 
essential for working towards an effective global AIDS response, as the pandemic represents 
complex political, social and biomedical concerns. Simultaneously, however, these various 
responses can also represent binaries of contested constructs shaped by how AIDS has been 
problematised and inter-subjectively understood. Vanwesenbeeck (2011) constructed a model 
that interrogates how problematisations of AIDS have affected global AIDS agendas as well 
as multilateral AIDS governance. The Vanwesenbeeck model suggests that although 
multilateral AIDS policies ought to be holistic for a comprehensive response, they have 
become increasingly focused on de-sexualised,   biomedical   and   vertically   distributed   ‘high-
road’   approaches   at   the   expense   of   the   more   contextual,   sexual,   human   rights-based and 
developmentally   focused   ‘low-road’   approaches.   This   high-road prioritisation, 
Vanwesenbeeck proposes, results from ideas and norms reflective of the market, moralism 
and medicalisation.  
It  was  the  aim  of  this  study  to  test  the  analytical  utility  of  the  Vanwesenbeeck  model’s  binary  
of problem definitions and response mechanisms to see if it could simplify the complexity and 
narrow the scope of effective and sustainable policy responses by valuably elucidating the 
relationship between ideas, global AIDS agendas and multilateral AIDS governance. For this 
purpose, this study investigated the following research question: 
Can  Vanwesenbeeck’s  (2011)  model  of  high-road and low-road solutions be identified in and 
illuminate the policy ideas, problem definitions and political binaries that play out in the 
discourse surrounding the biennial International AIDS Conferences between 1996 and 2012? 
Sub-questions complementing this primary research question included the following: 
 What  are  the  strengths  and  limitations  of  Vanwesenbeeck’s  (2011)  model? 
 What have been the general trends and developments in global AIDS policy/political 
responses as presented by policymakers, donors, civil society and multilateral 
organisations during, before and after the biennial International AIDS Conferences? 
 Has the Global Financial Crisis affected the global AIDS response, and if so, in what 
way(s)?  




This chapter concludes this study by summarising the main points from each chapter, 
answering the research questions and suggesting future research on the topic.  
5.2 Summary of the study  
Apart from presenting the research aim, question and supportive sub-questions as referred to 
above, Chapter 1 provided a general introduction to the study with an overview of the 
background and main discussions on the topic, the presentation of the problem statement, a 
demonstration of the theoretical background and model of scrutiny, the methodology of 
choice, as well as the limitations of the study.  
Chapter 2 went on further to explore   Vanwesenbeeck’s model and to explicate its 
contributions and limitations. The chapter started with a theoretical contextualisation of the 
model within theories of public policy problematisations and IR constructivism. These 
theories emphasise how inter-subjective ontological and epistemological assumptions and 
problematisations  of  issues  shape  what  is  perceived  as  ‘appropriate’  policies,  and  thereby  also  
epistemological preferences. Used as theoretical background, these theories can elucidate 
significant aspects with the Vanwesenbeeck   model’s   understanding   of   the   nexus   between  
ideas and materialism and the suggested effect of the market, moralism and medicalisation on 
norm  entrepreneurs’  ontological  assumptions.  As  such,  Vanwesenbeeck  argues  that  high-road 
approaches are prioritised in global AIDS agendas and responses because their biomedical, 
quantifiable, de-sexual and clinical characteristics are more aligned with ideas and norms of 
moralism, the market and medicalisation, as compared to low-road   approaches’   focus   on  
human rights, sexual and reproductive rights, communities and development. Chapter 2 
suggests some limitations of the Vanwesenbeeck model: the possible oversimplification of the 
model’s  binary,  as  well  as   its   ignorance  of   the  Global  Financial  Crisis’  effect  on the global 
AIDS response.  
Chapter 3 provided an historical outline of the key events and discourses surrounding the 
International AIDS Conferences between 1996 and 2012. In doing so, different frameworks – 
such   as   neoliberalism’s   complex   role,  HIV-exceptionalism and biomedical constructions of 
sex and culture – were explored for elucidating several perspectives and portrayals of how 
multilateral AIDS governance and global AIDS agendas have developed since 1996. The 
chapter pointed out three recognisable tendencies during the relevant timeframe of the study, 
most  specifically  the  ‘building  of  institutions’,  ‘increased  funding’  and  the  ‘remedicalisation  
and   eventual   funding   cuts’.   It   concluded   that   features   of   Vanwesenbeeck’s model could 
indeed be identified through increased focus on evidence-based research, the presence of 




moralistic approaches, and the legitimisation of biomedicine and top-down interventions – all 
indicators of high-road approaches. However, the underlying contributions for this high-road 
prioritisation were not clear, as the chapter found that there can be other factors affecting 
global AIDS agendas and policies than the moralistic, market-driven and medicalised ideas 
and norms suggested by Vanwesenbeeck.  
Consequently, Chapter 4 investigated various indicators of high-road and low-road 
approaches – such as epistemological understandings of evidence and knowledge, sexual and 
reproductive health, human rights and HIV-exceptionalism – for testing the explanation value 
of   Vanwesenbeeck’s model.   Particularly   under   scrutiny   were   Vanwesenbeeck’s   ideas   of  
medicalisation, the market and moralism, as compared to alternative explanations for high-
road  prioritisation.  The  chapter  concludes  that  Vanwesenbeeck’s  model  can  be  both  identified  
in and valuably elucidate the developments and political discourses and outcomes 
surrounding the International AIDS Conferences between 1996 and 2012. However, it fails to 
take into consideration the impact of the Global Financial Crisis, humanitarian engagement 
and the securitisation of AIDS on the development of high-road prioritisation in multilateral 
AIDS  governance,  which  affects  the  model’s  analytical  utility.     
5.3  The  study’s  findings  with  regards  to  the  research  question  and  sub-questions 
As the preceding section implies the short answer to   whether   Vanwesenbeeck’s model of 
high-road and low-road solutions can be identified in and illuminate the policy ideas, problem 
definitions and political binaries that play out in the discourse surrounding the biennial 
International AIDS Conferences between 1996 and 2012 is: yes, it can. However, although 
the model can be both identified in and elucidate these elements, it has significant 
shortcomings   that   limit   the  model’s   analytical   utility.   Hence,   Vanwesenbeeck’s  model   can 
valuably simplify some of the developments and discourses surrounding the International 
AIDS Conferences but not all, as it leaves out important information. The complementary 
sub-questions assisted in the findings for the development of this conclusion.  
One of the complementary sub-questions concerns what the general trends and developments 
have been in global AIDS policy/political responses as presented by policymakers, donors, 
civil society and multilateral organisations during, before and after the biennial International 
AIDS Conferences. This question allowed for an in-depth exploration of the case study of the 
International AIDS Conferences within the specific timeframe, which was necessary for the 
further   analysis   and   testing   of   Vanwesenbeeck’s   model. In response to this question key 
developments and tendencies were identified and it became evident that between 1996 and 




2012 the global and multilateral responses to the pandemic changed drastically. Access to 
HAART early became a global justice issue, signifying the fight against, as well as the 
dependency on, the neoliberal market and pharmaceutical companies. Institutions were built 
and political commitment and funding for the pandemic increased. After 2006 and the 
introduction of prevention technologies  and  ‘treatment  as  prevention’  (TASP)   the  pandemic  
became increasingly dependent on biomedical solutions, a trend that continued as funds for 
AIDS flatlined and decreased in the aftermath of the Global Financial Crisis (2008-2011). 
This sub-question assisted in exploring whether high-road and low-road approaches could be 
identified in the case study. Although low-road approaches were, as Table 3.1 suggests, 
prominent up until 2006, the increased focus on approaches aligned with evidence-based 
research, the presence of moralistic norms and policymakers, dependency of the neoliberal 
market and prominence of biomedical and vertically distributed solutions suggests a trend of 
high-road  prioritisation,  just  as  Vanwesenbeeck’s  model  suggests.   
This historically inclined sub-question is linked to the sub-question that addresses the 
strengths   and   limitations   of   Vanwesenbeeck’s   model.   Ultimately,   the   identification   of   the  
model’s   contributions   and   limitations   has   been   useful   for   clarifying   the  model’s   analytical  
utility.   Vanwesenbeeck’s   ideas   and   norms   of   the   market,   medicalisation   and   moralism   all  
have explanation value, albeit limited, for the development of high-road prioritisation. As 
Chapter 4 demonstrated, medicalised ideas and norms can be recognised in increased 
demands for monitoring and evaluation, evidence-based research and how knowledge has 
increasingly been defined according to scientific or biomedical epistemological preferences, 
at   the   expense   of   political   and   social   sciences’   understandings   of   epistemology and 
methodology.  Medicalised   and   moralistic   ideas’   preference   to   avoid   culturally   challenging  
debates and unquantifiable and sexual solutions can elucidate why sexual and reproductive 
health and structural approaches were marginalised after viable alternatives in form of 
biomedical prevention efforts were first presented at International AIDS Conferences in 2006 
and 2008. Furthermore, the belief that biomedical solutions can address structurally complex 
issues also suggests the prominence of a biomedical ontology where certain epistemological 
concerns are taken for granted.  
Furthermore,  Vanwesenbeeck’s emphasis on moralistic ideas is reasonable as such norms are 
still present in the pandemic in the form of the abovementioned marginalisation of sexual and 
reproductive health, but also via the continued stigmatisation and discrimination of people 
living  with  HIV.   In   light   of   constructivists’   emphasis   on   the   relationship   between  material  




existence   and   ideas,   and   on   the   significance   of   legitimacy   and   ‘norm   cascades’,   this   study  
suggests  that  moralistic  ideas  and  policymakers’  effect  on  global  AIDS  agendas  can  be  found  
in a nexus of financial authority, normative power and legitimacy. Although medicalised 
evidence-based research do not support many moralistic ideas, and have even been used to 
counter moralism, the simultaneous existence of both of these ideas – exemplified by 
PEPFAR   II’s   medicalised,   de-sexual and still moralistic programme and the separation of 
sexual and reproductive health from overall human rights at recent International AIDS 
Conferences – suggests the continued prominence of moralistic norms. The de-sexual and de-
contextual characteristics of high-road approaches are indeed something moralistic and 
medicalised ideas can agree upon, which  Vanwesenbeeck’s  model  manages  to  elucidate.   
Vanwesenbeeck’s  focus  on  the  market  also  has  explanatory  value  for  high-road prioritisation. 
While the distribution of ART has saved lives and is an essential element in global health, 
these medications are also  dependent  on  market  dynamics   and  donors’  preferences   and  can  
thus be said to have contributed to a re-legitimisation of the neoliberal market for accessing 
essential health services. This link between the market and biomedicine is amplified as global 
AIDS governance becomes increasingly dependent on biomedical solutions to the pandemic. 
The de-prioritisation of low-road   approaches   can   therefore   be   explained   by   the   market’s  
preference of profitable, targetable and readily quantifiable high-road solutions.  
However,   Vanwesenbeeck’s   model   has   several   limitations,   as   it   fails   to   elucidate   other  
explanations for high-road prioritisation. First of all, it ignores the link between human rights, 
activism and the access to lifesaving HAART drugs. This humanitarian idea – as compared to 
market-driven, medicalised or moralistic ideas – suggests a grey zone between low-road and 
high-road approaches, where the latter is dependent on the former in order to materialise. 
Thus,  although  Vanwesenbeeck’s  model  can  highlight the link between human rights and the 
market, the binary between high-road and low-road approaches is too pronounced and 
neglects the important impact that global justice and activism have had in the course of the 
pandemic and even on high-road prioritisation.  Secondly,  Vanwesenbeeck’s  model  sees  HIV-
exceptionalism as a consequence of market-driven, medicalised and moralistic ideas as well 
as the scale-up of funds for the pandemic, and does not recognise other ideas affecting HIV-
exceptionalism and high-road prioritisation. The model, therefore, ignores how HIV-
exceptionalism and the framing of AIDS as an urgent security issue were essential elements 
for the scale-up of funds to happen in the first place. An idea of sensationalism, reflecting the 
significance   of   framing   and   the   impact   of   donors’   emotional   preferences,   could   therefore  




valuably   be   added   to   Vanwesenbeeck’s   model,   especially   as   this   would   strengthen  
Vanwesenbeeck’s  own  argument  of  the  influence  of  ideas.   
Another limitation  to  Vanwesenbeeck’s model is how it does not explore whether, and if so in 
what way(s), the Global Financial Crisis affected the global AIDS response, which is also the 
third and last sub-question of this study. This question has assisted this study in focusing on a 
possible material and rational explanation for high-road prioritisation, as limited access to 
funds could have enhanced the need for measurable and evidence-based compatible high-road 
approaches for ensuring efficient use of already strained donor money instead of ideas and 
norms of medicalisation, the market and moralism. The Global Financial Crisis is recognised 
as a crucial factor for decreased funds for AIDS after 2008, and it is therefore significant that 
Vanwesenbeeck has not included this event in her model. However, such an undermining of 
ideas cannot explain the growing prominence of biomedical and quantifiable high-road 
approaches before the Global Financial Crisis hit and even as resources became increasingly 
abundant. The importance of securitisation/sensationalism is again demonstrated by these 
ideas’  impact  on  the  scale-up of funds, as well as the scale down when AIDS were considered 
less urgent before or at the same time as the Global Financial Crisis.  
Nevertheless, this study argues that the Global Financial Crisis has affected global AIDS 
responses  and  should   therefore  be   considered   in  Vanwesenbeeck’s  model.  The  exclusion  of  
the Global Financial Crisis from the model is particularly interesting when taking the 
ideational relationship between the neoliberal market and neoliberal medicalised ideas into 
consideration. While Vanwesenbeeck does not elaborate on this link, this ideological 
relationship of neoliberal principles supports the model in the sense that medicalisation and 
high-road prioritisation could be rooted in neoliberal beliefs of cost-efficient management of 
increasingly abundant funds. This is important because the recognition of this link can also 
explain  neoliberalism’s   impact  on  high-road prioritisation and remedicalisation as resources 
became more finite, as the amplified focus on these ideas thus would be based in already 
prominent and existing norms.  
The research sub-questions have thus assisted in exploring the main research question and 
reach   the  conclusion   that  Vanwesenbeeck’s  model  can be identified, valuably elucidate and 
explain certain key developments, political binaries and policy discourses surrounding the 
International AIDS Conferences between 1996 and 2012. This conclusion is based on the 
findings that suggest that high-road approaches indeed seem to be prioritised at the expense of 
low-road   approaches,   especially   from   2006   onwards.   Furthermore,  Vanwesenbeeck’s   claim  




that this development has been affected by medicalised, market-driven and moralistic ideas is 
reasonable. However,  despite  these  contributions,  the  model’s  analytical  utility  is  undermined  
by its neglect of humanitarian and sensational ideas, the Global Financial Crisis and 
neoliberalism as ideology.  
5.4 Recommendations for future research 
As Chapter 1 points out, this study is limited to a restricted timeframe and case study. 
Although the 1996-2012   timeframe   is   aligned   with   Vanwesenbeeck’s   model,   a   test   of   the  
model on a different case study would make for an interesting study, would contribute to the 
existing literature, and would be a good way to triangulate the findings from this study. An 
interesting case study could for instance be the policy documents from and discourses 
surrounding the establishment and evolution of UNAIDS since 1996. 
Furthermore, the constructivist   notion   of   ‘norm   cascades’   can   valuably   elucidate   several  
processes within multilateral and bilateral AIDS agendas and responses. With regards to 
donor dependency, vertically distributed responses and programmes such as PEPFAR, a study 
of   the   ‘norm   cascade’   focus   on   legitimacy   could   give   ideational   depth   to   otherwise   often  
exclusively materialist explanations of financial dependency and the market.  
Lastly, the theories of public policy problematisations and IR constructivism, as elaborated in 
Chapter 2, and their emphasis on inter-subjective understandings and problematisations of 
‘problems’   can   be   useful   theories   for   an   in-depth study where the aim is to understand the 
processes behind HIV-exceptionalism, securitisation/de-securitisation and sensationalism of 
AIDS, as well as the consequent impact on important issues such as sexual and reproductive 
health.  
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